BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305. [PMID: 15385656 DOI: 10.1056/nejmoa041031] [Cited by in Crossref: 7223] [Cited by in F6Publishing: 2767] [Article Influence: 401.3] [Reference Citation Analysis]
Number Citing Articles
1 Shoji T, Akiyama Y, Fujii H, Harada-shiba M, Ishibashi Y, Ishida T, Ishigaki Y, Kabata D, Kihara Y, Kotani K, Kurisu S, Masuda D, Matoba T, Matsuki K, Matsumura T, Mori K, Nakagami T, Nakazato M, Taniuchi S, Ueno H, Yamashita S, Yoshida H, Yoshida H. Association of Kidney Function with Serum Levels of Cholesterol Absorption and Synthesis Markers: The CACHE Study CKD Analysis. JAT. [DOI: 10.5551/jat.63311] [Reference Citation Analysis]
2 Nasif WA, Mukhtar MH, El-Emshaty HM, Alwazna AH. Redox State of Human Serum Albumin and Inflammatory Biomarkers in Hemodialysis Patients with Secondary Hyperparathyroidism During Oral Calcitriol Supplementation for Vitamin D. Open Med Chem J 2018;12:98-110. [PMID: 30450134 DOI: 10.2174/1874104501812010098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Peeters MJ, van den Brand JA, van Zuilen AD, Koster Y, Bots ML, Vervloet MG, Blankestijn PJ, Wetzels JF. Abdominal aortic calcification in patients with CKD. J Nephrol. 2017;30:109-118. [PMID: 27003153 DOI: 10.1007/s40620-015-0260-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
4 Peterson ED, Spertus JA, Cohen DJ, Hlatky MA, Go AS, Vickrey BG, Saver JL, Hinton PC. Vision and creation of the American Heart Association pharmaceutical roundtable outcomes research centers. Circ Cardiovasc Qual Outcomes 2009;2:663-70. [PMID: 20031906 DOI: 10.1161/CIRCOUTCOMES.109.868612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Lee Y, Park S, Lee S, Kim Y, Kang MW, Cho S, Park S, Han K, Kim YC, Han SS, Lee H, Lee JP, Joo KW, Lim CS, Kim YS, Kim DK. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study. PLoS One 2020;15:e0231328. [PMID: 32271842 DOI: 10.1371/journal.pone.0231328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Schrauben SJ, Hsu JY, Amaral S, Anderson AH, Feldman HI, Dember LM. Effect of Kidney Function on Relationships between Lifestyle Behaviors and Mortality or Cardiovascular Outcomes: A Pooled Cohort Analysis. J Am Soc Nephrol 2021;32:663-75. [PMID: 33547215 DOI: 10.1681/ASN.2020040394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Freeman JV, Tabada GH, Reynolds K, Sung SH, Liu TI, Gupta N, Go AS. Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation. Am J Cardiol 2018;121:602-8. [PMID: 29331355 DOI: 10.1016/j.amjcard.2017.11.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
8 Zal B, Chitalia N, Ng YS, Trieu V, Javed S, Warrington R, Kaski JC, Banerjee D, Baboonian C. Killer cell immunoglobulin receptor profile on CD4(+)  CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients. Immunology 2015;145:105-13. [PMID: 25484131 DOI: 10.1111/imm.12429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chand S, Chue CD, Edwards NC, Hodson J, Simmonds MJ, Hamilton A, Gough SC, Harper L, Steeds RP, Townend JN, Ferro CJ, Borrows R. Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease. PLoS One 2015;10:e0116160. [PMID: 25612295 DOI: 10.1371/journal.pone.0116160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
10 Lee SM, An WS. Cardioprotective effects of ω -3 PUFAs in chronic kidney disease. Biomed Res Int 2013;2013:712949. [PMID: 23653897 DOI: 10.1155/2013/712949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
11 Seo YK, Lee H, Kim H, Kim TY, Ryu H, Ju DL, Jang M, Oh KH, Ahn C, Han SN. Foods contributing to nutrients intake and assessment of nutritional status in pre-dialysis patients: a cross-sectional study. BMC Nephrol 2020;21:301. [PMID: 32711448 DOI: 10.1186/s12882-020-01958-8] [Reference Citation Analysis]
12 Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem 2012;58:139-47. [PMID: 22110018 DOI: 10.1373/clinchem.2011.169573] [Cited by in Crossref: 150] [Cited by in F6Publishing: 135] [Article Influence: 13.6] [Reference Citation Analysis]
13 Alkhatib B, Wolfe L, Naidu SS. Hemodynamic Support Devices for Complex Percutaneous Coronary Intervention. Interv Cardiol Clin 2016;5:187-200. [PMID: 28582203 DOI: 10.1016/j.iccl.2015.12.004] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Kujawa-Szewieczek A, Więcek A, Piecha G. The lipid story in chronic kidney disease: a long story with a happy end? Int Urol Nephrol 2013;45:1273-87. [PMID: 23054316 DOI: 10.1007/s11255-012-0296-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Park J. Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system. Cardiol Res Pract. 2012;2012:319432. [PMID: 22919537 DOI: 10.1155/2012/319432] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
16 Hayer MK, Edwards NC, Slinn G, Moody WE, Steeds RP, Ferro CJ, Price AM, Andujar C, Dutton M, Webster R, Webb DJ, Semple S, MacIntyre I, Melville V, Wilkinson IB, Hiemstra TF, Wheeler DC, Herrey A, Grant M, Mehta S, Ives N, Townend JN. A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial. Am Heart J 2017;191:37-46. [PMID: 28888268 DOI: 10.1016/j.ahj.2017.05.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
17 Pun PH, Smarz TR, Honeycutt EF, Shaw LK, Al-Khatib SM, Middleton JP. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int. 2009;76:652-658. [PMID: 19536082 DOI: 10.1038/ki.2009.219] [Cited by in Crossref: 135] [Cited by in F6Publishing: 104] [Article Influence: 10.4] [Reference Citation Analysis]
18 Hoevelmann J, Mahfoud F, Lauder L, Scheller B, Böhm M, Ewen S. Valvular heart disease in patients with chronic kidney disease. Herz 2021;46:228-33. [PMID: 33394059 DOI: 10.1007/s00059-020-05011-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Huang JC, Chen SC, Tsai YC, Kuo IC, Chiu YW, Chang JM, Hwang SJ, Chen HC. Prognostic Significance of Left Ventricular Mass Index and Renal Function Decline Rate in Chronic Kidney Disease G3 and G4. Sci Rep 2017;7:42578. [PMID: 28195182 DOI: 10.1038/srep42578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery. J Am Coll Cardiol 2015;66:1209-20. [PMID: 26361150 DOI: 10.1016/j.jacc.2015.06.1334] [Cited by in Crossref: 81] [Cited by in F6Publishing: 56] [Article Influence: 11.6] [Reference Citation Analysis]
21 Hruska KA, Mathew S, Lund R, Qiu P, Pratt R. Hyperphosphatemia of chronic kidney disease. Kidney Int 2008;74:148-57. [PMID: 18449174 DOI: 10.1038/ki.2008.130] [Cited by in Crossref: 230] [Cited by in F6Publishing: 187] [Article Influence: 16.4] [Reference Citation Analysis]
22 Chan E, Boyle SL, Campbell J, Luke PPW. Ipsilateral renal function preservation following minimally invasive partial nephrectomy: The effect of tumour characteristics and warm ischemic time. Can Urol Assoc J 2017;11:344-9. [PMID: 29382448 DOI: 10.5489/cuaj.4420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
23 Hsiung JT, Kleine CE, Naderi N, Park C, Soohoo M, Moradi H, Rhee CM, Obi Y, Kopple JD, Kovesdy CP, Kalantar-Zadeh K, Streja E. Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis. J Ren Nutr 2019;29:310-21. [PMID: 30642656 DOI: 10.1053/j.jrn.2018.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Hsu RK, Hsu CY. The Role of Acute Kidney Injury in Chronic Kidney Disease. Semin Nephrol 2016;36:283-92. [PMID: 27475659 DOI: 10.1016/j.semnephrol.2016.05.005] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 24.0] [Reference Citation Analysis]
25 Kiuchi MG, Chen S, Paz LMR, Pürerfellner H. Renal sympathetic denervation guided by renal nerve stimulation to treat ventricular arrhythmia in CKD patients with ICD. Oncotarget 2017;8:37296-307. [PMID: 28415795 DOI: 10.18632/oncotarget.16278] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 Bressendorff I, Hansen D, Schou M, Silver B, Pasch A, Bouchelouche P, Pedersen L, Rasmussen LM, Brandi L. Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial. Kidney Int Rep 2017;2:380-9. [PMID: 29142966 DOI: 10.1016/j.ekir.2016.12.008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
27 Astor BC, Levey AS, Stevens LA, Van Lente F, Selvin E, Coresh J. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol 2009;20:2214-22. [PMID: 19762497 DOI: 10.1681/ASN.2008090980] [Cited by in Crossref: 94] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
28 Hu SL, Chang A, Perazella MA, Okusa MD, Jaimes EA, Weiss RH; American Society of Nephrology Onco-Nephrology Forum. The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma. J Am Soc Nephrol 2016;27:2227-37. [PMID: 26961346 DOI: 10.1681/ASN.2015121335] [Cited by in Crossref: 44] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
29 Kato T, Nakayama R, Haba T, Kawaguchi M, Komiya A, Koike H. Oncological and renal outcomes of segmental ureterectomy vs. radical nephroureterectomy for upper tract urothelial carcinoma. Oncol Lett 2018;16:6861-7. [PMID: 30405830 DOI: 10.3892/ol.2018.9463] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Rolla R, De Mauri A, Valsesia A, Vidali M, Chiarinotti D, Bellomo G. Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients. J Nephrol 2015;28:749-55. [PMID: 25971848 DOI: 10.1007/s40620-015-0194-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
31 Reynolds MR, Gong T, Li S, Herzog CA, Charytan DM. Cost-Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease and Acute Coronary Syndromes in the US Medicare Program. J Am Heart Assoc 2021;10:e019391. [PMID: 33787323 DOI: 10.1161/JAHA.120.019391] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Sonmez A, Yilmaz MI, Saglam M, Unal HU, Gok M, Cetinkaya H, Karaman M, Haymana C, Eyileten T, Oguz Y, Vural A, Rizzo M, Toth PP. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease. Lipids Health Dis 2015;14:29. [PMID: 25885289 DOI: 10.1186/s12944-015-0031-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
33 Shroff R, Dégi A, Kerti A, Kis E, Cseprekál O, Tory K, Szabó AJ, Reusz GS. Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol 2013;28:875-84. [PMID: 23070276 DOI: 10.1007/s00467-012-2325-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
34 Milovanova L, Fomin V, Moiseev S, Taranova M, Milovanov Y, Lysenko Kozlovskaya L, Kozlov V, Kozevnikova E, Milovanova S, Lebedeva M, Reshetnikov V. Effect of essential amino acid кetoanalogues and protein restriction diet on morphogenetic proteins (FGF-23 and Кlotho) in 3b-4 stages chronic кidney disease patients: a randomized pilot study. Clin Exp Nephrol 2018;22:1351-9. [PMID: 29948444 DOI: 10.1007/s10157-018-1591-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
35 Hessey E, Morissette G, Lacroix J, Perreault S, Samuel S, Dorais M, Phan V, Jouvet P, Lafrance JP, LeLorier J, Palijan A, Pizzi M, Roy L, Zappitelli M. Healthcare Utilization after Acute Kidney Injury in the Pediatric Intensive Care Unit. Clin J Am Soc Nephrol 2018;13:685-92. [PMID: 29678895 DOI: 10.2215/CJN.09350817] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
36 Garg N, Thomas G, Jackson G, Rickard J, Nally JV Jr, Tang WH, Navaneethan SD. Cardiac resynchronization therapy in CKD: a systematic review. Clin J Am Soc Nephrol 2013;8:1293-303. [PMID: 23660183 DOI: 10.2215/CJN.00750113] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
37 Huang N, Chen J, Fan L, Zhou Q, Xu Q, Xu R, Xiong L, Yu X, Mao H. High peritoneal transport status was not associated with mortality in peritoneal dialysis patients with diabetes. PLoS One 2014;9:e110445. [PMID: 25329459 DOI: 10.1371/journal.pone.0110445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
38 Couser WG, Riella MC; Joint International Society of Nephrology and International Federation of Kidney Foundations World Kidney Day 2011 Steering Committee. Cardiovascular disease: World Kidney Day 2011: protect your kidneys, save your heart. Nat Rev Nephrol 2011;7:130-2. [PMID: 21358694 DOI: 10.1038/nrneph.2011.11] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
39 Lin CJ, Pan CF, Chuang CK, Sun FJ, Wang DJ, Chen HH, Liu HL, Wu CJ. P-cresyl sulfate is a valuable predictor of clinical outcomes in pre-ESRD patients. Biomed Res Int 2014;2014:526932. [PMID: 24592393 DOI: 10.1155/2014/526932] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
40 Chen NX, Kiattisunthorn K, O'Neill KD, Chen X, Moorthi RN, Gattone VH 2nd, Allen MR, Moe SM. Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One 2013;8:e64558. [PMID: 23717629 DOI: 10.1371/journal.pone.0064558] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 7.7] [Reference Citation Analysis]
41 Jalal D, Chonchol M, Etgen T, Sander D. C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease. J Nephrol. 2012;25:719-725. [PMID: 22038335 DOI: 10.5301/jn.5000047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
42 Navarro-garcía JA, Salguero-bodes R, González-lafuente L, Martín-nunes L, Rodríguez-sánchez E, Bada-bosch T, Hernández E, Mérida-herrero E, Praga M, Solís J, Arribas F, Bueno H, Kuro-o M, Fernández-velasco M, Ruilope LM, Delgado C, Ruiz-hurtado G. The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23. BMC Med 2022;20. [DOI: 10.1186/s12916-021-02209-9] [Reference Citation Analysis]
43 de Lusignan S, Gallagher H, Chan T, Thomas N, van Vlymen J, Nation M, Jain N, Tahir A, du Bois E, Crinson I, Hague N, Reid F, Harris K. The QICKD study protocol: a cluster randomised trial to compare quality improvement interventions to lower systolic BP in chronic kidney disease (CKD) in primary care. Implement Sci 2009;4:39. [PMID: 19602233 DOI: 10.1186/1748-5908-4-39] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
44 Hasegawa M, Ishii J, Kitagawa F, Takahashi H, Sugiyama K, Tada M, Kanayama K, Takahashi K, Hayashi H, Koide S, Nakai S, Ozaki Y, Yuzawa Y. Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney Disease. Biomed Res Int 2016;2016:8761475. [PMID: 27051671 DOI: 10.1155/2016/8761475] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
45 Kon V, Linton MF, Fazio S. Atherosclerosis in chronic kidney disease: the role of macrophages. Nat Rev Nephrol. 2011;7:45-54. [PMID: 21102540 DOI: 10.1038/nrneph.2010.157] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
46 Mut TT, Acar Ö, Armutlu A, Incir S, Uhlig A, Ertuglu LA, Özel M, Taskin AC, Baydar DE, Kanbay M, Esen T. Can remote ischemic preconditioning counteract the renal functional deterioration attributable to partial nephrectomy under warm ischemia? Results of an animal study. BMC Nephrol 2021;22:266. [PMID: 34271871 DOI: 10.1186/s12882-021-02359-1] [Reference Citation Analysis]
47 Gnudi L, Karalliedde J. Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents. Nephrol Dial Transplant 2016;31:1036-43. [PMID: 25858586 DOI: 10.1093/ndt/gfv093] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
48 Lunyera J, Davenport CA, Bhavsar NA, Sims M, Scialla J, Pendergast J, Hall R, Tyson CC, Russell JSC, Wang W, Correa A, Boulware LE, Diamantidis CJ. Nondepressive Psychosocial Factors and CKD Outcomes in Black Americans. Clin J Am Soc Nephrol 2018;13:213-22. [PMID: 29298761 DOI: 10.2215/CJN.06430617] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
49 Landau D, Schreiber R, Kleinman A, Vodonos A, Shalev H. Pediatric chronic kidney disease rates in Southern Israel are higher than reported. F1000Res 2013;2:186. [PMID: 24555088 DOI: 10.12688/f1000research.2-186.v1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Asserraji M, Maoujoud O, Belarbi M, Oualim Z. [Epidemiological profile of end stage renal disease at the Military Hospital in Rabat, Morocco]. Pan Afr Med J 2015;20:439. [PMID: 26309471 DOI: 10.11604/pamj.2015.20.439.3352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Jesky M, Lambert A, Burden AC, Cockwell P. The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study. BMJ Open 2013;3:e003458. [PMID: 24302500 DOI: 10.1136/bmjopen-2013-003458] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
52 Wan H, Wang J, Yang Y, Fan X, Chen D, Bian N. Impact of estimated glomerular filtration rate on long-term clinical outcomes among Chinese patients with atrial fibrillation. BMC Cardiovasc Disord 2020;20:490. [PMID: 33213382 DOI: 10.1186/s12872-020-01786-6] [Reference Citation Analysis]
53 Miyazaki H, Babazono A, Nishi T, Maeda T, Imatoh T, Ichiba M, Une H. Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease? BMC Pharmacol Toxicol 2015;16:22. [PMID: 26362195 DOI: 10.1186/s40360-015-0024-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Kim J, Yun KS, Cho A, Kim DH, Lee YK, Choi MJ, Kim SH, Kim H, Yoon JW, Park HC. High cortisol levels are associated with oxidative stress and mortality in maintenance hemodialysis patients. BMC Nephrol 2022;23:98. [PMID: 35260104 DOI: 10.1186/s12882-022-02722-w] [Reference Citation Analysis]
55 Mukundan S, Steigner ML, Hsiao LL, Malek SK, Tullius SG, Chin MS, Siedlecki AM. Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD. Am J Kidney Dis 2016;67:984-8. [PMID: 26786296 DOI: 10.1053/j.ajkd.2015.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
56 Kuemmerli C, Habrina D, Puchner S, Laminger F, Werzowa J, Roka S. Primary External Stenting of an Autogenous Brachial-Basilic Upper Arm Transposition. Ann Vasc Surg 2020;65:288.e1-4. [PMID: 31778764 DOI: 10.1016/j.avsg.2019.11.033] [Reference Citation Analysis]
57 Higashihara T, Nishi H, Takemura K, Watanabe H, Maruyama T, Inagi R, Tanaka T, Nangaku M. β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice. Sci Rep 2021;11:9130. [PMID: 33911115 DOI: 10.1038/s41598-021-88438-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Choi H, Lee WW, So Y, Ha S, Byun SS, Kim SE. Tc-99m Hydroxymethylene Diphosphonate (HMDP) Renal Uptake as a Surrogate Marker of Postoperative Impairment of the Glomerular Filtration Rate in Renal Tumor Patients Following Nephron-Sparing Surgery. Nucl Med Mol Imaging 2014;48:262-71. [PMID: 26396630 DOI: 10.1007/s13139-014-0284-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Ryoo JH, Kim SG, Suh BS, Kim DI, Park SK. Relationship between chronic kidney disease and risk of coronary heart disease in Korean men. J Korean Med Sci 2011;26:753-8. [PMID: 21655060 DOI: 10.3346/jkms.2011.26.6.753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
60 Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T. Cause-specific mortality in the general population with transient dipstick-proteinuria. PLoS One 2019;14:e0223005. [PMID: 31577820 DOI: 10.1371/journal.pone.0223005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
61 Catar R, Moll G, Kamhieh-Milz J, Luecht C, Chen L, Zhao H, Ernst L, Willy K, Girndt M, Fiedler R, Witowski J, Morawietz H, Ringdén O, Dragun D, Eckardt KU, Schindler R, Zickler D. Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling. Front Immunol 2021;12:774052. [PMID: 34858433 DOI: 10.3389/fimmu.2021.774052] [Reference Citation Analysis]
62 Wolf M, Auerbach M, Kalra PA, Glaspy J, Thomsen LL, Bhandari S. Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials. Am J Hematol 2021;96:E11-5. [PMID: 33027541 DOI: 10.1002/ajh.26015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Heyse A, Manhaeghe L, Mahieu E, Vanfraechem C, Van Durme F. Sacubitril/valsartan in heart failure and end-stage renal insufficiency. ESC Heart Fail 2019;6:1331-3. [PMID: 31668014 DOI: 10.1002/ehf2.12544] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
64 Klomjit N, Lerman A, Lerman LO. It Comes As a Shock: Kidney Repair Using Shockwave Therapy. Hypertension 2020;76:1696-703. [PMID: 33131308 DOI: 10.1161/HYPERTENSIONAHA.120.14595] [Reference Citation Analysis]
65 Zha Y, Qian Q. Protein Nutrition and Malnutrition in CKD and ESRD. Nutrients 2017;9:E208. [PMID: 28264439 DOI: 10.3390/nu9030208] [Cited by in Crossref: 72] [Cited by in F6Publishing: 51] [Article Influence: 14.4] [Reference Citation Analysis]
66 Smaldone MC, Churukanti G, Simhan J, Kim SP, Reyes J, Zhu F, Kutikov A, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment. Urology 2013;81:269-75. [PMID: 23374778 DOI: 10.1016/j.urology.2012.09.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
67 Guzzo TJ. Small renal masses: the promise of thulium laser enucleation partial nephrectomy. Nat Rev Urol 2013;10:259-60. [PMID: 23609849 DOI: 10.1038/nrurol.2013.88] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
68 Jansz TT, Özyilmaz A, Grooteman MPC, Hoekstra T, Romijn M, Blankestijn PJ, Bots ML, van Jaarsveld BC. Long-term clinical parameters after switching to nocturnal haemodialysis: a Dutch propensity-score-matched cohort study comparing patients on nocturnal haemodialysis with patients on three-times-a-week haemodialysis/haemodiafiltration. BMJ Open 2018;8:e019900. [PMID: 29523566 DOI: 10.1136/bmjopen-2017-019900] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
69 Ishigami J, Grams ME, Naik RP, Coresh J, Matsushita K. Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study. Clin J Am Soc Nephrol. 2016;11:1735-1743. [PMID: 27515592 DOI: 10.2215/cjn.02170216] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
70 Nagai K, Hosoi T, Nakajima K, Arai T, Nakamura Y. Screening for chronic kidney disease over hospital integration. J Gen Fam Med 2020;21:294-5. [PMID: 33304733 DOI: 10.1002/jgf2.375] [Reference Citation Analysis]
71 Li CH, Chen HJ, Chen WC, Tu CY, Hsia TC, Hsu WH, Chang CT, Huang CC, Bau DT, Chou CY. The Risk of Tuberculosis Infection in Non-dialysis Chronic Kidney Disease Patients. Front Med (Lausanne) 2021;8:715010. [PMID: 34485344 DOI: 10.3389/fmed.2021.715010] [Reference Citation Analysis]
72 Shaw C, Nitsch D, Steenkamp R, Junghans C, Shah S, O'Donoghue D, Fogarty D, Weston C, Sharpe CC. Inpatient coronary angiography and revascularisation following non-ST-elevation acute coronary syndrome in patients with renal impairment: a cohort study using the Myocardial Ischaemia National Audit Project. PLoS One 2014;9:e99925. [PMID: 24937680 DOI: 10.1371/journal.pone.0099925] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
73 Koch V, Weber C, Riffel JH, Buchner K, Buss SJ, Hein S, Mereles D, Hagenmueller M, Erbel C, März W, Booz C, Albrecht MH, Vogl TJ, Frey N, Hardt SE, Ochs M. Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure. J Cardiovasc Pharmacol Ther 2022;27:10742484211054620. [PMID: 34994208 DOI: 10.1177/10742484211054620] [Reference Citation Analysis]
74 Gonzalez K, Ulloa JG, Moreno G, Echeverría O, Norris K, Talamantes E. Intensive procedure preferences at the end of life (EOL) in older Latino adults with end stage renal disease (ESRD) on dialysis. BMC Nephrol 2017;18:319. [PMID: 29061178 DOI: 10.1186/s12882-017-0739-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Silswal N, Touchberry CD, Daniel DR, McCarthy DL, Zhang S, Andresen J, Stubbs JR, Wacker MJ. FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. Am J Physiol Endocrinol Metab 2014;307:E426-36. [PMID: 25053401 DOI: 10.1152/ajpendo.00264.2014] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 12.8] [Reference Citation Analysis]
76 Lerma E, White WB, Bakris G. Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease. Postgrad Med 2022. [PMID: 35392754 DOI: 10.1080/00325481.2022.2060598] [Reference Citation Analysis]
77 Yuan Z, Zhao M, Zhang B, Zhang H, Zhang X, Guan Q, Ning G, Gao L, Xue F, Zhao J. Thyroid function modifies the association between ratio of triglyceride to high-density lipoprotein cholesterol and renal function: a multicenter cross-sectional study. Sci Rep 2015;5:11052. [PMID: 26179571 DOI: 10.1038/srep11052] [Reference Citation Analysis]
78 Yoshida T, Kato K, Yokoi K, Oguri M, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Nozawa Y, Yamada Y. Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus. Exp Ther Med 2010;1:137-45. [PMID: 23136606 DOI: 10.3892/etm_00000023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
79 Trimarchi H, Muryan A, Raña MS, Paggi P, Lombi F, Forrester M, Pomeranz V, Karl A, Alonso M, Young P, Dicugno M. Proteinuria and its relation to diverse biomarkers and body mass index in chronic hemodialysis. Int J Nephrol Renovasc Dis 2013;6:113-9. [PMID: 23843697 DOI: 10.2147/IJNRD.S47292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
80 Steinberg PL, Munver R, Ghavamian R. Impact of repeated hilar clamping on renal function during laparoscopic and robot-assisted partial nephrectomy. J Endourol 2011;25:1525-30. [PMID: 21815808 DOI: 10.1089/end.2010.0657] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
81 Wyld MLR, Morton RL, Clayton P, Wong MG, Jardine M, Polkinghorne K, Chadban S. The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study. Qual Life Res 2019;28:2081-90. [PMID: 30937731 DOI: 10.1007/s11136-019-02173-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
82 Glassock RJ, Rule AD. Optimally predicting mortality with kidney function markers is not the same as optimally determining how kidney function predicts mortality. Nephrol Dial Transplant 2017;32:585-7. [PMID: 28339938 DOI: 10.1093/ndt/gfx007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
83 Ma YR, Xin MY, Li K, Wang H, Rao Z, Liu TX, Wu XA. An LC-MS/MS analytical method for the determination of uremic toxins in patients with end-stage renal disease. J Pharm Biomed Anal 2020;191:113551. [PMID: 32889350 DOI: 10.1016/j.jpba.2020.113551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Sena BF, Figueiredo JL, Aikawa E. Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease. Front Cardiovasc Med 2017;4:88. [PMID: 29379789 DOI: 10.3389/fcvm.2017.00088] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
85 Mirrakhimov AE. Obstructive sleep apnea and kidney disease: is there any direct link? Sleep Breath 2012;16:1009-16. [PMID: 22170216 DOI: 10.1007/s11325-011-0624-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
86 Simhan J, Smaldone MC, Egleston BL, Canter D, Sterious SN, Corcoran AT, Ginzburg S, Uzzo RG, Kutikov A. Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU Int 2014;114:216-20. [PMID: 24053485 DOI: 10.1111/bju.12341] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
87 Kelly TN, Raj D, Rahman M, Kretzler M, Kallem RR, Ricardo AC, Rosas SE, Tao K, Xie D, Hamm LL, He J; CRIC Study Investigators. The role of renin-angiotensin-aldosterone system genes in the progression of chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Nephrol Dial Transplant 2015;30:1711-8. [PMID: 25906781 DOI: 10.1093/ndt/gfv125] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
88 Boris R, Proano M, Linehan WM, Pinto PA, Bratslavsky G. Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol 2009;182:1280-6. [PMID: 19683275 DOI: 10.1016/j.juro.2009.06.036] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
89 D'Marco L, Salazar J, Cortez M, Salazar M, Wettel M, Lima-Martínez M, Rojas E, Roque W, Bermúdez V. Perirenal fat thickness is associated with metabolic risk factors in patients with chronic kidney disease. Kidney Res Clin Pract 2019;38:365-72. [PMID: 31357262 DOI: 10.23876/j.krcp.18.0155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
90 Grams ME, Plantinga LC, Hedgeman E, Saran R, Myers GL, Williams DE, Powe NR; CDC CKD Surveillance Team. Validation of CKD and related conditions in existing data sets: A systematic review. Am J Kidney Dis 2011;57:44-54. [PMID: 20692079 DOI: 10.1053/j.ajkd.2010.05.013] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
91 Hall RK, Sloane R, Pieper C, Van Houtven C, LaFleur J, Adler R, Colón-Emeric C. Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease. J Am Geriatr Soc 2018;66:532-8. [PMID: 29319880 DOI: 10.1111/jgs.15256] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
92 Horii T, Iwasawa M, Kabeya Y, Shimizu J, Atsuda K. Investigating the risk of bone fractures in elderly patients with type 2 diabetes mellitus: a retrospective study. BMC Endocr Disord 2019;19:81. [PMID: 31349845 DOI: 10.1186/s12902-019-0413-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Mizushiri S, Daimon M, Murakami H, Kamba A, Osonoi S, Yamaichi M, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Tokuda I, Kurauchi S, Sawada K. Lower serum calcium levels are a risk factor for a decrease in eGFR in a general non-chronic kidney disease population. Sci Rep 2018;8:14213. [PMID: 30242201 DOI: 10.1038/s41598-018-32627-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
94 Martins D, Agodoa L, Norris K. Kidney disease in disadvantaged populations. Int J Nephrol 2012;2012:469265. [PMID: 22567281 DOI: 10.1155/2012/469265] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
95 Freedman BI, Gadegbeku CA, Bryan RN, Palmer ND, Hicks PJ, Ma L, Rocco MV, Smith SC, Xu J, Whitlow CT, Wagner BC, Langefeld CD, Hawfield AT, Bates JT, Lerner AJ, Raj DS, Sadaghiani MS, Toto RD, Wright JT Jr, Bowden DW, Williamson JD, Sink KM, Maldjian JA, Pajewski NM, Divers J. APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume. Kidney Int 2016;90:440-9. [PMID: 27342958 DOI: 10.1016/j.kint.2016.04.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
96 Sciacqua A, Perticone M, Tassone EJ, Cimellaro A, Caroleo B, Miceli S, Andreucci M, Licata A, Sesti G, Perticone F. Renal function is impaired in normotensive chronic HCV patients: role of insulin resistance. Intern Emerg Med 2016;11:553-9. [PMID: 26597876 DOI: 10.1007/s11739-015-1349-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
97 Vida C, Carracedo J, de Sequera P, Bodega G, Pérez R, Alique M, Ramírez R. A high magnesium concentration in citrate dialysate prevents oxidative stress and damage in human monocytes in vitro. Clin Kidney J 2021;14:1403-11. [PMID: 33959268 DOI: 10.1093/ckj/sfaa131] [Reference Citation Analysis]
98 Smaldone MC, Egleston B, Uzzo RG, Kutikov A. Does partial nephrectomy result in a durable overall survival benefit in the Medicare population? J Urol 2012;188:2089-94. [PMID: 23083877 DOI: 10.1016/j.juro.2012.07.099] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
99 Luo R, Zhang W, Zhao C, Zhang Y, Wu H, Jin J, Zhang W, Grenz A, Eltzschig HK, Tao L, Kellems RE, Xia Y. Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease. Hypertension 2015;66:75-84. [PMID: 25987665 DOI: 10.1161/HYPERTENSIONAHA.115.05578] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
100 Aminzadeh MA, Reisman SA, Vaziri ND, Shelkovnikov S, Farzaneh SH, Khazaeli M, Meyer CJ. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease. Redox Biol 2013;1:527-31. [PMID: 24363993 DOI: 10.1016/j.redox.2013.10.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
101 Tsai IT, Wang CP, Lu YC, Hung WC, Wu CC, Lu LF, Chung FM, Hsu CC, Lee YJ, Yu TH. The burden of major adverse cardiac events in patients with coronary artery disease. BMC Cardiovasc Disord 2017;17:1. [PMID: 28052754 DOI: 10.1186/s12872-016-0436-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
102 Tuot DS, Rubinsky AD, Velasquez A, McCulloch CE, Schillinger D, Handley MA, Hsu CY, Powe NR. Interventions to Improve Blood Pressure Control Among Socioeconomically Disadvantaged Patients With CKD: Kidney Awareness Registry and Education Pilot Randomized Controlled Trial. Kidney Med 2019;1:242-52. [PMID: 32734204 DOI: 10.1016/j.xkme.2019.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
103 Panetta CJ, Herzog CA, Henry TD. Acute coronary syndromes in patients with renal disease: what are the issues? Curr Cardiol Rep 2006;8:296-300. [PMID: 16822365 DOI: 10.1007/s11886-006-0062-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
104 Walker RC, Marshall MR, Polaschek NR. A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: a quality improvement report. BMC Fam Pract 2014;15:155. [PMID: 25239726 DOI: 10.1186/1471-2296-15-155] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
105 Fesler P, Mimran A. Estimation of glomerular filtration rate: what are the pitfalls? Curr Hypertens Rep 2011;13:116-21. [PMID: 21207252 DOI: 10.1007/s11906-010-0176-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
106 Doris PA. Genetic susceptibility to hypertensive renal disease. Cell Mol Life Sci 2012;69:3751-63. [PMID: 22562581 DOI: 10.1007/s00018-012-0996-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
107 Hoogeveen EK, Geleijnse JM, Kromhout D, Stijnen T, Gemen EF, Kusters R, Giltay EJ. Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial. Clin J Am Soc Nephrol 2014;9:1676-83. [PMID: 25104273 DOI: 10.2215/CJN.10441013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
108 Wu X, Yang X, Liu X, Yi C, Guo Q, Feng X, Mao H, Huang F, Yu X. Patient Survival and Technique Failure in Continuous Ambulatory Peritoneal Dialysis Patients with Prior Stroke. Perit Dial Int 2016;36:308-14. [PMID: 26634563 DOI: 10.3747/pdi.2014.00030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
109 Zheng Y, Tang Z, You L, Wu Y, Liu J, Xue J. Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis. Ren Fail 2020;42:580-6. [PMID: 32576072 DOI: 10.1080/0886022X.2020.1781170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
110 Fink JC, Brown J, Hsu VD, Seliger SL, Walker L, Zhan M. CKD as an underrecognized threat to patient safety. Am J Kidney Dis 2009;53:681-8. [PMID: 19246142 DOI: 10.1053/j.ajkd.2008.12.016] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
111 Liu KD, Yang J, Tan TC, Glidden DV, Zheng S, Pravoverov L, Hsu CY, Go AS. Risk Factors for Recurrent Acute Kidney Injury in a Large Population-Based Cohort. Am J Kidney Dis 2019;73:163-73. [PMID: 30482577 DOI: 10.1053/j.ajkd.2018.08.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
112 Weiner S, Fink JC. Telemedicine to Promote Patient Safety: Use of Phone-Based Interactive Voice-Response System to Reduce Adverse Safety Events in Pre-dialysis CKD. Adv Chronic Kidney Dis 2017;24:31-8. [PMID: 28224940 DOI: 10.1053/j.ackd.2016.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
113 Cohen EP, Krzesinski JM. C-reactive protein and dialysis access. Kidney Int 2009;76:1025-6. [PMID: 19876056 DOI: 10.1038/ki.2009.301] [Reference Citation Analysis]
114 Textor SC, Schwartz GL. BP Targets in CKD, Mortality, and SPRINT: What Have We Learned? J Am Soc Nephrol 2017;28:2561-3. [PMID: 28729287 DOI: 10.1681/ASN.2017060652] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
115 Stringer S, Sharma P, Dutton M, Jesky M, Ng K, Kaur O, Chapple I, Dietrich T, Ferro C, Cockwell P. The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrol 2013;14:95. [PMID: 23617441 DOI: 10.1186/1471-2369-14-95] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
116 Schulz CA, Persson M, Christensson A, Hindy G, Almgren P, Nilsson PM, Melander O, Engström G, Orho-Melander M. Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study. Kidney Int Rep 2017;2:239-47. [PMID: 28367534 DOI: 10.1016/j.ekir.2016.11.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
117 Norris KC, Nicholas SB. Strategies for Controlling Blood Pressure and Reducing Cardiovascular Disease Risk in Patients with Chronic Kidney Disease. Ethn Dis 2015;25:515-20. [PMID: 26675050 DOI: 10.18865/ed.25.4.515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
118 Nielen MM, Schellevis FG, Verheij RA. The usefulness of a free self-test for screening albuminuria in the general population: a cross-sectional survey. BMC Public Health 2009;9:381. [PMID: 19818129 DOI: 10.1186/1471-2458-9-381] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
119 Jacobs BL, Tan HJ, Montgomery JS, Weizer AZ, Wood DP, Miller DC, Wolf JS Jr, Hafez KS. Understanding criteria for surveillance of patients with a small renal mass. Urology 2012;79:1027-32. [PMID: 22546379 DOI: 10.1016/j.urology.2011.12.052] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
120 Liabeuf S, Desjardins L, Diouf M, Temmar M, Renard C, Choukroun G, Massy ZA. The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease. PLoS One. 2015;10:e0131707. [PMID: 26181592 DOI: 10.1371/journal.pone.0131707] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
121 Van Pottelbergh G, Den Elzen WP, Degryse J, Gussekloo J. Prediction of mortality and functional decline by changes in eGFR in the very elderly: the Leiden 85-plus study. BMC Geriatr 2013;13:61. [PMID: 23777458 DOI: 10.1186/1471-2318-13-61] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
122 Memmos E, Sarafidis P, Pateinakis P, Tsiantoulas A, Faitatzidou D, Giamalis P, Vasilikos V, Papagianni A. Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis. BMC Nephrol 2019;20:217. [PMID: 31185930 DOI: 10.1186/s12882-019-1391-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
123 Bruno G, Merletti F, Bargero G, Novelli G, Melis D, Soddu A, Perotto M, Pagano G, Cavallo-Perin P. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia. 2007;50:941-948. [PMID: 17333106 DOI: 10.1007/s000125-007-0616-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Kawamoto R, Kikuchi A, Akase T, Ninomiya D, Tokumoto Y, Kumagi T. Alcohol consumption and serum uric acid are synergistically associated with renal dysfunction among community-dwelling persons. J Clin Lab Anal 2021;35:e23812. [PMID: 33960442 DOI: 10.1002/jcla.23812] [Reference Citation Analysis]
125 Assi LK, McIntyre N, Fraser S, Harris S, Hutchison CA, McIntyre CW, Cockwell P, Taal MW. The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease. PLoS One 2015;10:e0129980. [PMID: 26132658 DOI: 10.1371/journal.pone.0129980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
126 Schroers JE, Shanmugalingam R, Lee G, Rutherford D, Makris A. Prevalence of long term metabolic, cardiovascular, cerebrovascular and renal disease in patients with hypertensive disorders in pregnancy remote from pregnancy (POMCH). Pregnancy Hypertension 2022;28:162-7. [DOI: 10.1016/j.preghy.2022.04.004] [Reference Citation Analysis]
127 Hall G, Wang L, Spurney RF. TRPC Channels in Proteinuric Kidney Diseases. Cells 2019;9:E44. [PMID: 31877991 DOI: 10.3390/cells9010044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
128 McPherson R, Frohlich J, Fodor G, Genest J, Canadian Cardiovascular Society. Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006;22:913-27. [PMID: 16971976 DOI: 10.1016/s0828-282x(06)70310-5] [Cited by in Crossref: 200] [Cited by in F6Publishing: 78] [Article Influence: 12.5] [Reference Citation Analysis]
129 Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF. Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. J Am Soc Nephrol. 2015;26:2328-2339. [PMID: 25967123 DOI: 10.1681/asn.2015020117] [Cited by in Crossref: 86] [Cited by in F6Publishing: 56] [Article Influence: 12.3] [Reference Citation Analysis]
130 Agarwal R, Song RJ, Vasan RS, Xanthakis V. Left Ventricular Mass and Incident Chronic Kidney Disease. Hypertension 2020;75:702-6. [PMID: 31928112 DOI: 10.1161/HYPERTENSIONAHA.119.14258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
131 Koiwa F, Yokoyama K, Fukagawa M, Akizawa T. Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients. Kidney Int Rep 2018;3:185-92. [PMID: 29340330 DOI: 10.1016/j.ekir.2017.10.003] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
132 Goto T, Kawasaki Y, Takemoto J, Abe Y, Namima T. Evaluating estimated glomerular filtration rates of creatinine and cystatin C for male patients with chronic spinal cord injury. Spinal Cord 2018;56:447-52. [PMID: 29321550 DOI: 10.1038/s41393-017-0045-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
133 Amadi CE, Mbakwem AC, Kushimo OA, Ajuluchukwu JN, Akinkunmi M. Prevalence of positive chronic kidney Disease screening in professional male long haul drivers at risk of cardiovascular Disease in Lagos, Nigeria: a cross-section study. BMC Public Health 2019;19:1032. [PMID: 31370832 DOI: 10.1186/s12889-019-7328-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Price AM, Moody WE, Stoll VM, Vijapurapu R, Hayer MK, Biasiolli L, Weston CJ, Webster R, Wesolowski R, McGee KC, Liu B, Baig S, Pickup LC, Radhakrishnan A, Law JP, Edwards NC, Steeds RP, Ferro CJ, Townend JN. Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors at 5 Years. Hypertension 2021;77:1273-84. [PMID: 33550822 DOI: 10.1161/HYPERTENSIONAHA.120.15398] [Reference Citation Analysis]
135 Dai D, Alvarez PJ, Woods SD. A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure Using a Large Administrative Claims Database. Clinicoecon Outcomes Res 2021;13:475-86. [PMID: 34113139 DOI: 10.2147/CEOR.S313857] [Reference Citation Analysis]
136 Briet M, Collin C, Karras A, Laurent S, Bozec E, Jacquot C, Stengel B, Houillier P, Froissart M, Boutouyrie P; Nephrotest Study Group. Arterial remodeling associates with CKD progression. J Am Soc Nephrol 2011;22:967-74. [PMID: 21493771 DOI: 10.1681/ASN.2010080863] [Cited by in Crossref: 99] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
137 Singh V, Deedwania P. Reducing morbidity and mortality in high risk patients with statins. Vasc Health Risk Manag 2009;5:495-507. [PMID: 19554090 DOI: 10.2147/vhrm.s3389] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
138 Kim KH, Lee HH, Yoon YE, Na JC, Kim KS, Han WK. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker. Investig Clin Urol 2019;60:425-31. [PMID: 31692952 DOI: 10.4111/icu.2019.60.6.425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
139 Knop W, Serwin NM, Cecerska-Heryć E, Grygorcewicz B, Dołęgowska B, Gomółka A, Wiśniewska M, Ciechanowski K. Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease. Biomolecules 2021;11:1514. [PMID: 34680147 DOI: 10.3390/biom11101514] [Reference Citation Analysis]
140 Husain SA, Willey JZ, Park Moon Y, Elkind MSV, Sacco RL, Wolf M, Cheung K, Wright CB, Mohan S. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study. PLoS One 2018;13:e0206839. [PMID: 30427947 DOI: 10.1371/journal.pone.0206839] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
141 Tsujimoto T, Kajio H, Takahashi Y, Kishimoto M, Noto H, Yamamoto-Honda R, Kamimura M, Morooka M, Kubota K, Shimbo T, Hiroe M, Noda M. Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study. BMJ Open 2011;1:e000139. [PMID: 22021872 DOI: 10.1136/bmjopen-2011-000139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
142 Kose E, An T, Kikkawa A, Hayashi H. Early rehospitalization after initial chronic kidney disease educational hospitalization relates with a multidisciplinary medical team. J Pharm Health Care Sci 2016;2:27. [PMID: 27800173 DOI: 10.1186/s40780-016-0061-8] [Reference Citation Analysis]
143 Wong E, Ballew SH, Daya N, Ishigami J, Rebholz CM, Matsushita K, Grams ME, Coresh J. Hospitalization Risk among Older Adults with Chronic Kidney Disease. Am J Nephrol 2019;50:212-20. [PMID: 31311014 DOI: 10.1159/000501539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
144 O'Leary JM, Assad TR, Xu M, Birdwell KA, Farber-Eger E, Wells QS, Hemnes AR, Brittain EL. Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes. Pulm Circ 2017;7:674-83. [PMID: 28660793 DOI: 10.1177/2045893217716108] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
145 Fujita Y, Ichikawa D, Sugaya T, Ohata K, Tanabe J, Inoue K, Hoshino S, Togo T, Watanabe M, Kimura K, Shibagaki Y, Kamijo-Ikemori A. Angiotensin II type 1a receptor loss ameliorates chronic tubulointerstitial damage after renal ischemia reperfusion. Sci Rep 2021;11:982. [PMID: 33441837 DOI: 10.1038/s41598-020-80209-0] [Reference Citation Analysis]
146 Bernstein DE, Tran A, Martin P, Kowdley KV, Bourliere M, Sulkowski MS, Pockros PJ, Renjifo B, Wang D, Shuster DL, Cohen DE, Jacobson IM. Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease. Kidney Int Rep 2019;4:245-56. [PMID: 30775621 DOI: 10.1016/j.ekir.2018.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
147 Liu KD, Hsu CY, Yang J, Tan TC, Zheng S, Ordonez JD, Go AS. Acute Kidney Injury Ascertainment Is Affected by the Use of First Inpatient Versus Outpatient Baseline Serum Creatinine. Kidney Int Rep 2018;3:211-5. [PMID: 29340333 DOI: 10.1016/j.ekir.2017.08.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
148 Ochiai H, Shirasawa T, Yoshimoto T, Nagahama S, Sakamoto K, Azuma M, Kokaze A. Hepatic Steatosis Index and Chronic Kidney Disease among Middle-Aged Individuals: A Large-Scale Study in Japan. Dis Markers 2021;2021:9941834. [PMID: 34211614 DOI: 10.1155/2021/9941834] [Reference Citation Analysis]
149 Platania I, Terranova V, Tomasello SD, Boukhris M, Cilia C, Di Marca S, Pisano M, Mastrosimone G, Cataudella E, Stancanelli B, Malatino L. Mean Transaortic Gradient is an Emerging Predictor of Chronic Kidney Disease in Elderly Patients. Angiology 2017;68:528-34. [DOI: 10.1177/0003319716672527] [Reference Citation Analysis]
150 Tanaka K, Nakayama M, Kanno M, Kimura H, Watanabe K, Tani Y, Hayashi Y, Asahi K, Terawaki H, Watanabe T. Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial. Clin Exp Nephrol 2015;19:1044-53. [PMID: 25676011 DOI: 10.1007/s10157-015-1095-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 7.9] [Reference Citation Analysis]
151 Itano Y, Sobajima H, Ohashi N, Shibata T, Fujiya A, Nagata T, Ando M, Imaizumi T, Kubo Y, Ozeki T, Katsuno T, Kato S, Yasuda Y, Maruyama S. High urinary glucose is associated with improved renal prognosis in patients with diabetes mellitus. J Diabetes Investig 2021;12:998-1006. [PMID: 33034138 DOI: 10.1111/jdi.13428] [Reference Citation Analysis]
152 Willems JM, Vlasveld T, den Elzen WP, Westendorp RG, Rabelink TJ, de Craen AJ, Blauw GJ. Performance of Cockcroft-Gault, MDRD, and CKD-EPI in estimating prevalence of renal function and predicting survival in the oldest old. BMC Geriatr 2013;13:113. [PMID: 24160772 DOI: 10.1186/1471-2318-13-113] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
153 Chang SH, Tsai CT, Yen AM, Lei MH, Chen HH, Tseng CD. Proteinuria and Reduced Estimated Glomerular Filtration Rate Independently Predict Risk for Acute Myocardial Infarction: Findings from a Population-Based Study in Keelung, Taiwan. Acta Cardiol Sin 2015;31:106-12. [PMID: 27122856 DOI: 10.6515/acs20141201a] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Hayashi T, Kimura T, Yasuda K, Sasaki K, Obi Y, Rakugi H, Isaka Y. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy. Clin Exp Nephrol 2017;21:333-41. [PMID: 27178276 DOI: 10.1007/s10157-016-1278-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
155 Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 2010;21:1641-4. [PMID: 20616170 DOI: 10.1681/ASN.2010030253] [Cited by in Crossref: 122] [Cited by in F6Publishing: 66] [Article Influence: 10.2] [Reference Citation Analysis]
156 Chen DC, Shlipak MG, Scherzer R, Bauer SR, Potok OA, Rifkin DE, Ix JH, Muiru AN, Hsu CY, Estrella MM. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality. JAMA Netw Open 2022;5:e2148940. [PMID: 35175342 DOI: 10.1001/jamanetworkopen.2021.48940] [Reference Citation Analysis]
157 Bansal N, Roy J, Chen HY, Deo R, Dobre M, Fischer MJ, Foster E, Go AS, He J, Keane MG, Kusek JW, Mohler E, Navaneethan SD, Rahman M, Hsu CY; CRIC Study Investigators. Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study. Am J Kidney Dis 2018;72:390-9. [PMID: 29784617 DOI: 10.1053/j.ajkd.2018.02.363] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
158 Charytan DM, Zelevinsky K, Wolf R, Normand ST. All-Cause Mortality and Progression to End-Stage Kidney Disease Following Percutaneous Revascularization or Surgical Coronary Revascularization in Patients with CKD. Kidney Int Rep 2021;6:1580-91. [PMID: 34169198 DOI: 10.1016/j.ekir.2021.03.882] [Reference Citation Analysis]
159 Jalal D, Sanford B, Renner B, Ten Eyck P, Laskowski J, Cooper J, Sun M, Zakharia Y, Spitz D, Dokun A, Attanasio M, Jones K, Thurman JM. Detection of pro angiogenic and inflammatory biomarkers in patients with CKD. Sci Rep 2021;11:8786. [PMID: 33888746 DOI: 10.1038/s41598-021-87710-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Xu JP, Zeng RX, Liao PD, Zhang MZ. Effect of lanthanum carbonate on the progression of coronary artery calcification in hemodialysis patients: A meta-analysis of randomized controlled trials. Hemodial Int 2021. [PMID: 34897963 DOI: 10.1111/hdi.12988] [Reference Citation Analysis]
161 Lessey G, Stavropoulos K, Papademetriou V. Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus. Vasc Health Risk Manag 2019;15:365-73. [PMID: 31686830 DOI: 10.2147/VHRM.S203925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
162 Mills KT, Hamm LL, Alper AB, Miller C, Hudaihed A, Balamuthusamy S, Chen CS, Liu Y, Tarsia J, Rifai N, Kleinpeter M, He J, Chen J. Circulating adipocytokines and chronic kidney disease. PLoS One 2013;8:e76902. [PMID: 24116180 DOI: 10.1371/journal.pone.0076902] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
163 Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV Jr. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol 2016;43:39-46. [PMID: 26891053 DOI: 10.1159/000444422] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
164 Sagara M, Suzuki K, Aoki C, Tanaka S, Taguchi I, Inoue T, Aso Y. Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study. Cardiovasc Diabetol 2016;15:76. [PMID: 27184495 DOI: 10.1186/s12933-016-0396-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
165 Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, Remer EM, Shinagare AB, Curci NE, Raman SS, Wells SA, Kaffenberger SD, Wang ZJ, Chandarana H, Davenport MS. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology 2019;292:475-88. [PMID: 31210616 DOI: 10.1148/radiol.2019182646] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 27.0] [Reference Citation Analysis]
166 Ferreira-Filho SR, Rosa CA, Reis SS, Botelho RV, Pereira VJ, Pellaza BB. Systolic Heart Function, Kidney Filtration and the Number of Coronary Atherosclerotic Plaques in Lean and Overweight Patients. Cardiorenal Med 2012;2:110-6. [PMID: 22619658 DOI: 10.1159/000335561] [Reference Citation Analysis]
167 Sasaki K, Shoji T, Kabata D, Shintani A, Okute Y, Tsuchikura S, Shimomura N, Tsujimoto Y, Nakatani S, Mori K, Shioi A, Inaba M, Emoto M. Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort. J Atheroscler Thromb 2021;28:249-60. [PMID: 32741893 DOI: 10.5551/jat.56069] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
168 Athyros VG, Hatzitolios AI, Karagiannis A, Savopoulos C, Katsiki N, Tziomalos K, Papagianni A, Kakafika A, Gossios TD, Mikhailidis DP; IMPERATIVE Collaborative Group. IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Arch Med Sci 2011;7:984-92. [PMID: 22328881 DOI: 10.5114/aoms.2011.26610] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
169 Seetharam Bhat KR, Moschovas MC, Onol FF, Rogers T, Roof S, Patel VR, Schatloff O. Robotic renal and adrenal oncologic surgery: A contemporary review. Asian J Urol 2021;8:89-99. [PMID: 33569275 DOI: 10.1016/j.ajur.2020.05.010] [Reference Citation Analysis]
170 Ohsugi H, Akiyama K, Taniguchi H, Yanishi M, Sugi M, Matsuda T, Kinoshita H. Tumor volume and tumor crossing of the axial renal midline predict renal function after robotic partial nephrectomy. Sci Rep 2021;11:22526. [PMID: 34795330 DOI: 10.1038/s41598-021-01539-1] [Reference Citation Analysis]
171 Zhao Q, Nooren SJL, Zijlstra LE, Westenberg JJM, Kroft LJM, Jukema JW, Berkhout-byrne NC, Rabelink TJ, van Zonneveld AJ, van Buren M, Mooijaart SP, Bijkerk R. Circulating miRNAs and Vascular Injury Markers Associate with Cardiovascular Function in Older Patients Reaching End-Stage Kidney Disease. ncRNA 2022;8:2. [DOI: 10.3390/ncrna8010002] [Reference Citation Analysis]
172 Price AM, Greenhall GHB, Moody WE, Steeds RP, Mark PB, Edwards NC, Hayer MK, Pickup LC, Radhakrishnan A, Law JP, Banerjee D, Campbell T, Tomson CRV, Cockcroft JR, Shrestha B, Wilkinson IB, Tomlinson LA, Ferro CJ, Townend JN; EARNEST investigators. Changes in Blood Pressure and Arterial Hemodynamics following Living Kidney Donation. Clin J Am Soc Nephrol 2020;15:1330-9. [PMID: 32843374 DOI: 10.2215/CJN.15651219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
173 Wakasugi M, Kazama JJ, Narita I. Use of Japanese Society for Dialysis Therapy dialysis tables to compare the local and national incidence of dialysis. Ther Apher Dial 2012;16:63-7. [PMID: 22248197 DOI: 10.1111/j.1744-9987.2011.01030.x] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
174 Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Arita K, Kato A, Shimizu M. Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD. J Am Soc Nephrol 2015;26:1732-46. [PMID: 25349205 DOI: 10.1681/ASN.2014010042] [Cited by in Crossref: 155] [Cited by in F6Publishing: 91] [Article Influence: 19.4] [Reference Citation Analysis]
175 Townsend RR. Arterial Stiffness in CKD: A Review. Am J Kidney Dis 2019;73:240-7. [PMID: 29908694 DOI: 10.1053/j.ajkd.2018.04.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
176 Miyazaki T, Ashikaga T, Asano M, Sasaoka T, Kurihara K, Yoshikawa S, Isobe M; Tokyo-MD PCI Study Investigators. Impact of chronic kidney disease on long-term clinical outcomes of everolimus-eluting stent implantation: A subanalysis of the Tokyo-MD PCI registry. Catheter Cardiovasc Interv 2019;94:E9-E16. [PMID: 30714680 DOI: 10.1002/ccd.28070] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
177 Kim CS, Bae EH, Ma SK, Han SH, Lee KB, Lee J, Oh KH, Chae DW, Kim SW; KNOW-CKD Study Group. Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci 2017;32:240-8. [PMID: 28049234 DOI: 10.3346/jkms.2017.32.2.240] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
178 Liss MA, Wang S, Palazzi K, Jabaji R, Patel N, Lee HJ, Parsons JK, Derweesh IH. Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses. BMC Urol 2014;14:101. [PMID: 25519922 DOI: 10.1186/1471-2490-14-101] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
179 Gutiérrez OM, Irvin MR, Zakai NA, Naik RP, Chaudhary NS, Estrella MM, Limou S, Judd SE, Cushman M, Kopp JB, Winkler CA. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study. Am J Kidney Dis 2020;75:54-60. [PMID: 31563468 DOI: 10.1053/j.ajkd.2019.05.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
180 Snelson M, Tan SM, Clarke RE, de Pasquale C, Thallas-Bonke V, Nguyen TV, Penfold SA, Harcourt BE, Sourris KC, Lindblom RS, Ziemann M, Steer D, El-Osta A, Davies MJ, Donnellan L, Deo P, Kellow NJ, Cooper ME, Woodruff TM, Mackay CR, Forbes JM, Coughlan MT. Processed foods drive intestinal barrier permeability and microvascular diseases. Sci Adv 2021;7:eabe4841. [PMID: 33789895 DOI: 10.1126/sciadv.abe4841] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
181 Yokose C, Lu N, Xie H, Li L, Zheng Y, McCormick N, Rai SK, Aviña-Zubieta JA, Choi HK. Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study. CMAJ 2019;191:E1070-7. [PMID: 31570545 DOI: 10.1503/cmaj.190339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
182 Bajaj A, Damrauer SM, Anderson AH, Xie D, Budoff MJ, Go AS, He J, Lash JP, Ojo A, Post WS, Rahman M, Reilly MP, Saleheen D, Townsend RR, Chen J, Rader DJ; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators*. Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort). Arterioscler Thromb Vasc Biol 2017;37:1971-8. [PMID: 28838919 DOI: 10.1161/ATVBAHA.117.309920] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 5.2] [Reference Citation Analysis]
183 Montandon M, Hamidouche T, Yart L, Duret LC, Pons C, Soubeiran N, Pousse M, Cervera L, Vial V, Fassy J, Croce O, Gilson E, Shkreli M. Telomerase is required for glomerular renewal in kidneys of adult mice. NPJ Regen Med 2022;7:15. [PMID: 35149726 DOI: 10.1038/s41536-022-00212-z] [Reference Citation Analysis]
184 Dussol B, Reggio P, Morange S, Fathallah M, Natali F, Ripoll J, Ronflé E, Chanut C, Berland Y. [A case-control study of health benefits in patients with moderate renal failure]. Nephrol Ther 2008;4:99-104. [PMID: 18053787 DOI: 10.1016/j.nephro.2007.09.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
185 Provenzano M, Coppolino G, De Nicola L, Serra R, Garofalo C, Andreucci M, Bolignano D. Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale. Front Cell Dev Biol 2019;7:314. [PMID: 31850348 DOI: 10.3389/fcell.2019.00314] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
186 Wenzel M, Yu H, Uhlig A, Würnschimmel C, Wallbach M, Becker A, Fisch M, Chun FKH, Meyer CP, Leitsmann M. Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy. Int Urol Nephrol 2021. [PMID: 34269968 DOI: 10.1007/s11255-021-02957-w] [Reference Citation Analysis]
187 Premužić V, Jelaković B. Different circadian patterns of arterial stiffness are responsible for increased cardiovascular mortality in hemodialyzed patients. Physiol Rep 2021;9:e15082. [PMID: 34751519 DOI: 10.14814/phy2.15082] [Reference Citation Analysis]
188 Gracia M, Betriu À, Martínez-Alonso M, Arroyo D, Abajo M, Fernández E, Valdivielso JM; NEFRONA Investigators. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD. Clin J Am Soc Nephrol 2016;11:287-96. [PMID: 26668022 DOI: 10.2215/CJN.01240215] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 5.6] [Reference Citation Analysis]
189 Agrawal H, Aggarwal K, Littrell R, Velagapudi P, Turagam MK, Mittal M, Alpert MA. Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease. Curr Cardiol Rev 2015;11:261-9. [PMID: 25981315 DOI: 10.2174/1573403x1103150514155757] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
190 Ou YC, Hu CY, Cheng HL, Yang WH. Long-term outcomes of total ureterectomy with ileal-ureteral substitution treatment for ureteral cancer: a single-center experience. BMC Urol 2018;18:73. [PMID: 30170590 DOI: 10.1186/s12894-018-0389-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
191 Davies EW, Matza LS, Worth G, Feeny DH, Kostelec J, Soroka S, Mendelssohn D, McFarlane P, Belozeroff V. Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health Qual Life Outcomes 2015;13:90. [PMID: 26122041 DOI: 10.1186/s12955-015-0266-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
192 Gutiérrez OM, Anderson C, Isakova T, Scialla J, Negrea L, Anderson AH, Bellovich K, Chen J, Robinson N, Ojo A, Lash J, Feldman HI, Wolf M; CRIC Study Group. Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 2010;21:1953-60. [PMID: 20847142 DOI: 10.1681/ASN.2010020221] [Cited by in Crossref: 78] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
193 Shi Y, Hu L, Li M, Zhou W, Wang T, Zhu L, Bao H, Cheng X, Li P. Association Between the Surrogate Markers of Insulin Resistance and Chronic Kidney Disease in Chinese Hypertensive Patients. Front Med 2022;9:831648. [DOI: 10.3389/fmed.2022.831648] [Reference Citation Analysis]
194 Lee H, Oh YJ, Kim M, Kim H, Lee JP, Kim S, Oh KH, Jun Chin H, Joo KW, Lim CS, Kim S, Kim YS, Kim DK. The association of moderate renal dysfunction with impaired preference-based health-related quality of life: third Korean national health and nutritional examination survey. BMC Nephrol 2012;13:19. [PMID: 22530944 DOI: 10.1186/1471-2369-13-19] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
195 Gul CB, Yildiz A, Sag S, Oruc A, Ersoy A, Gullulu S. The Effect of Smoking on Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease Patients with Preserved Renal Function. Ren Fail 2021;43:1124-9. [PMID: 34256663 DOI: 10.1080/0886022X.2021.1949348] [Reference Citation Analysis]
196 Lee JW, Cho E, Kim MG, Jo SK, Cho WY, Kim HK. Proinflammatory CD14(+)CD16(+) monocytes are associated with vascular stiffness in predialysis patients with chronic kidney disease. Kidney Res Clin Pract 2013;32:147-52. [PMID: 26877933 DOI: 10.1016/j.krcp.2013.08.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
197 Kim SH, Oh D, Jung KS, Lee JE, Kim H, Kim HJ, Kim BS, Park HC, Lee BK, Choi HY. The association between the apolipoprotein B/A-I ratio and coronary calcification may differ depending on kidney function in a healthy population. PLoS One 2017;12:e0185522. [PMID: 28957410 DOI: 10.1371/journal.pone.0185522] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
198 Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Group. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 2009;4:1302-11. [PMID: 19541818 DOI: 10.2215/CJN.00070109] [Cited by in Crossref: 345] [Cited by in F6Publishing: 261] [Article Influence: 26.5] [Reference Citation Analysis]
199 Lecamwasam AR, Mohebbi M, Ekinci EI, Dwyer KM, Saffery R. Identification of Potential Biomarkers of Chronic Kidney Disease in Individuals with Diabetes: Protocol for a Cross-sectional Observational Study. JMIR Res Protoc 2020;9:e16277. [PMID: 32734931 DOI: 10.2196/16277] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
200 Kétszeri M, Kirsch A, Frauscher B, Moschovaki-Filippidou F, Mooslechner AA, Kirsch AH, Schabhuettl C, Aringer I, Artinger K, Pregartner G, Ekart R, Breznik S, Hojs R, Goessler W, Schilcher I, Müller H, Obermayer-Pietsch B, Frank S, Rosenkranz AR, Eller P, Eller K. MicroRNA-142-3p improves vascular relaxation in uremia. Atherosclerosis 2019;280:28-36. [PMID: 30453118 DOI: 10.1016/j.atherosclerosis.2018.11.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
201 Kim KM, Oh HJ, Choi HY, Lee H, Ryu DR. Impact of chronic kidney disease on mortality: A nationwide cohort study. Kidney Res Clin Pract 2019;38:382-90. [PMID: 31382730 DOI: 10.23876/j.krcp.18.0128] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
202 Small DM, Beetham KS, Howden EJ, Briskey DR, Johnson DW, Isbel NM, Gobe GC, Coombes JS. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Rep 2017;22:127-36. [PMID: 28075321 DOI: 10.1080/13510002.2016.1276314] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
203 Parr SK, Siew ED. Delayed Consequences of Acute Kidney Injury. Adv Chronic Kidney Dis 2016;23:186-94. [PMID: 27113695 DOI: 10.1053/j.ackd.2016.01.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
204 Goldfarb-Rumyantzev AS, Gautam S, Dong N, Brown RS. Prediction Model and Risk Stratification Tool for Survival in Patients With CKD. Kidney Int Rep 2018;3:417-25. [PMID: 29725646 DOI: 10.1016/j.ekir.2017.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
205 Yagi S, Aihara K, Ikeda Y, Akaike M, Sata M, Matsumoto T. Effects of statins on cardiorenal syndrome. Int J Vasc Med 2012;2012:162545. [PMID: 22792467 DOI: 10.1155/2012/162545] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
206 Bratslavsky G, Linehan WM. Long-term management of bilateral, multifocal, recurrent renal carcinoma. Nat Rev Urol 2010;7:267-75. [PMID: 20448660 DOI: 10.1038/nrurol.2010.44] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
207 Collister D, Ferguson TW, Funk SE, Reaven NL, Mathur V, Tangri N. Metabolic Acidosis and Cardiovascular Disease in CKD. Kidney Med 2021;3:753-761.e1. [PMID: 34746740 DOI: 10.1016/j.xkme.2021.04.011] [Reference Citation Analysis]
208 Golle L, Gerth HU, Beul K, Heitplatz B, Barth P, Fobker M, Pavenstädt H, Di Marco GS, Brand M. Bone marrow-derived cells and their conditioned medium induce microvascular repair in uremic rats by stimulation of endogenous repair mechanisms. Sci Rep 2017;7:9444. [PMID: 28842629 DOI: 10.1038/s41598-017-09883-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
209 Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2013;3:19-62. [PMID: 25018975 DOI: 10.1038/kisup.2012.64] [Cited by in Crossref: 387] [Cited by in F6Publishing: 271] [Article Influence: 43.0] [Reference Citation Analysis]
210 Haneda M, Kadowaki T, Ito H, Sasaki K, Hiraide S, Ishii M, Matsukawa M, Ueno M. Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance. Diabetes Ther 2018;9:1083-97. [PMID: 29637459 DOI: 10.1007/s13300-018-0416-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
211 Lecamwasam A, Nelson TM, Rivera L, Ekinci EI, Saffery R, Dwyer KM. Gut Microbiome Composition Remains Stable in Individuals with Diabetes-Related Early to Late Stage Chronic Kidney Disease. Biomedicines 2020;9:19. [PMID: 33383810 DOI: 10.3390/biomedicines9010019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Jhamb M, Cavanaugh KL, Bian A, Chen G, Ikizler TA, Unruh ML, Abdel-Kader K. Disparities in Electronic Health Record Patient Portal Use in Nephrology Clinics. Clin J Am Soc Nephrol 2015;10:2013-22. [PMID: 26493242 DOI: 10.2215/CJN.01640215] [Cited by in Crossref: 69] [Cited by in F6Publishing: 42] [Article Influence: 9.9] [Reference Citation Analysis]
213 De Luca L, Cappadona F, Temporelli PL, Gonzini L, Ledda A, Raisaro A, Viazzi F, Gabrielli D, Colivicchi F, Gulizia MM, Pontremoli R; On-Behalf-of-the-START-Investigators. Impact of eGFR rate on 1-year all-cause mortality in patients with stable coronary artery disease. Eur J Intern Med 2022:S0953-6205(22)00164-9. [PMID: 35513990 DOI: 10.1016/j.ejim.2022.04.021] [Reference Citation Analysis]
214 Van Craenenbroeck AH, Van Craenenbroeck EM, Kouidi E, Vrints CJ, Couttenye MM, Conraads VM. Vascular effects of exercise training in CKD: current evidence and pathophysiological mechanisms. Clin J Am Soc Nephrol 2014;9:1305-18. [PMID: 24832091 DOI: 10.2215/CJN.13031213] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
215 El-Menyar A, Zubaid M, Sulaiman K, Singh R, Al Thani H, Akbar M, Bulbanat B, Al-Hamdan R, Almahmmed W, Al Suwaidi J. In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a Registry of 8176 patients. Mayo Clin Proc 2010;85:332-40. [PMID: 20360292 DOI: 10.4065/mcp.2009.0513] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
216 Karpetas A, Sarafidis PA, Georgianos PI, Protogerou A, Vakianis P, Koutroumpas G, Raptis V, Stamatiadis DN, Syrganis C, Liakopoulos V, Efstratiadis G, Lasaridis AN. Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis. Clin J Am Soc Nephrol 2015;10:630-8. [PMID: 25635033 DOI: 10.2215/CJN.08180814] [Cited by in Crossref: 42] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
217 Jarrick S, Lundberg S, Sundström J, Symreng A, Warnqvist A, Ludvigsson JF. Immunoglobulin A nephropathy and ischemic heart disease: a nationwide population-based cohort study. BMC Nephrol 2021;22:165. [PMID: 33952193 DOI: 10.1186/s12882-021-02353-7] [Reference Citation Analysis]
218 Yamasaki Y, Nakajima K, Kusuoka H, Izumi T, Kashiwagi A, Kawamori R, Shimamoto K, Yamada N, Nishimura T. Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: the J-ACCESS 2 investigation. Diabetes Care 2010;33:2320-6. [PMID: 20724653 DOI: 10.2337/dc09-2370] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
219 Janus N, Launay-Vacher V, Juillard L, Deray G, Hannedouche T, Isnard-Rouchon M, Burtey S, Vanhille P, Ortiz JP, Janin G, Nicoud P, Touam M, Laville M. Course of chronic kidney disease in French patients. Clin Kidney J 2017;10:74-8. [PMID: 28638607 DOI: 10.1093/ckj/sfw092] [Reference Citation Analysis]
220 Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF). BMJ Open 2019;9:e022478. [PMID: 30928922 DOI: 10.1136/bmjopen-2018-022478] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
221 Peralta CA, Lee A, Odden MC, Lopez L, Zeki Al Hazzouri A, Neuhaus J, Haan MN. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging. J Am Geriatr Soc. 2013;61:90-95. [PMID: 23252993 DOI: 10.1111/jgs.12040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
222 Iyngkaran P, Thomas M, Majoni W, Anavekar NS, Ronco C. Comorbid Heart Failure and Renal Impairment: Epidemiology and Management. Cardiorenal Med 2012;2:281-97. [PMID: 23381594 DOI: 10.1159/000342487] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
223 Palmer SC, Nistor I, Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A, Strippoli GF. Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med. 2013;10:e1001436. [PMID: 23637579 DOI: 10.1371/journal.pmed.1001436] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 10.2] [Reference Citation Analysis]
224 Tsai HJ, Tsai YC, Huang JC, Wu PY, Chen SC, Chiu YW, Chang JM, Chen HC. Investigation of Acoustic Cardiographic Parameters before and after Hemodialysis. Dis Markers 2019;2019:5270159. [PMID: 31781303 DOI: 10.1155/2019/5270159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
225 Brancaccio D, Bommer J, Coyne D. Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies. Drugs 2007;67:1981-98. [PMID: 17883283 DOI: 10.2165/00003495-200767140-00002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
226 Taddei S, Nami R, Bruno RM, Quatrini I, Nuti R. Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev. 2011;16:615-620. [PMID: 21116711 DOI: 10.1007/s10741-010-9197-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
227 Jurkovitz CT, Elliott D, Li S, Saab G, Bomback AS, Norris KC, Chen SC, McCullough PA, Whaley-Connell AT; KEEP Investigators. Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2012;59:S24-33. [PMID: 22339899 DOI: 10.1053/j.ajkd.2011.11.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
228 Denker M, Boyle S, Anderson AH, Appel LJ, Chen J, Fink JC, Flack J, Go AS, Horwitz E, Hsu CY, Kusek JW, Lash JP, Navaneethan S, Ojo AO, Rahman M, Steigerwalt SP, Townsend RR, Feldman HI; Chronic Renal Insufficiency Cohort Study Investigators. Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clin J Am Soc Nephrol 2015;10:2073-83. [PMID: 26265715 DOI: 10.2215/CJN.04260415] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
229 Kaya E, Cuneo A, Hochadel M, Jünger C, Stepper W, Bramlage P, Kuck KH, Nienaber CA, Senges J, Eckardt L, Tebbe U, Reinecke H. Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents. Clin Res Cardiol 2011;100:1103-9. [PMID: 21912915 DOI: 10.1007/s00392-011-0347-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
230 Coyle M, Flaherty G, Jennings C. A critical review of chronic kidney disease as a risk factor for coronary artery disease. Int J Cardiol Heart Vasc 2021;35:100822. [PMID: 34179334 DOI: 10.1016/j.ijcha.2021.100822] [Reference Citation Analysis]
231 Kara M, Gurluler E, Cakır U. The effect of two different high-flux dialysis membranes on insulin resistance in non-diabetic end-stage renal disease patients. Ren Fail 2015;37:1293-6. [PMID: 26399977 DOI: 10.3109/0886022X.2015.1073053] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
232 Nishikawa K, Takahashi K, Yamada R, Kinaga T, Masato M, Yamamoto M. Influence of chronic kidney disease on hospitalization, chronic dialysis, and mortality in Japanese men: a longitudinal analysis. Clin Exp Nephrol 2017;21:316-23. [PMID: 27339450 DOI: 10.1007/s10157-016-1293-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
233 Yan G, Cheung AK, Greene T, Yu AJ, Oliver MN, Yu W, Ma JZ, Norris KC. Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD: Race, Age, and State Characteristics. Clin J Am Soc Nephrol 2015;10:1979-88. [PMID: 26450930 DOI: 10.2215/CJN.02800315] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
234 Ravel V, Streja E, Molnar MZ, Rezakhani S, Soohoo M, Kovesdy CP, Kalantar-Zadeh K, Moradi H. Association of aspartate aminotransferase with mortality in hemodialysis patients. Nephrol Dial Transplant 2016;31:814-22. [PMID: 26333544 DOI: 10.1093/ndt/gfv310] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
235 Pontremoli R, Bellizzi V, Bianchi S, Bigazzi R, Cernaro V, Del Vecchio L, De Nicola L, Leoncini G, Mallamaci F, Zoccali C, Buemi M. Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology. J Nephrol 2020;33:417-30. [PMID: 32065354 DOI: 10.1007/s40620-020-00707-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
236 Bansal N, Vittinghoff E, Peralta CA, Shlipak MG, Grubbs V, Jacobs DR, Siscovick D, Steffes M, Carr JJ, Bibbins-Domingo K. Estimated kidney function based on serum cystatin C and risk of subsequent coronary artery calcium in young and middle-aged adults with preserved kidney function: results from the CARDIA study. Am J Epidemiol 2013;178:410-7. [PMID: 23813702 DOI: 10.1093/aje/kws581] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
237 Lee SJ, Son H, Shin SK. Influence of frailty on health-related quality of life in pre-dialysis patients with chronic kidney disease in Korea: a cross-sectional study. Health Qual Life Outcomes 2015;13:70. [PMID: 26021987 DOI: 10.1186/s12955-015-0270-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
238 Habedank D, Schefold JC, Bernhardt C, Karhausen T, Doehner W, Anker SD, Reinke P. Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study. Cardiorenal Med 2016;7:50-9. [PMID: 27994602 DOI: 10.1159/000449174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
239 Terawaki H, Yamagishi S, Funakoshi Y, Matsuyama Y, Terada T, Nakayama K, Ogura M, Hosoya T, Ito S, Era S, Nakayama M. Pigment epithelium-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis. Ther Apher Dial 2013;17:625-30. [PMID: 24330558 DOI: 10.1111/1744-9987.12020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
240 Bansal N, Zelnick L, Go A, Anderson A, Christenson R, Deo R, Defilippi C, Lash J, He J, Ky B, Seliger S, Soliman E, Shlipak M; CRIC Study Investigators †., CRIC Study Investigators. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. J Am Heart Assoc 2019;8:e012336. [PMID: 31645163 DOI: 10.1161/JAHA.119.012336] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
241 Cruz DN, Bagshaw SM. Heart-kidney interaction: epidemiology of cardiorenal syndromes. Int J Nephrol 2010;2011:351291. [PMID: 21234309 DOI: 10.4061/2011/351291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
242 López-Costea MÁ, Bonet X, Pérez-Reggeti J, Etcheverry B, Vigués F. Oncological outcomes and prognostic factors after nephron-sparing surgery in renal cell carcinoma. Int Urol Nephrol 2016;48:681-6. [PMID: 26861062 DOI: 10.1007/s11255-016-1217-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
243 Mues AC, Korets R, Graversen JA, Badani KK, Bird VG, Best SL, Cadeddu JA, Clayman RV, McDougall E, Barwari K, Laguna P, de la Rosette J, Kavoussi L, Okhunov Z, Munver R, Patel SR, Nakada S, Tsivian M, Polascik TJ, Shalhav A, Shingleton WB, Johnson EK, Wolf JS Jr, Landman J. Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience. J Endourol 2012;26:1361-6. [PMID: 22667344 DOI: 10.1089/end.2012.0114] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
244 Esen B, Sahin I, Atay AE, Saglam Gokmen E, Harmankaya Kaptanogullari O, Yılmaz M, Kucuk SH, Kahvecioglu S, Seyahi N. Decreased Serum 25-hydroxyvitamin D Level Causes Interventricular Septal Hypertrophy in Patients on Peritoneal Dialysis: Cardiovascular Aspects of Endogenous Vitamin D Deficiency. Int J Nephrol 2016;2016:2464953. [PMID: 28018677 DOI: 10.1155/2016/2464953] [Reference Citation Analysis]
245 Proczko M, Kaska L, Kobiela J, Stefaniak T, Zadrożny D, Sledziński Z. Roux-en-Y gastric bypass in dialysed morbidly obese patients as a preparation for a kidney transplantation: case series. Wideochir Inne Tech Maloinwazyjne 2013;8:174-7. [PMID: 23837104 DOI: 10.5114/wiitm.2011.32852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
246 Gnanaraj J, Radhakrishnan J. Cardio-renal syndrome. F1000Res 2016;5:F1000 Faculty Rev-2123. [PMID: 27635229 DOI: 10.12688/f1000research.8004.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
247 Krmar RT, Ferraris JR. Clinical value of ambulatory blood pressure in pediatric patients after renal transplantation. Pediatr Nephrol 2018;33:1327-36. [PMID: 28842790 DOI: 10.1007/s00467-017-3781-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
248 Lemoine S, Fournier T, Kocevar G, Belloi A, Normand G, Ibarrola D, Sappey-Marinier D, Juillard L. Intracellular Phosphate Dynamics in Muscle Measured by Magnetic Resonance Spectroscopy during Hemodialysis. J Am Soc Nephrol 2016;27:2062-8. [PMID: 26561642 DOI: 10.1681/ASN.2015050546] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
249 Nashar K, Egan BM. Relationship between chronic kidney disease and metabolic syndrome: current perspectives. Diabetes Metab Syndr Obes 2014;7:421-35. [PMID: 25258547 DOI: 10.2147/DMSO.S45183] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
250 Bang JY, Kim SO, Kim SG, Song JG, Hwang GS. Cystatin-C is associated with partial recovery of kidney function and progression to chronic kidney disease in living kidney donors: Observational study. Medicine (Baltimore) 2017;96:e6037. [PMID: 28151912 DOI: 10.1097/MD.0000000000006037] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
251 Buscher K, Marcovecchio P, Hedrick CC, Ley K. Patrolling Mechanics of Non-Classical Monocytes in Vascular Inflammation. Front Cardiovasc Med 2017;4:80. [PMID: 29312957 DOI: 10.3389/fcvm.2017.00080] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
252 Muramaki M, Miyake H, Sakai I, Fujisawa M. Prognostic Factors Influencing Postoperative Development of Chronic Kidney Disease in Patients with Small Renal Tumors who Underwent Partial Nephrectomy. Curr Urol 2013;6:129-35. [PMID: 24917730 DOI: 10.1159/000343526] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
253 Kim IY, Kim JH, Kim MJ, Lee DW, Hwang CG, Han M, Rhee H, Song SH, Seong EY, Lee SB. Plasma neutrophil gelatinase-associated lipocalin is independently associated with left ventricular hypertrophy and diastolic dysfunction in patients with chronic kidney disease. PLoS One 2018;13:e0205848. [PMID: 30325973 DOI: 10.1371/journal.pone.0205848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
254 Lone Z, Murthy PB, Zhang JH, Ericson KJ, Thomas L, Khanna A, Haber GP, Lee BH. Comparison of renal function after open radical cystectomy, extracorporeal robot assisted radical cystectomy, and intracorporeal robot assisted radical cystectomy. Urol Oncol 2021;39:301.e1-9. [PMID: 33036904 DOI: 10.1016/j.urolonc.2020.09.018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
255 Methven S, MacGregor MS. Clinical management of chronic kidney disease. Clin Med (Lond) 2009;9:269-72. [PMID: 19634396 DOI: 10.7861/clinmedicine.9-3-269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
256 Winkelmayer WC, Levin R, Setoguchi S. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol 2008;3:1415-22. [PMID: 18614775 DOI: 10.2215/CJN.02010408] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
257 Sonkar SK, Singh PK, Chandra S, Sonkar GK, Bhosale V, Sharma S. Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients. J Bras Nefrol 2022:S0101-28002022005002401. [PMID: 35023538 DOI: 10.1590/2175-8239-JBN-2021-0135] [Reference Citation Analysis]
258 Fisher MA, Taylor GW, West BT, McCarthy ET. Bidirectional relationship between chronic kidney and periodontal disease: a study using structural equation modeling. Kidney Int 2011;79:347-55. [PMID: 20927035 DOI: 10.1038/ki.2010.384] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 6.0] [Reference Citation Analysis]
259 Holzer M, Birner-Gruenberger R, Stojakovic T, El-Gamal D, Binder V, Wadsack C, Heinemann A, Marsche G. Uremia alters HDL composition and function. J Am Soc Nephrol 2011;22:1631-41. [PMID: 21804091 DOI: 10.1681/ASN.2010111144] [Cited by in Crossref: 190] [Cited by in F6Publishing: 108] [Article Influence: 17.3] [Reference Citation Analysis]
260 Krane V, Wanner C. Should we aim for oral health to improve outcomes in chronic kidney disease? Nephrol Dial Transplant 2016;31:1551-4. [PMID: 27190378 DOI: 10.1093/ndt/gfw049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
261 Kulkarni S, Lenin M, Ramesh R, Delphine SCW, Velu K. Evaluation of Single-Nucleotide Polymorphisms of Transcription Factor 7-Like 2 and ATP2B1 Genes as Cardiovascular Risk Predictors in Chronic Kidney Disease. Int J Appl Basic Med Res 2019;9:221-5. [PMID: 31681547 DOI: 10.4103/ijabmr.IJABMR_92_19] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
262 Martens CR, Edwards DG. Peripheral vascular dysfunction in chronic kidney disease. Cardiol Res Pract 2011;2011:267257. [PMID: 21637718 DOI: 10.4061/2011/267257] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
263 Shastri S, Katz R, Shlipak MG, Kestenbaum B, Peralta CA, Kramer H, Jacobs DR Jr, de Boer IH, Cushman M, Siscovick D, Sarnak MJ. Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2011;57:832-40. [PMID: 21296473 DOI: 10.1053/j.ajkd.2010.11.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
264 Tajima R, Kondo M, Kai H, Saito C, Okada M, Takahashi H, Doi M, Tsuruoka S, Yamagata K. Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D). Clin Exp Nephrol 2010;14:340-8. [PMID: 20567874 DOI: 10.1007/s10157-010-0304-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
265 Larcher A, Meskawi M, Valdivieso R, Boehm K, Trudeau V, Tian Z, Fossati N, Dell'Oglio P, Lughezzani G, Buffi N, Sun M, Karakiewicz P. Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma. World J Urol 2016;34:383-9. [PMID: 26047653 DOI: 10.1007/s00345-015-1606-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
266 Susantitaphong P, Sewaralthahab K, Balk EM, Eiam-ong S, Madias NE, Jaber BL. Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis. Am J Hypertens 2013;26:424-41. [PMID: 23382494 DOI: 10.1093/ajh/hps038] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
267 O'Callaghan CA, Shine B, Lasserson DS. Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open 2011;1:e000308. [PMID: 22184586 DOI: 10.1136/bmjopen-2011-000308] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
268 Pradhan A, Bhandari M, Sethi R. Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and Perspectives. Cardiol Res Pract 2020;2020:9815016. [PMID: 32670636 DOI: 10.1155/2020/9815016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Endlich N, Lange T, Kuhn J, Klemm P, Kotb AM, Siegerist F, Kindt F, Lindenmeyer MT, Cohen CD, Kuss AW, Nath N, Rettig R, Lendeckel U, Zimmermann U, Amann K, Stracke S, Endlich K. BDNF: mRNA expression in urine cells of patients with chronic kidney disease and its role in kidney function. J Cell Mol Med 2018;22:5265-77. [PMID: 30133147 DOI: 10.1111/jcmm.13762] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
270 Leibowitz D. Left ventricular hypertrophy and chronic renal insufficiency in the elderly. Cardiorenal Med 2014;4:168-75. [PMID: 25737681 DOI: 10.1159/000366455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
271 Gisondi P, Girolomoni G. Glomerular filtration rate in patients with psoriasis treated with etanercept. J Int Med Res 2016;44:106-8. [PMID: 27683151 DOI: 10.1177/0300060515613495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
272 Nishida S, Hidaka Y, Toyoda M, Kinoshita K, Tanaka K, Kawabata C, Hamanoue S, Inadome A, Yokomizo H, Takeda A, Uekihara S, Yamanaga S. Factors related to suboptimal recovery of renal function after living donor nephrectomy: a retrospective study. BMC Nephrol 2019;20:403. [PMID: 31703636 DOI: 10.1186/s12882-019-1588-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
273 Hikasa S, Shimabukuro S, Hideta K, Higasa S, Sawada A, Tokugawa T, Tanaka K, Yanai M, Kimura T. Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on estimated glomerular filtration rate slope in patients with HIV: A retrospective observational study. J Infect Chemother 2021:S1341-321X(21)00327-5. [PMID: 34896027 DOI: 10.1016/j.jiac.2021.11.016] [Reference Citation Analysis]
274 Sesti G, Fiorentino TV, Arturi F, Perticone M, Sciacqua A, Perticone F. Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease. PLoS One. 2014;9:e88569. [PMID: 24520400 DOI: 10.1371/journal.pone.0088569] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
275 Eduok U, Camara H, Abdelrasoul A, Shoker A. Influence of UV-irradiation intensity and exposure duration on the hemobiocompatibility enhancement of a novel synthesized phosphobetaine zwitterions polyethersulfone clinical hemodialysis membranes. J Biomed Mater Res B Appl Biomater 2021. [PMID: 34510718 DOI: 10.1002/jbm.b.34936] [Reference Citation Analysis]
276 van der Velde M, Bakker SJ, de Jong PE, Gansevoort RT. Influence of age and measure of eGFR on the association between renal function and cardiovascular events. Clin J Am Soc Nephrol 2010;5:2053-9. [PMID: 20705964 DOI: 10.2215/CJN.08851209] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
277 Bramlage P, Gitt AK, Schneider S, Deeg E, Tschöpe D; DiaRegis Study Group. Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up. BMC Cardiovasc Disord 2014;14:162. [PMID: 25410473 DOI: 10.1186/1471-2261-14-162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
278 Sejima T, Iwamoto H, Masago T, Morizane S, Yao A, Umekita Y, Honda M, Takenaka A. Initial evidence demonstrating the association between the vascular status in surgically resected renal parenchymal pathology and sexual function. Int J Impot Res 2015;27:90-4. [PMID: 25471317 DOI: 10.1038/ijir.2014.38] [Reference Citation Analysis]
279 Anker N, Scherzer R, Peralta C, Powe N, Banjeree T, Shlipak M. Racial Disparities in Creatinine-based Kidney Function Estimates Among HIV-infected Adults. Ethn Dis 2016;26:213-20. [PMID: 27103772 DOI: 10.18865/ed.26.2.213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
280 Boorjian SA, Uzzo RG. The evolving management of small renal masses. Curr Oncol Rep 2009;11:211-7. [PMID: 19336013 DOI: 10.1007/s11912-009-0030-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
281 Abernathy OL, Okut H, Paull-Forney BG, Schwasinger-Schmidt TE. Bariatric Surgery Improves Renal Function in Patients With Obesity. Cureus 2021;13:e17458. [PMID: 34603860 DOI: 10.7759/cureus.17458] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
282 Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359:584-592. [PMID: 18687639 DOI: 10.1056/nejmoa0706130] [Cited by in Crossref: 1211] [Cited by in F6Publishing: 603] [Article Influence: 86.5] [Reference Citation Analysis]
283 Tsuda N, Shiraishi S, Sakamoto F, Yuki H, Ogasawara K, Yoshida M, Tomiguchi S, Tsujita K, Yamashita Y. Quantification of myocardial perfusion reserve using dynamic SPECT images of patients with chronic kidney disease. Journal of Cardiology 2018;71:174-80. [DOI: 10.1016/j.jjcc.2017.07.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
284 Tuot DS, Powe NR. Chronic kidney disease in primary care: an opportunity for generalists. J Gen Intern Med 2011;26:356-8. [PMID: 21359580 DOI: 10.1007/s11606-011-1650-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
285 Dulabon LM, Lowrance WT, Russo P, Huang WC. Trends in renal tumor surgery delivery within the United States. Cancer 2010;116:2316-21. [PMID: 20225227 DOI: 10.1002/cncr.24965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 43] [Article Influence: 0.4] [Reference Citation Analysis]
286 AlAnizy L, AlMatham K, Al Basheer A, AlFayyad I. Complementary and Alternative Medicine Practice Among Saudi Patients with Chronic Kidney Disease: A Cross-Sectional Study. Int J Nephrol Renovasc Dis 2020;13:11-8. [PMID: 32099440 DOI: 10.2147/IJNRD.S240705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
287 Kelly DM, Li L, Burgess AI, Poole DL, Duerden JM, Rothwell PM. Associations of blood biomarkers with glomerular filtration rate in patients with TIA and stroke: population-based study. Stroke Vasc Neurol 2021;6:48-56. [PMID: 32883874 DOI: 10.1136/svn-2020-000422] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
288 Navai N, Ramos P, Zhao LC, Meeks JJ, Nadler RB, Smith ND. Why not partial nephrectomy? Urology 2008;72:243-6. [PMID: 18584853 DOI: 10.1016/j.urology.2008.04.056] [Reference Citation Analysis]
289 Gao H, Peng H, Shen A, Chen H, Li H. Predictive Effect of Renal Function on Clinical Outcomes in Older Adults With Acute Myocardial Infarction: Results From an Observational Cohort Study in China. Front Cardiovasc Med 2021;8:772774. [PMID: 34938788 DOI: 10.3389/fcvm.2021.772774] [Reference Citation Analysis]
290 Kimura H, Tanaka K, Saito H, Iwasaki T, Oda A, Watanabe S, Kanno M, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Association of Polypharmacy with Kidney Disease Progression in Adults with CKD. Clin J Am Soc Nephrol 2021;16:1797-804. [PMID: 34782408 DOI: 10.2215/CJN.03940321] [Reference Citation Analysis]
291 Liss MA, DeConde R, Caovan D, Hofler J, Gabe M, Palazzi KL, Patel ND, Lee HJ, Ideker T, Van Poppel H, Karow D, Aertsen M, Casola G, Derweesh IH. Parenchymal Volumetric Assessment as a Predictive Tool to Determine Renal Function Benefit of Nephron-Sparing Surgery Compared with Radical Nephrectomy. J Endourol 2016;30:114-21. [PMID: 26192380 DOI: 10.1089/end.2015.0411] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
292 Remzi M, Javadli E, Ozsoy M. Management of small renal masses: a review. World J Urol 2010;28:275-81. [PMID: 20177900 DOI: 10.1007/s00345-010-0516-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
293 Hatta T, Nishimura S, Nishimura T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 2009;36:1835-41. [PMID: 19471925 DOI: 10.1007/s00259-009-1165-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
294 Simeoni M, Borrelli S, Garofalo C, Fuiano G, Esposito C, Comi A, Provenzano M. Atherosclerotic-nephropathy: an updated narrative review. J Nephrol 2021;34:125-36. [PMID: 32270411 DOI: 10.1007/s40620-020-00733-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
295 Ghany MA, Wageeh M, Roshdy S. Correlation between indices of kidney function (estimated Glomerular Filteration Rate and proteinuria) and SYNTAX Score in non diabetic chronic kidney disease patients. The Egyptian Heart Journal 2015;67:21-6. [DOI: 10.1016/j.ehj.2013.09.003] [Reference Citation Analysis]
296 McArthur E, Bota SE, Sood MM, Nesrallah GE, Kim SJ, Garg AX, Dixon SN. Comparing Five Comorbidity Indices to Predict Mortality in Chronic Kidney Disease: A Retrospective Cohort Study. Can J Kidney Health Dis 2018;5:2054358118805418. [PMID: 30349730 DOI: 10.1177/2054358118805418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
297 Bangalore S, Maron DJ, Fleg JL, O'Brien SM, Herzog CA, Stone GW, Mark DB, Spertus JA, Alexander KP, Sidhu MS, Chertow GM, Boden WE, Hochman JS; ISCHEMIA-CKD Research Group. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design. Am Heart J 2018;205:42-52. [PMID: 30172098 DOI: 10.1016/j.ahj.2018.07.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
298 Radfar MH, Ameri F, Dadpour M, Khabazian R, Borumandnia N, Kabir SA. Partial nephrectomy and positive surgical margin, oncologic outcomes and predictors: a 15-year single institution experience. Cent European J Urol 2021;74:516-22. [PMID: 35083070 DOI: 10.5173/ceju.2021.0191] [Reference Citation Analysis]
299 Zhang X, Su Z, Lv P, Liu Z, Bai S. Functional, oncological outcomes and safety of nephron-sparing surgery versus radical nephrectomy in patients with localised renal cell carcinoma with high anatomical complexity: a retrospective cohort study with propensity score matching method. BMJ Open 2021;11:e051622. [PMID: 34952876 DOI: 10.1136/bmjopen-2021-051622] [Reference Citation Analysis]
300 Ho SY, Liu PH, Hsu CY, Ko CC, Huang YH, Su CW, Hsia CY, Lee RC, Hou MC, Huo TI. ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategy. J Gastrointest Oncol 2021;12:722-34. [PMID: 34012661 DOI: 10.21037/jgo-20-332] [Reference Citation Analysis]
301 Yap E, Prysyazhnyuk Y, Ouyang J, Puri I, Boutin-Foster C, Salifu M. The Implication of Dropping Race from the MDRD Equation to Estimate GFR in an African American-Only Cohort. Int J Nephrol 2021;2021:1880499. [PMID: 34824870 DOI: 10.1155/2021/1880499] [Reference Citation Analysis]
302 Marino A, Tannock LR. Role of dyslipidemia in patients with chronic kidney disease. Postgrad Med 2013;125:28-37. [PMID: 23842535 DOI: 10.3810/pgm.2013.07.2676] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
303 Pi M, Ye R, Han X, Armstrong B, Liu X, Chen Y, Sun Y, Quarles LD. Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II. Sci Rep 2018;8:12398. [PMID: 30120363 DOI: 10.1038/s41598-018-30098-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
304 Thomas G, Drawz PE. BP Measurement Techniques: What They Mean for Patients with Kidney Disease. Clin J Am Soc Nephrol 2018;13:1124-31. [PMID: 29483139 DOI: 10.2215/CJN.12551117] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
305 Lowrance WT, Ordoñez J, Udaltsova N, Russo P, Go AS. CKD and the risk of incident cancer. J Am Soc Nephrol 2014;25:2327-34. [PMID: 24876115 DOI: 10.1681/ASN.2013060604] [Cited by in Crossref: 109] [Cited by in F6Publishing: 53] [Article Influence: 13.6] [Reference Citation Analysis]
306 Wolfe R, Wetmore JB, Woods RL, McNeil JJ, Gallagher H, Roderick P, Walker R, Nelson MR, Reid CM, Shah RC, Ernst ME, Lockery JE, Tonkin AM, Abhayaratna WP, Gibbs P, Wood EM, Mahady SE, Williamson JD, Donnan GA, Cloud GC, Murray AM, Polkinghorne KR. Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease. Kidney Int 2021;99:466-74. [PMID: 32920022 DOI: 10.1016/j.kint.2020.08.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
307 Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J; GESIDA HIV/HCV Cohort Study Group. Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2017;66:344-56. [PMID: 28109003 DOI: 10.1002/hep.29071] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
308 Weiner DE, Sarnak MJ. Chronic kidney disease and cardiovascular disease: A bi-directional relationship? Dial Transplant 2007;36:113-20. [DOI: 10.1002/dat.20104] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
309 Bosworth C, de Boer IH, Targher G, Kendrick J, Smits G, Chonchol M. The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease. Clin Nephrol 2012;77:358-65. [PMID: 22551881 DOI: 10.5414/cn107180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
310 Ohta S, Asanoma M, Irie N, Tachibana N, Kohno M. Soy Phospholipids Exert a Renoprotective Effect by Inhibiting the Nuclear Factor Kappa B Pathway in Macrophages. Metabolites 2022;12:330. [DOI: 10.3390/metabo12040330] [Reference Citation Analysis]
311 Lopez-Jaramillo P, Lopez-Lopez J, Lopez-Lopez C, Rodriguez-Alvarez MI. The goal of blood pressure in the hypertensive patient with diabetes is defined: now the challenge is go from recommendations to practice. Diabetol Metab Syndr 2014;6:31. [PMID: 24594121 DOI: 10.1186/1758-5996-6-31] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
312 Carrero JJ, Qureshi AR, Parini P, Arver S, Lindholm B, Bárány P, Heimbürger O, Stenvinkel P. Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol 2009;20:613-20. [PMID: 19144759 DOI: 10.1681/ASN.2008060664] [Cited by in Crossref: 113] [Cited by in F6Publishing: 35] [Article Influence: 8.7] [Reference Citation Analysis]
313 Chan KE, Ikizler TA, Gamboa JL, Yu C, Hakim RM, Brown NJ. Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. Kidney Int 2011;80:978-85. [PMID: 21775975 DOI: 10.1038/ki.2011.228] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
314 Lasserson DS, Shine B, O'Callaghan CA, James T. Requirement for cystatin C testing in chronic kidney disease: a retrospective population-based study. Br J Gen Pract 2017;67:e732-5. [PMID: 28893765 DOI: 10.3399/bjgp17X692585] [Reference Citation Analysis]
315 Bruchfeld A, Carrero JJ, Qureshi AR, Lindholm B, Barany P, Heimburger O, Hu M, Lin X, Stenvinkel P, Miller EJ. Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation. Mol Med 2009;15:70-5. [PMID: 19081768 DOI: 10.2119/molmed.2008.00109] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
316 Navaneethan SD, Jolly SE, Sharp J, Jain A, Schold JD, Schreiber MJ Jr, Nally JV Jr. Electronic health records: a new tool to combat chronic kidney disease? Clin Nephrol 2013;79:175-83. [PMID: 23320972 DOI: 10.5414/CN107757] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
317 Nativ O, Levi A, Farfara R, Halachmi S, Moskovitz B. Degree and Predictors of Functional Loss of the Operated Kidney following Nephron-Sparing Surgery: Assessment by Quantitative SPECT of 99m Tc-Dimercaptosuccinic Acid Scintigraphy. Adv Urol 2011;2011:961525. [PMID: 21845188 DOI: 10.1155/2011/961525] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
318 Koeda Y, Tanaka F, Segawa T, Ohta M, Ohsawa M, Tanno K, Makita S, Ishibashi Y, Itai K, Omama SI, Onoda T, Sakata K, Ogasawara K, Okayama A, Nakamura M. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study. BMC Nephrol 2016;17:46. [PMID: 27169575 DOI: 10.1186/s12882-016-0261-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
319 Coskunfirat N, Hadimioglu N, Ertug Z, Akbas H, Davran F, Ozdemir B, Aktas Samur A, Arici G. Homocysteine levels after nitrous oxide anesthesia for living-related donor renal transplantation: a randomized, controlled, double-blind study. Transplant Proc 2015;47:313-8. [PMID: 25648379 DOI: 10.1016/j.transproceed.2014.10.014] [Reference Citation Analysis]
320 Kurth T, de Jong PE, Cook NR, Buring JE, Ridker PM. Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ 2009;338:b2392. [PMID: 19564178 DOI: 10.1136/bmj.b2392] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
321 Pestka JJ. n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis. Prostaglandins Leukot Essent Fatty Acids 2010;82:251-8. [PMID: 20189790 DOI: 10.1016/j.plefa.2010.02.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
322 Sim JJ, Shi J, Kovesdy CP, Kalantar-Zadeh K, Jacobsen SJ. Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population. J Am Coll Cardiol. 2014;64:588-597. [PMID: 25104529 DOI: 10.1016/j.jacc.2014.04.065] [Cited by in Crossref: 94] [Cited by in F6Publishing: 74] [Article Influence: 11.8] [Reference Citation Analysis]
323 Shiba T, Takahashi M, Maeno T. Pulse-Wave Analysis of Optic Nerve Head Circulation Is Significantly Correlated with Kidney Function in Patients with and without Chronic Kidney Disease. J Ophthalmol 2014;2014:291687. [PMID: 24678413 DOI: 10.1155/2014/291687] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
324 Noce A, Marrone G, Di Lauro M, Urciuoli S, Pietroboni Zaitseva A, Wilson Jones G, Di Daniele N, Romani A. Cardiovascular Protection of Nephropathic Male Patients by Oral Food Supplements. Cardiovasc Ther 2020;2020:1807941. [PMID: 32670409 DOI: 10.1155/2020/1807941] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
325 Liu M, Cardilla A, Ngeow J, Gong X, Xia Y. Studying Kidney Diseases Using Organoid Models. Front Cell Dev Biol 2022;10:845401. [DOI: 10.3389/fcell.2022.845401] [Reference Citation Analysis]
326 Dalton GD, Xie J, An SW, Huang CL. New Insights into the Mechanism of Action of Soluble Klotho. Front Endocrinol (Lausanne) 2017;8:323. [PMID: 29250031 DOI: 10.3389/fendo.2017.00323] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 13.0] [Reference Citation Analysis]
327 Baniel J. Management of a patient with a mass in an ectopic kidney. Curr Urol Rep 2007;8:427-30. [PMID: 18042320 DOI: 10.1007/s11934-007-0043-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
328 Gosmanova EO, Le NA. Cardiovascular Complications in CKD Patients: Role of Oxidative Stress. Cardiol Res Pract 2011;2011:156326. [PMID: 21253517 DOI: 10.4061/2011/156326] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
329 Fam JM, Khoo CY, Lau YH, Lye WK, Cai XJ, Choong LHL, Allen JC, Yeo KK. Age and diabetes mellitus associated with worse outcomes after percutaneous coronary intervention in a multi-ethnic Asian dialysis patient population. Singapore Med J 2021;62:300-4. [PMID: 32179924 DOI: 10.11622/smedj.2020025] [Reference Citation Analysis]
330 Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961-973. [PMID: 19346042 DOI: 10.1053/j.ajkd.2008.11.034] [Cited by in Crossref: 670] [Cited by in F6Publishing: 603] [Article Influence: 51.5] [Reference Citation Analysis]
331 Khaled S, Matahen R. Cardiovascular risk factors profile in patients with acute coronary syndrome with particular reference to left ventricular ejection fraction. Indian Heart J 2018;70:45-9. [PMID: 29455787 DOI: 10.1016/j.ihj.2017.05.019] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
332 Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol 2014;10:193-207. [PMID: 24445744 DOI: 10.1038/nrneph.2013.282] [Cited by in Crossref: 323] [Cited by in F6Publishing: 304] [Article Influence: 40.4] [Reference Citation Analysis]
333 Vinnakota S, Scott CG, Rodeheffer RJ, Chen HH. Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort. Mayo Clin Proc 2019;94:2189-98. [PMID: 31668448 DOI: 10.1016/j.mayocp.2019.03.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
334 Matsumoto S, Takayama T, Wakatsuki K, Tanaka T, Migita K, Nakajima Y. Short-term and long-term outcomes after gastrectomy for gastric cancer in patients with chronic kidney disease. World J Surg 2014;38:1453-60. [PMID: 24378553 DOI: 10.1007/s00268-013-2436-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
335 Lin S, Luan X, He W, Ruan Y, Yuan C, Fan A, Chen X, He J. Post-Stroke Depression and Estimated Glomerular Filtration Rate: A Prospective Stroke Cohort. Neuropsychiatr Dis Treat 2020;16:201-8. [PMID: 32021214 DOI: 10.2147/NDT.S225905] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
336 Kücükköylü S, Rump L. Niereninsuffizienz und kardiovaskuläre Erkrankungen. Internist 2012;53:791-801. [DOI: 10.1007/s00108-011-3010-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
337 Di Angelantonio E, Danesh J, Eiriksdottir G, Gudnason V. Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review. PLoS Med 2007;4:e270. [PMID: 17803353 DOI: 10.1371/journal.pmed.0040270] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
338 McIntosh AG, Parker DC, Egleston BL, Uzzo RG, Haseebuddin M, Joshi SS, Viterbo R, Greenberg RE, Chen DYT, Smaldone MC, Kutikov A. Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function. BJU Int 2019;124:999-1005. [PMID: 31145523 DOI: 10.1111/bju.14839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
339 Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T. Antihypertensive treatment and risk of cardiovascular mortality in patients with chronic kidney disease diagnosed based on the presence of proteinuria and renal function: A large longitudinal study in Japan. PLoS One 2019;14:e0225812. [PMID: 31800605 DOI: 10.1371/journal.pone.0225812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
340 Twerenbold R, Wildi K, Jaeger C, Gimenez MR, Reiter M, Reichlin T, Walukiewicz A, Gugala M, Krivoshei L, Marti N, Moreno Weidmann Z, Hillinger P, Puelacher C, Rentsch K, Honegger U, Schumacher C, Zurbriggen F, Freese M, Stelzig C, Campodarve I, Bassetti S, Osswald S, Mueller C. Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction. Circulation 2015;131:2041-50. [PMID: 25948542 DOI: 10.1161/CIRCULATIONAHA.114.014245] [Cited by in Crossref: 120] [Cited by in F6Publishing: 38] [Article Influence: 17.1] [Reference Citation Analysis]
341 Oka H, Goto H, Koizumi K, Nakamura S, Tsuneyama K, Zhou Y, Jo M, Fujimoto T, Sakurai H, Shibahara N, Saiki I, Shimada Y. Effect of Hachimijiogan against Renal Dysfunction and Involvement of Hypoxia-Inducible Factor-1α in the Remnant Kidney Model. Evid Based Complement Alternat Med 2011;2011:348686. [PMID: 21423692 DOI: 10.1155/2011/348686] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
342 Su SL, Lin C, Kao S, Wu CC, Lu KC, Lai CH, Yang HY, Chiu YL, Chen JS, Sung FC. Risk factors and their interaction on chronic kidney disease: A multi-centre case control study in Taiwan. BMC Nephrol. 2015;16:83. [PMID: 26077152 DOI: 10.1186/s12882-015-0065-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
343 Hishida M, Tamai H, Morinaga T, Maekawa M, Aoki T, Tomida H, Komatsu S, Kamiya T, Maruyama S, Matsuo S, Inaguma D. Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy. Clin Exp Nephrol 2016;20:795-807. [PMID: 26905064 DOI: 10.1007/s10157-015-1206-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
344 Susnik N, Sen P, Melk A, Schmitt R. Aging, Cellular Senescence, and Kidney Fibrosis. Curr Pathobiol Rep 2017;5:123-31. [DOI: 10.1007/s40139-017-0143-9] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
345 Kim DH, Kwon HJ, Ji SA, Jang HR, Jung SH, Kim JH, Kim JH, Lee JE, Huh W, Kim YG, Kim DJ, Oh HY. Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism. Medicine (Baltimore) 2016;95:e3930. [PMID: 27399066 DOI: 10.1097/MD.0000000000003930] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
346 Zickert A, Sundelin B, Svenungsson E, Gunnarsson I. Role of early repeated renal biopsies in lupus nephritis. Lupus Sci Med 2014;1:e000018. [PMID: 25379188 DOI: 10.1136/lupus-2014-000018] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
347 Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis. 2010;17:225-236. [PMID: 20439091 DOI: 10.1053/j.ackd.2010.03.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
348 Kitada M, Xu J, Ogura Y, Monno I, Koya D. Manganese Superoxide Dismutase Dysfunction and the Pathogenesis of Kidney Disease. Front Physiol 2020;11:755. [PMID: 32760286 DOI: 10.3389/fphys.2020.00755] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
349 Quarles LD. A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease. Semin Nephrol 2013;33:130-42. [PMID: 23465500 DOI: 10.1016/j.semnephrol.2012.12.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
350 Xie J, Cha SK, An SW, Kuro-O M, Birnbaumer L, Huang CL. Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat Commun. 2012;3:1238. [PMID: 23212367 DOI: 10.1038/ncomms2240] [Cited by in Crossref: 195] [Cited by in F6Publishing: 169] [Article Influence: 21.7] [Reference Citation Analysis]
351 Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study. PLoS Med 2016;13:e1002128. [PMID: 27648564 DOI: 10.1371/journal.pmed.1002128] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
352 Bouma-de Krijger A, van Ittersum FJ, Hoekstra T, Ter Wee PM, Vervloet MG. Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3. Clin Kidney J 2019;12:678-85. [PMID: 31584563 DOI: 10.1093/ckj/sfz027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
353 Saluk J, Hoppensteadt D, Syed D, Liles J, Abro S, Walborn A, Bansal V, Fareed J. Biomarker profiling of plasma samples utilizing RANDOX biochip array technology. Int Angiol 2017;36:499-504. [PMID: 28598140 DOI: 10.23736/S0392-9590.17.03854-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
354 Lee SW, Han SH, Yoo TH, Chung W, Park SK, Chae DW, Ahn C, Oh KH. Relationship between brachial-ankle and heart-femoral pulse wave velocities and the rapid decline of kidney function. Sci Rep 2018;8:821. [PMID: 29339822 DOI: 10.1038/s41598-018-19334-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
355 Derose SF, Rutkowski MP, Crooks PW, Shi JM, Wang JQ, Kalantar-Zadeh K, Kovesdy CP, Levin NW, Jacobsen SJ. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis 2013;62:236-44. [PMID: 23499049 DOI: 10.1053/j.ajkd.2013.01.019] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
356 Liu SY, Huang P, Zhang N. Efficacy and safety of the Fu-Zheng-Qu-Zhuo method on retarding the progress of chronic kidney disease (stage 3-4): a systematic review and meta-analysis. Ann Transl Med 2019;7:114. [PMID: 31032269 DOI: 10.21037/atm.2018.12.29] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
357 Rahman M, Hsu JY, Desai N, Hsu CY, Anderson AH, Appel LJ, Chen J, Cohen DL, Drawz PE, He J, Qiang P, Ricardo AC, Steigerwalt S, Weir MR, Wright JT Jr, Zhang X, Townsend RR; CRIC Study Investigators. Central Blood Pressure and Cardiovascular Outcomes in Chronic Kidney Disease. Clin J Am Soc Nephrol 2018;13:585-95. [PMID: 29475992 DOI: 10.2215/CJN.08620817] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
358 Esen T, Acar Ö, Musaoğlu A, Vural M. Morphometric profile of the localised renal tumors managed either by open or robot-assisted nephron-sparing surgery: the impact of scoring systems on the decision making process. BMC Urol 2013;13:63. [PMID: 24279386 DOI: 10.1186/1471-2490-13-63] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
359 Padhy S, Kar P, Ramachandran G. Prediction of Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) after Thoracic Surgery- The Role of Estimated GFR. J Clin Diagn Res 2017;11:UC13-6. [PMID: 29207812 DOI: 10.7860/JCDR/2017/27428.10616] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
360 Krishnan A, Teixeira-Pinto A, Lim WH, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Williams G, Lok CE, Diekmann F, Cross N, Sen S, Allen RDM, Chadban SJ, Pollock CA, Turner R, Tong A, Yang JYH, Williams N, Au E, Kieu A, James L, Francis A, Wong G, Craig JC. Health-Related Quality of Life in People Across the Spectrum of CKD. Kidney Int Rep 2020;5:2264-74. [PMID: 33305120 DOI: 10.1016/j.ekir.2020.09.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
361 Chen CM, Lai CC, Cheng KC, Weng SF, Liu WL, Shen HN. Effect of end-stage renal disease on long-term survival after a first-ever mechanical ventilation: a population-based study. Crit Care. 2015;19:354. [PMID: 26423892 DOI: 10.1186/s13054-015-1071-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
362 Corradi R, Kabra A, Suarez M, Oppenheimer J, Okhunov Z, White H, Nougaret S, Vargas HA, Landman J, Coleman J, Liss MA. Validation of 3D volumetric-based renal function prediction calculator for nephron sparing surgery. Int Urol Nephrol 2017;49:615-21. [PMID: 28161843 DOI: 10.1007/s11255-017-1525-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
363 Hsieh TC, Jarrett TW, Pinto PA. Current status of nephron-sparing robotic partial nephrectomy. Curr Opin Urol 2010;20:65-9. [PMID: 19898240 DOI: 10.1097/MOU.0b013e3283337b76] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
364 Rassaf T, Rammos C, Hendgen-Cotta UB, Heiss C, Kleophas W, Dellanna F, Floege J, Hetzel GR, Kelm M. Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial. Clin J Am Soc Nephrol 2016;11:108-18. [PMID: 26681132 DOI: 10.2215/CJN.05560515] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
365 Padullés A, Rama I, Llaudó I, Lloberas N. Developments in renal pharmacogenomics and applications in chronic kidney disease. Pharmgenomics Pers Med 2014;7:251-66. [PMID: 25206311 DOI: 10.2147/PGPM.S52763] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
366 Viazzi F, Leoncini G, Conti N, Tomolillo C, Giachero G, Vercelli M, Deferrari G, Pontremoli R. Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC study. Clin J Am Soc Nephrol 2010;5:1099-106. [PMID: 20430941 DOI: 10.2215/CJN.07271009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
367 Boubred F, Saint-Faust M, Buffat C, Ligi I, Grandvuillemin I, Simeoni U. Developmental origins of chronic renal disease: an integrative hypothesis. Int J Nephrol 2013;2013:346067. [PMID: 24073334 DOI: 10.1155/2013/346067] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
368 Laurita KR, Khan S, McMahon T, Dennis AT, Li V, Gaivin R, Sapa H, Fu JD, Schelling JR. Ventricular arrhythmias in mouse models of diabetic kidney disease. Sci Rep 2021;11:20570. [PMID: 34663875 DOI: 10.1038/s41598-021-99891-9] [Reference Citation Analysis]
369 Bansal N, Hsu CY, Chandra M, Iribarren C, Fortmann SP, Hlatky MA, Go AS. Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study. BMC Nephrol 2011;12:44. [PMID: 21917174 DOI: 10.1186/1471-2369-12-44] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
370 Plawecki M, Morena M, Kuster N, Chenine L, Leray-Moragues H, Jover B, Fesler P, Lotierzo M, Dupuy AM, Klouche K, Cristol JP. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction. Mediators Inflamm 2018;2018:3952526. [PMID: 30402040 DOI: 10.1155/2018/3952526] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
371 Wang XY, Tang XQ, Huang YJ, Chen WY, Yu XQ. Frequency of established cardiovascular disease and its risk factors in Chinese patients with systemic lupus erythematosus. Clin Rheumatol 2012;31:669-75. [PMID: 22193369 DOI: 10.1007/s10067-011-1910-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
372 Farmer SA, Lenzo J, Magid DJ, Gurwitz JH, Smith DH, Hsu G, Sung SH, Go AS. Hospital-level variation in use of cardiovascular testing for adults with incident heart failure: findings from the cardiovascular research network heart failure study. JACC Cardiovasc Imaging 2014;7:690-700. [PMID: 24954463 DOI: 10.1016/j.jcmg.2014.02.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
373 Kao CC, Wu MS, Chuang MT, Lin YC, Huang CY, Chang WC, Chen CW, Chang TH. Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease. PLoS One 2021;16:e0255645. [PMID: 34347826 DOI: 10.1371/journal.pone.0255645] [Reference Citation Analysis]
374 Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int. 2014;85:142-150. [PMID: 23884339 DOI: 10.1038/ki.2013.271] [Cited by in Crossref: 130] [Cited by in F6Publishing: 117] [Article Influence: 14.4] [Reference Citation Analysis]
375 Park M, Shlipak MG, Katz R, Agarwal S, Ix JH, Hsu CY, Peralta CA. Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 2012;7:1137-44. [PMID: 22580783 DOI: 10.2215/CJN.01230212] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
376 An JY, Ball MW, Gorin MA, Hong JJ, Johnson MH, Pavlovich CP, Allaf ME, Pierorazio PM. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes. Urology 2017;100:151-7. [PMID: 27889493 DOI: 10.1016/j.urology.2016.10.047] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
377 Brady M, O'Donoghue D. The role of primary care in managing chronic kidney disease. Br J Gen Pract 2010;60:396-7. [PMID: 20529491 DOI: 10.3399/bjgp10X502065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
378 Eckel RH, Bornfeldt KE, Goldberg IJ. Cardiovascular disease in diabetes, beyond glucose. Cell Metab 2021;33:1519-45. [PMID: 34289375 DOI: 10.1016/j.cmet.2021.07.001] [Reference Citation Analysis]
379 Porter A, Fischer MJ, Wang X, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Hiremath L, Kendrick C, Kusek JW, Norris KC, Thornley-Brown D, Greene T, Lash JP; AASK Study Group. Quality of life and outcomes in African Americans with CKD. J Am Soc Nephrol 2014;25:1849-55. [PMID: 24700865 DOI: 10.1681/ASN.2013080835] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
380 Peralta CA, Frigaard M, Rubinsky AD, Rolon L, Lo L, Voora S, Seal K, Tuot D, Chao S, Lui K, Chiao P, Powe N, Shlipak M. Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans. BMC Nephrol 2017;18:132. [PMID: 28399844 DOI: 10.1186/s12882-017-0541-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
381 Lin C, Yang HY, Wu CC, Lee HS, Lin YF, Lu KC, Chu CM, Lin FH, Kao SY, Su SL. Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension--a meta-regression analysis of 98 observational studies. PLoS One 2014;9:e87604. [PMID: 24498151 DOI: 10.1371/journal.pone.0087604] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
382 Horibe H, Fujimaki T, Oguri M, Kato K, Matsuoka R, Abe S, Tokoro F, Arai M, Noda T, Watanabe S, Yamada Y. Association of a polymorphism of the interleukin 6 receptor gene with chronic kidney disease in Japanese individuals. Nephrology (Carlton) 2015;20:273-8. [PMID: 25524550 DOI: 10.1111/nep.12381] [Cited by in Crossref: 9] [Article Influence: 1.1] [Reference Citation Analysis]
383 Sugano N, Maruyama Y, Kidoguchi S, Ohno I, Wada A, Shigematsu T, Masakane I, Yokoo T. Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study. PLoS One 2019;14:e0217859. [PMID: 31170241 DOI: 10.1371/journal.pone.0217859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
384 Wang X, Chen H, Shao X, Xiong C, Hong G, Chen J, Li X, You X, Gao P, Chen Y, Zou Z, Ning J, Xiao H, Zou H, Wei L. Association of Lipid Parameters with the Risk of Chronic Kidney Disease: A Longitudinal Study Based on Populations in Southern China. Diabetes Metab Syndr Obes 2020;13:663-70. [PMID: 32184645 DOI: 10.2147/DMSO.S229362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
385 Davenport MS, Chandarana H, Curci NE, Doshi A, Kaffenberger SD, Pedrosa I, Remer EM, Schieda N, Shinagare AB, Smith AD, Wang ZJ, Wells SA, Silverman SG. Society of Abdominal Radiology disease-focused panel on renal cell carcinoma: update on past, current, and future goals. Abdom Radiol (NY) 2018;43:2213-20. [PMID: 29948056 DOI: 10.1007/s00261-018-1663-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
386 Zhang R, Yu Y, Deng J, Zhang C, Zhang J, Cheng Y, Luo X, Han B, Yang H. Sesamin Ameliorates High-Fat Diet-Induced Dyslipidemia and Kidney Injury by Reducing Oxidative Stress. Nutrients 2016;8:E276. [PMID: 27171111 DOI: 10.3390/nu8050276] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
387 Khatri M, Nickolas T, Moon YP, Paik MC, Rundek T, Elkind MS, Sacco RL, Wright CB. CKD associates with cognitive decline. J Am Soc Nephrol. 2009;20:2427-2432. [PMID: 19729443 DOI: 10.1681/asn.2008101090] [Cited by in Crossref: 92] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
388 Chang TI, Gao L, Brown TM, Safford MM, Judd SE, McClellan WM, Limdi NA, Muntner P, Winkelmayer WC. Use of secondary prevention medications among adults with reduced kidney function. Clin J Am Soc Nephrol 2012;7:604-11. [PMID: 22344513 DOI: 10.2215/CJN.11441111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
389 Matkar PN, Ariyagunarajah R, Leong-Poi H, Singh KK. Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis. Biomolecules 2017;7:E74. [PMID: 28974056 DOI: 10.3390/biom7040074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
390 Alique M, Ramírez-Carracedo R, Bodega G, Carracedo J, Ramírez R. Senescent Microvesicles: A Novel Advance in Molecular Mechanisms of Atherosclerotic Calcification. Int J Mol Sci 2018;19:E2003. [PMID: 29987251 DOI: 10.3390/ijms19072003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
391 Liu ES, Thoonen R, Petit E, Yu B, Buys ES, Scherrer-Crosbie M, Demay MB. Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH. Endocrinology 2018;159:2165-72. [PMID: 29635291 DOI: 10.1210/en.2018-00174] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
392 Bansal N, Szpiro A, Masoudi F, Greenlee RT, Smith DH, Magid DJ, Gurwitz JH, Reynolds K, Tabada GH, Sung SH, Dighe A, Cassidy-Bushrow A, Garcia-Montilla R, Hammill S, Hayes J, Kadish A, Sharma P, Varosy P, Vidaillet H, Go AS. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart 2017;103:529-37. [PMID: 27742796 DOI: 10.1136/heartjnl-2016-309842] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
393 Peters LJF, Floege J, Biessen EAL, Jankowski J, van der Vorst EPC. MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application. Int J Mol Sci 2020;21:E6547. [PMID: 32906849 DOI: 10.3390/ijms21186547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
394 Tsuchida Y, Zhong J, Otsuka T, Dikalova A, Pastan I, Anantharamaiah GM, Linton MF, Yancey PG, Ikizler TA, Fogo AB, Yang H, Kon V. Lipoprotein modulation of proteinuric renal injury. Lab Invest 2019;99:1107-16. [PMID: 31019291 DOI: 10.1038/s41374-019-0253-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
395 Tuegel C, Katz R, Alam M, Bhat Z, Bellovich K, de Boer I, Brosius F, Gadegbeku C, Gipson D, Hawkins J, Himmelfarb J, Ju W, Kestenbaum B, Kretzler M, Robinson-Cohen C, Steigerwalt S, Bansal N. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD. Am J Kidney Dis 2018;72:519-28. [PMID: 29866459 DOI: 10.1053/j.ajkd.2018.03.025] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
396 Uffort EE, Jensen JC. Two-year outcomes after robotic renal surgery: a single surgeon's experience. J Robot Surg 2010;4:205-10. [PMID: 27627946 DOI: 10.1007/s11701-010-0198-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
397 Königsbrügge O, Posch F, Antlanger M, Kovarik J, Klauser-Braun R, Kletzmayr J, Schmaldienst S, Auinger M, Zuntner G, Lorenz M, Grilz E, Stampfel G, Steiner S, Pabinger I, Säemann M, Ay C. Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI). PLoS One 2017;12:e0169400. [PMID: 28052124 DOI: 10.1371/journal.pone.0169400] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
398 Kodera R, Shikata K, Kataoka HU, Takatsuka T, Miyamoto S, Sasaki M, Kajitani N, Nishishita S, Sarai K, Hirota D, Sato C, Ogawa D, Makino H. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia 2011;54:965-78. [PMID: 21253697 DOI: 10.1007/s00125-010-2028-x] [Cited by in Crossref: 222] [Cited by in F6Publishing: 211] [Article Influence: 20.2] [Reference Citation Analysis]
399 Htun P, Fateh-Moghadam S, Bischofs C, Banya W, Müller K, Bigalke B, Stellos K, May AE, Flather M, Gawaz M, Geisler T. Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. J Am Soc Nephrol 2011;22:627-33. [PMID: 21273381 DOI: 10.1681/ASN.2010020220] [Cited by in Crossref: 58] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
400 Beller GA. Chronic kidney disease and risk for coronary events: value of myocardial perfusion imaging. J Nucl Cardiol 2010;17:759-60. [PMID: 20811968 DOI: 10.1007/s12350-010-9286-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
401 Sánchez E, Betriu À, Arroyo D, López C, Hernández M, Rius F, Fernández E, Lecube A. Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study. PLoS One 2017;12:e0170778. [PMID: 28141808 DOI: 10.1371/journal.pone.0170778] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
402 Mafham M, Emberson J, Landray MJ, Wen CP, Baigent C. Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis. PLoS One 2011;6:e25920. [PMID: 22039429 DOI: 10.1371/journal.pone.0025920] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
403 Bay BN, Black P. Double jeopardy? Renal-sparing management of simultaneous ipsilateral renal cell carcinoma and urothelial carcinoma. Can Urol Assoc J 2013;7:E508-10. [PMID: 23914271 DOI: 10.5489/cuaj.409] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
404 Liu KD, Yang W, Go AS, Anderson AH, Feldman HI, Fischer MJ, He J, Kallem RR, Kusek JW, Master SR, Miller ER, Rosas SE, Steigerwalt S, Tao K, Weir MR, Hsu CY; CRIC Study Investigators. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015;65:267-274. [PMID: 25311702 DOI: 10.1053/j.ajkd.2014.07.025] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
405 Kaesler N, Schreibing F, Speer T, Puente-Secades S, Rapp N, Drechsler C, Kabgani N, Kuppe C, Boor P, Jankowski V, Schurgers L, Kramann R, Floege J. Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease. Kidney Int 2021:S0085-2538(21)01056-5. [PMID: 34774554 DOI: 10.1016/j.kint.2021.10.029] [Reference Citation Analysis]
406 Büyükbakkal M, Canbakan B, Eser B, Yayar Ö, Ercan Z, Merhametsiz Ö, Haspulat A, Ayli MD. The relation between apelin levels, echocardiographic findings and carotid intima media thickness in peritoneal dialysis patients. Ren Fail 2015;37:433-8. [PMID: 25578816 DOI: 10.3109/0886022X.2014.996108] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
407 Ichii T, Morimoto R, Okumura T, Ishii H, Tatami Y, Yamamoto D, Aoki S, Hiraiwa H, Furusawa K, Kondo T, Watanabe N, Kano N, Fukaya K, Sawamura A, Suzuki S, Yasuda Y, Murohara T. Impact of Renal Functional/Morphological Dynamics on the Calcification of Coronary and Abdominal Arteries in Patients with Chronic Kidney Disease. J Atheroscler Thromb 2017;24:1092-104. [PMID: 28392544 DOI: 10.5551/jat.39271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
408 . Survey of Endourology Howard N. Winfield, M.D., Section Editor. Journal of Endourology 2012;26:1392-408. [DOI: 10.1089/end.2012.1542] [Reference Citation Analysis]
409 Pereira RMR, Freitas TQ, Franco AS, Takayama L, Caparbo VF, Domiciano DS, Machado LG, Figueiredo CP, Menezes PR, Onuchic LF, de Castro I. KLOTHO polymorphisms and age-related outcomes in community-dwelling older subjects: The São Paulo Ageing & Health (SPAH) Study. Sci Rep 2020;10:8574. [PMID: 32444684 DOI: 10.1038/s41598-020-65441-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
410 Gorriz JL, Arroyo D, D'Marco L, Torra R, Tomás P, Puchades MJ, Panizo N, Pantoja J, Montomoli M, Llisterri JL, Pallares-Carratalá V, Valdivielso JM. Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease. BMC Nephrol 2021;22:110. [PMID: 33765945 DOI: 10.1186/s12882-021-02313-1] [Reference Citation Analysis]
411 D'Marco L, Bellasi A, Raggi P. Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability. Dis Markers 2015;2015:586569. [PMID: 25944976 DOI: 10.1155/2015/586569] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
412 Oh YJ, Cha RH, Lee SH, Yu KS, Kim SE, Kim H, Kim YS. Validation of the Korean coefficient for the modification of diet in renal disease study equation. Korean J Intern Med 2016;31:344-56. [PMID: 26759158 DOI: 10.3904/kjim.2015.227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
413 Grams ME, Coresh J, Segev DL, Kucirka LM, Tighiouart H, Sarnak MJ. Vascular disease, ESRD, and death: interpreting competing risk analyses. Clin J Am Soc Nephrol. 2012;7:1606-1614. [PMID: 22859747 DOI: 10.2215/cjn.03460412] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
414 van Bladel ER, de Jager RL, Walter D, Cornelissen L, Gaillard CA, Boven LA, Roest M, Fijnheer R. Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro. BMC Nephrol 2012;13:127. [PMID: 23020133 DOI: 10.1186/1471-2369-13-127] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
415 Van Treuren W, Dodd D. Microbial Contribution to the Human Metabolome: Implications for Health and Disease. Annu Rev Pathol 2020;15:345-69. [PMID: 31622559 DOI: 10.1146/annurev-pathol-020117-043559] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
416 Tanasa A, Burlacu A, Popa C, Kanbay M, Brinza C, Macovei L, Crisan-Dabija R, Covic A. A Systematic Review on the Correlations between Left Atrial Strain and Cardiovascular Outcomes in Chronic Kidney Disease Patients. Diagnostics (Basel) 2021;11:671. [PMID: 33917937 DOI: 10.3390/diagnostics11040671] [Reference Citation Analysis]
417 Chen L, Wang Y, Li S, Zuo B, Zhang X, Wang F, Sun D. Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1/eNOS signaling pathway. Theranostics 2020;10:9425-42. [PMID: 32802201 DOI: 10.7150/thno.43315] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
418 Chen SC, Su HM, Hung CC, Chang JM, Liu WC, Tsai JC, Lin MY, Hwang SJ, Chen HC. Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:2750-2758. [PMID: 21980185 DOI: 10.2215/cjn.04660511] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
419 Al-Shamsi S, Oulhaj A, Regmi D, Govender RD. Use of estimated glomerular filtration rate to predict incident chronic kidney disease in patients at risk of cardiovascular disease: a retrospective study. BMC Nephrol 2019;20:325. [PMID: 31429712 DOI: 10.1186/s12882-019-1494-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
420 Giorgino F, Vora J, Fenici P, Solini A. Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk. Cardiovasc Diabetol 2020;19:196. [PMID: 33222693 DOI: 10.1186/s12933-020-01163-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
421 Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014;25:349-360. [PMID: 24158986 DOI: 10.1681/asn.2013050465] [Cited by in Crossref: 262] [Cited by in F6Publishing: 165] [Article Influence: 29.1] [Reference Citation Analysis]
422 Nair SM, Power NE, Coleman JA. Examining Mannitol Use in Kidney Cancer Surgery: A Cautionary Tale of Extrapolated Surgical Data. Eur Urol Focus 2019;5:930-4. [PMID: 31628080 DOI: 10.1016/j.euf.2019.09.021] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
423 Stevens LA, Padala S, Levey AS. Advances in glomerular filtration rate-estimating equations. Curr Opin Nephrol Hypertens 2010;19:298-307. [PMID: 20393287 DOI: 10.1097/MNH.0b013e32833893e2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
424 Zhao X, Liu C, Zhou P, Sheng Z, Li J, Zhou J, Chen R, Wang Y, Chen Y, Song L, Zhao H, Yan H. Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study. Front Cardiovasc Med 2020;7:603621. [PMID: 33330667 DOI: 10.3389/fcvm.2020.603621] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
425 Sureshkumar KK, Chopra B. Induction Type and Outcomes in HLA-DR Mismatch Kidney Transplantation. Transplant Proc 2019;51:1796-800. [PMID: 31399165 DOI: 10.1016/j.transproceed.2019.04.059] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
426 Tanner RM, Gutiérrez OM, Judd S, McClellan W, Bowling CB, Bradbury BD, Safford MM, Cushman M, Warnock D, Muntner P. Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis 2013;61:395-403. [PMID: 23228944 DOI: 10.1053/j.ajkd.2012.10.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
427 Marney AM, Ma J, Luther JM, Ikizler TA, Brown NJ. Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis. J Am Soc Nephrol 2009;20:2246-52. [PMID: 19628666 DOI: 10.1681/ASN.2009050505] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
428 Stubbs JR, Stedman MR, Liu S, Long J, Franchetti Y, West RE 3rd, Prokopienko AJ, Mahnken JD, Chertow GM, Nolin TD. Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis. Clin J Am Soc Nephrol 2019;14:261-7. [PMID: 30665924 DOI: 10.2215/CJN.06190518] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 8.7] [Reference Citation Analysis]
429 Kroner PT, Mareth K, Raimondo M, Lee DD, Alsaad A, Aslam N, Abader P, Wadei HM. Acute Pancreatitis in Advanced Chronic Kidney Disease and Kidney Transplant Recipients: Results of a US Nationwide Analysis. Mayo Clin Proc Innov Qual Outcomes 2019;3:160-8. [PMID: 31193877 DOI: 10.1016/j.mayocpiqo.2019.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
430 Oh KH, Park SK, Park HC, Chin HJ, Chae DW, Choi KH, Han SH, Yoo TH, Lee K, Kim YS, Chung W, Hwang YH, Kim SW, Kim YH, Kang SW, Park BJ, Lee J, Ahn C; Representing KNOW-CKD Study Group. KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. BMC Nephrol 2014;15:80. [PMID: 24884708 DOI: 10.1186/1471-2369-15-80] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 10.9] [Reference Citation Analysis]
431 Wiggins JE, Patel SR, Shedden KA, Goyal M, Wharram BL, Martini S, Kretzler M, Wiggins RC. NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J Am Soc Nephrol 2010;21:587-97. [PMID: 20150534 DOI: 10.1681/ASN.2009060663] [Cited by in Crossref: 74] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
432 Kampmann JD, Goya Heaf J, Mogensen CB, Mickley H, Brandt F. Kidney Disease Cohort (KidDiCo) of Southern Denmark: Design, Coverage, Generalizability and Implications for Use. Clin Epidemiol 2021;13:971-80. [PMID: 34703319 DOI: 10.2147/CLEP.S328512] [Reference Citation Analysis]
433 Pickering W. Home haemodialysis dose: how much of a good thing? J Ren Care 2013;39 Suppl 1:35-41. [PMID: 23464912 DOI: 10.1111/j.1755-6686.2013.00344.x] [Reference Citation Analysis]
434 Sattar S, Ahmed N, Akhter Z, Aijaz S, Lakhani S, Malik R, Pathan A. In-Hospital outcomes in acute coronary syndrome patients with concomitant severe chronic kidney disease undergoing percutaneous coronary intervention. Pak J Med Sci 2019;35:291-7. [PMID: 31086503 DOI: 10.12669/pjms.35.2.276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
435 Van den Eynde J, Salaets T, Louw JJ, Herman J, Breysem L, Vlasselaers D, Desmet L, Meyns B, Budts W, Gewillig M, Mekahli D. Persistent Markers of Kidney Injury in Children Who Developed Acute Kidney Injury After Pediatric Cardiac Surgery: A Prospective Cohort Study. J Am Heart Assoc 2022;:e024266. [PMID: 35301866 DOI: 10.1161/JAHA.121.024266] [Reference Citation Analysis]
436 Wouters OJ, O’Donoghue DJ, Ritchie J, Kanavos PG, Narva AS. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol. 2015;11:491-502. [PMID: 26055354 DOI: 10.1038/nrneph.2015.85] [Cited by in Crossref: 96] [Cited by in F6Publishing: 73] [Article Influence: 13.7] [Reference Citation Analysis]
437 How PP, Mason DL, Lau AH. Current Approaches in the Treatment of Chronic Kidney Disease Mineral and Bone Disorder. Journal of Pharmacy Practice 2008;21:196-213. [DOI: 10.1177/0897190008315905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
438 Kaysen G. Dialysis removes apolipoprotein C-I, improving very low-density lipoprotein clearance. Kidney International 2007;72:779-81. [DOI: 10.1038/sj.ki.5002478] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
439 Taniguchi Y, Sakakura K, Wada H, Sugawara Y, Funayama H, Kubo N, Momomura S, Ako J. Contrast induced exacerbation of renal dysfunction in the advanced chronic kidney disease. Cardiovasc Interv Ther 2013;28:157-61. [PMID: 23136052 DOI: 10.1007/s12928-012-0143-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
440 Lee CC, Hsu CC, Lin MH, Sung JM, Kuo TH. Healthcare utilization and expenditure among individuals with end-stage kidney disease in Taiwan. J Formos Med Assoc 2021:S0929-6646(21)00575-1. [PMID: 34980549 DOI: 10.1016/j.jfma.2021.12.010] [Reference Citation Analysis]
441 Coleman KJ, Shu YH, Fischer H, Johnson E, Yoon TK, Taylor B, Imam T, DeRose S, Haneuse S, Herrinton LJ, Fisher D, Li RA, Theis MK, Liu L, Courcoulas AP, Smith DH, Arterburn DE, Friedman AN. Bariatric Surgery and Risk of Death in Persons with Chronic Kidney Disease. Ann Surg 2021. [PMID: 33914480 DOI: 10.1097/SLA.0000000000004851] [Reference Citation Analysis]
442 Ye M, Tian N, Liu Y, Li W, Lin H, Fan R, Li C, Liu D, Yao F. High Serum Phosphorus Level Is Associated with Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis Patients. PLoS One 2016;11:e0163659. [PMID: 27661984 DOI: 10.1371/journal.pone.0163659] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
443 Shroff GR, Frederick PD, Herzog CA. Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. Am Heart J 2012;163:399-406. [PMID: 22424010 DOI: 10.1016/j.ahj.2011.12.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
444 Voylenko OA, Stakhovsky OE, Vitruk IV, Kononenko OA, Pikul MV, Semko SL, Stakhovsky EO. Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localised Clear-Cell Renal Cell Carcinoma. Adv Urol 2021;2021:6674637. [PMID: 34012466 DOI: 10.1155/2021/6674637] [Reference Citation Analysis]
445 Anderson JLC, Pagano S, Virzi J, Dullaart RPF, Annema W, Kuipers F, Bakker SJL, Vuilleumier N, Tietge UJF. Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients. J Clin Med 2019;8:E948. [PMID: 31261925 DOI: 10.3390/jcm8070948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
446 Tsujimoto T, Sugiyama T, Yamamoto-Honda R, Kishimoto M, Noto H, Morooka M, Kubota K, Kamimura M, Hara H, Kajio H, Kakei M, Noda M. Beneficial effects through aggressive coronary screening for type 2 diabetes patients with advanced vascular complications. Medicine (Baltimore) 2016;95:e4307. [PMID: 27537556 DOI: 10.1097/MD.0000000000004307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
447 Meijers BK, Claes K, Bammens B, de Loor H, Viaene L, Verbeke K, Kuypers D, Vanrenterghem Y, Evenepoel P. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin J Am Soc Nephrol 2010;5:1182-9. [PMID: 20430946 DOI: 10.2215/CJN.07971109] [Cited by in Crossref: 194] [Cited by in F6Publishing: 99] [Article Influence: 16.2] [Reference Citation Analysis]
448 Lee H, Choi S, Jang EJ, Lee J, Kim D, Yoo S, Oh SY, Ryu HG. Effect of Institutional Case Volume on In-Hospital and Long-Term Mortality in Critically Ill Patients Requiring Mechanical Ventilation for 48 Hours or More. J Korean Med Sci 2019;34:e212. [PMID: 31456380 DOI: 10.3346/jkms.2019.34.e212] [Reference Citation Analysis]
449 Vetrovec GW. Recognizing and reducing the cardiac risk of renal failure. Catheter Cardiovasc Interv 2008;72:355-6. [PMID: 18729175 DOI: 10.1002/ccd.21734] [Reference Citation Analysis]
450 Karur GR, Wald R, Goldstein MB, Wald R, Jimenez-Juan L, Kiaii M, Leipsic J, Kirpalani A, Bello O, Barthur A, Ng MY, Deva DP, Yan AT. Association between conversion to in-center nocturnal hemodialysis and right ventricular remodeling. Nephrol Dial Transplant 2018;33:1010-6. [PMID: 28992094 DOI: 10.1093/ndt/gfx232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
451 Kurata M, Takenouchi A, Tsuboi A, Minato S, Takeuchi M, Kitaoka K, Fukuo K, Kazumi T. The Cluster of Abnormalities Related to Metabolic Syndrome Is Associated With Reduced Glomerular Filtration Rate and Raised Albuminuria in Patients With Type 2 Diabetes Mellitus. J Clin Med Res 2017;9:759-64. [PMID: 28811852 DOI: 10.14740/jocmr3097w] [Reference Citation Analysis]
452 Go AS, Yang J, Tan TC, Cabrera CS, Stefansson BV, Greasley PJ, Ordonez JD; Kaiser Permanente Northern California CKD Outcomes Study. Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus. BMC Nephrol 2018;19:146. [PMID: 29929484 DOI: 10.1186/s12882-018-0942-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
453 Wang J, Lv J, He K, Wang F, Gao B, Zhao MH, Zhang L; Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). Association of left ventricular hypertrophy and functional impairment with cardiovascular outcomes and mortality among patients with chronic kidney disease, results from the C-STRIDE study. Nephrology (Carlton) 2021. [PMID: 34843156 DOI: 10.1111/nep.14009] [Reference Citation Analysis]
454 Abdallah E, Mosbah O, Khalifa G, Metwaly A, El-Bendary O. Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients. Kidney Res Clin Pract 2016;35:42-9. [PMID: 27069857 DOI: 10.1016/j.krcp.2015.12.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
455 Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, Malluche HH, Hruska KA. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney Int 2018;93:147-58. [PMID: 28843411 DOI: 10.1016/j.kint.2017.06.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
456 Ide H, Iwase M, Fujii H, Ohkuma T, Kaizu S, Jodai T, Kikuchi Y, Idewaki Y, Sumi A, Nakamura U, Kitazono T. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry. Clin Exp Nephrol 2017;21:383-90. [PMID: 27339449 DOI: 10.1007/s10157-016-1296-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
457 Otobe Y, Rhee CM, Nguyen M, Kalantar-Zadeh K, Kopple JD. Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients. Curr Opin Nephrol Hypertens 2022;31:109-28. [PMID: 34772840 DOI: 10.1097/MNH.0000000000000763] [Reference Citation Analysis]
458 Yang F, Zhou Q, Xing N. Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma. J Cancer Res Clin Oncol 2020;146:261-72. [DOI: 10.1007/s00432-019-03058-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
459 Adam WR, Wright JR. Use of renin angiotensin system inhibitors in patients with chronic kidney disease. Intern Med J 2016;46:626-30. [PMID: 27170242 DOI: 10.1111/imj.13060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
460 Toto RD. Pressure, waves, and kidney outcomes in kidney transplant donors and recipients. Hypertension 2006;47:141-2. [PMID: 16401760 DOI: 10.1161/01.HYP.0000201235.90035.6c] [Reference Citation Analysis]
461 Talbot B, Athavale A, Jha V, Gallagher M. Data Challenges in Addressing Chronic Kidney Disease in Low- and Lower-Middle-Income Countries. Kidney Int Rep 2021;6:1503-12. [PMID: 34169191 DOI: 10.1016/j.ekir.2021.03.901] [Reference Citation Analysis]
462 DeBoer MD, Filipp SL, Musani SK, Sims M, Okusa MD, Gurka M. Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study. Kidney Blood Press Res 2018;43:555-67. [PMID: 29642060 DOI: 10.1159/000488829] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
463 Dan K, Miyoshi T, Nakahama M, Mizuno T, Kagawa K, Naito Y, Kawada S, Ito H. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein. Cardiorenal Med 2018;8:151-9. [PMID: 29617004 DOI: 10.1159/000486971] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
464 Horikoshi S, Higurashi A, Kaneko E, Yoshimura H, Ohsawa I, Suzuki Y, Hamada C, Tomino Y. A new screening method for proteinuria using Erythrosin B and an automated analyzer--rapid, sensitive and inexpensive determination. Clin Chim Acta 2012;413:1087-91. [PMID: 22465201 DOI: 10.1016/j.cca.2012.02.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
465 Wang Z, Xiao J, Zhang Z, Qiu X, Chen Y. Chronic kidney disease can increase the risk of preoperative deep vein thrombosis in middle-aged and elderly patients with hip fractures. Clin Interv Aging 2018;13:1669-74. [PMID: 30237703 DOI: 10.2147/CIA.S174691] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
466 Yu L, Zhou L, Zhou D, Hu G. Nonlinear relationship between triglyceride/high-density lipoprotein cholesterol ratio and chronic kidney disease in US adults: a National Health and Nutrition Examination Survey investigation. Int Urol Nephrol 2019;51:2005-14. [PMID: 31538278 DOI: 10.1007/s11255-019-02287-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
467 Boriani G, Savelieva I, Dan GA, Deharo JC, Ferro C, Israel CW, Lane DA, La Manna G, Morton J, Mitjans AM, Vos MA, Turakhia MP, Lip GY; Document reviewers. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 2015;17:1169-96. [PMID: 26108808 DOI: 10.1093/europace/euv202] [Cited by in Crossref: 89] [Cited by in F6Publishing: 70] [Article Influence: 12.7] [Reference Citation Analysis]
468 Park M, Vittinghoff E, Shlipak MG, Mishra R, Whooley M, Bansal N. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study. Am Heart J 2014;168:931-9.e2. [PMID: 25458658 DOI: 10.1016/j.ahj.2014.09.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
469 Schmidt B, Velaer KN, Thomas IC, Ganesan C, Song S, Pao AC, Thong AE, Liao JC, Chertow GM, Skinner EC, Leppert JT. Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer. Eur Urol Open Sci 2022;35:29-36. [PMID: 35024629 DOI: 10.1016/j.euros.2021.11.001] [Reference Citation Analysis]
470 Ose L. Pitavastatin: finding its place in therapy. Ther Adv Chronic Dis 2011;2:101-17. [PMID: 23251745 DOI: 10.1177/2040622310389227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
471 Odden MC, Amadu AR, Smit E, Lo L, Peralta CA. Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002. Am J Kidney Dis 2014;64:550-7. [PMID: 24906981 DOI: 10.1053/j.ajkd.2014.04.024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 11.3] [Reference Citation Analysis]
472 Nagai K, Iseki C, Iseki K, Kondo M, Asahi K, Saito C, Tsunoda R, Okubo R, Yamagata K. Higher medical costs for CKD patients with a rapid decline in eGFR: A cohort study from the Japanese general population. PLoS One 2019;14:e0216432. [PMID: 31100069 DOI: 10.1371/journal.pone.0216432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
473 Minutolo R, Aghemo A, Chirianni A, Fabrizi F, Gesualdo L, Giannini EG, Maggi P, Montinaro V, Paoletti E, Persico M, Perticone F, Petta S, Puoti M, Raimondo G, Rendina M, Zignego AL; Italian Society of Nephrology (SIN)., Italian Association for the Study of the Liver (AISF)., Italian Society of Infectious and Tropical Disease (SIMIT)., Italian Society of Internal Medicine (SIMI). Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Intern Emerg Med 2018;13:1139-66. [PMID: 30255464 DOI: 10.1007/s11739-018-1940-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
474 Park HS, Kim CJ, Hwang BH, Kim TH, Koh YS, Park HJ, Her SH, Jang SW, Park CS, Lee JM, Kim HY, Jeon DS, Kim PJ, Yoo KD, Chang K, Jin DC, Seung KB. HDL Cholesterol Level Is Associated with Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing PCI. Sci Rep 2016;6:35774. [PMID: 27775043 DOI: 10.1038/srep35774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
475 Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GF. Dietary interventions for adults with chronic kidney disease. Cochrane Database Syst Rev 2017;4:CD011998. [PMID: 28434208 DOI: 10.1002/14651858.CD011998.pub2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
476 Charlton JR, Guillet R. Neonatal Acute Kidney Injury: Diagnosis, Exposures, and Long-term Outcomes. NeoReviews 2018;19:e322-36. [DOI: 10.1542/neo.19-6-e322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
477 Rashid P, Goad J, Aron M, Gianduzzo T, Gill IS. Re: dilemma of small renal masses. ANZ J Surg 2009;79:88; author reply 88. [PMID: 19183392 DOI: 10.1111/j.1445-2197.2008.04812_1.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
478 Iwagami M, Caplin B, Smeeth L, Tomlinson LA, Nitsch D. Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data. Br J Gen Pract 2018;68:e512-23. [PMID: 30012811 DOI: 10.3399/bjgp18X697973] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
479 Glassock RJ, Winearls C. Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol 2008;3:1563-8. [PMID: 18667744 DOI: 10.2215/CJN.00960208] [Cited by in Crossref: 117] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
480 Özcan MF, Altınova S, Atan A. Treatment approaches to small renal masses in patients of advanced age (≥75 years). Turk J Urol 2018;44:281-6. [PMID: 29932396 DOI: 10.5152/tud.2018.04829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
481 Buffi NM, Lughezzani G, Lazzeri M, Casale P, Fiorini G, Hurle R, Taverna GL, Guazzoni G. [The added value of robotic surgery]. Urologia 2015;82 Suppl 1:S11-3. [PMID: 26429388 DOI: 10.5301/uro.5000149] [Reference Citation Analysis]
482 Jose MD, Raj R, Jose K, Kitsos A, Saunder T, McKercher C, Radford J. Competing risks of death and kidney failure in a cohort of Australian adults with severe chronic kidney disease. Med J Aust 2021. [PMID: 34866191 DOI: 10.5694/mja2.51361] [Reference Citation Analysis]
483 Li J, Yu J, Huang N, Ye H, Wang D, Peng Y, Guo X, Yi C, Yang X, Yu X. Prevalence, risk factors and impact on outcomes of 30-day unexpected rehospitalization in incident peritoneal dialysis patients. BMC Nephrol 2021;22:4. [PMID: 33407231 DOI: 10.1186/s12882-020-02201-0] [Reference Citation Analysis]
484 Zhang X, Hu L, Zheng W. Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction. Sci Rep 2018;8:2283. [PMID: 29396517 DOI: 10.1038/s41598-018-20651-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
485 van der Zee S, Baber U, Elmariah S, Winston J, Fuster V. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol 2009;6:580-9. [PMID: 19621012 DOI: 10.1038/nrcardio.2009.121] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
486 Kritmetapak K, Losbanos L, Berent TE, Ashrafzadeh-Kian SL, Algeciras-Schimnich A, Hines JM, Singh RJ, Kumar R. Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)2D and normal FGF7 concentrations characterize patients with CKD. BMC Nephrol 2021;22:114. [PMID: 33784965 DOI: 10.1186/s12882-021-02311-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
487 Sharma P, Fenton A, Dias IHK, Heaton B, Brown CLR, Sidhu A, Rahman M, Griffiths HR, Cockwell P, Ferro CJ, Chapple IL, Dietrich T. Oxidative stress links periodontal inflammation and renal function. J Clin Periodontol 2021;48:357-67. [PMID: 33368493 DOI: 10.1111/jcpe.13414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
488 Jaworska K, Hering D, Mosieniak G, Bielak-Zmijewska A, Pilz M, Konwerski M, Gasecka A, Kapłon-Cieślicka A, Filipiak K, Sikora E, Hołyst R, Ufnal M. TMA, A Forgotten Uremic Toxin, but Not TMAO, Is Involved in Cardiovascular Pathology. Toxins (Basel) 2019;11:E490. [PMID: 31454905 DOI: 10.3390/toxins11090490] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 12.7] [Reference Citation Analysis]
489 Zijlstra LE, Trompet S, Mooijaart SP, van Buren M, Sattar N, Stott DJ, Jukema JW. The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis. BMC Nephrol 2020;21:81. [PMID: 32138689 DOI: 10.1186/s12882-020-01745-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
490 Foote C, Hockham C, Sukkar L, Campain A, Kang A, Young T, Cass A, Chow CK, Comino E, Gallagher M, Jan S, Knight J, Liu B, McNamara M, Peiris D, Pollock C, Sullivan D, Wong G, Zoungas S, Rogers K, Jun M, Jardine M. EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study. JMIR Res Protoc 2020;9:e15646. [PMID: 32285803 DOI: 10.2196/15646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
491 Zeng J, Liu M, Wu L, Wang J, Yang S, Wang Y, Yao Y, Jiang B, He Y. The Association of Hypertriglyceridemic Waist Phenotype with Chronic Kidney Disease and Its Sex Difference: A Cross-Sectional Study in an Urban Chinese Elderly Population. Int J Environ Res Public Health 2016;13:E1233. [PMID: 27983610 DOI: 10.3390/ijerph13121233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
492 Jadoon A, Mathew AV, Byun J, Gadegbeku CA, Gipson DS, Afshinnia F, Pennathur S; for the Michigan Kidney Translational Core CPROBE Investigator Group. Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients. Am J Nephrol 2018;48:269-77. [PMID: 30326477 DOI: 10.1159/000493862] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
493 Yamada Y, Sakuma J, Takeuchi I, Yasukochi Y, Kato K, Oguri M, Fujimaki T, Horibe H, Muramatsu M, Sawabe M, Fujiwara Y, Taniguchi Y, Obuchi S, Kawai H, Shinkai S, Mori S, Arai T, Tanaka M. Identification of C21orf59 and ATG2A as novel determinants of renal function-related traits in Japanese by exome-wide association studies. Oncotarget 2017;8:45259-73. [PMID: 28410202 DOI: 10.18632/oncotarget.16696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
494 Afsar B, Yilmaz MI, Siriopol D, Unal HU, Saglam M, Karaman M, Gezer M, Sonmez A, Eyileten T, Aydin I, Hamcan S, Oguz Y, Covic A, Kanbay M. Thyroid function and cardiovascular events in chronic kidney disease patients. J Nephrol 2017;30:235-42. [PMID: 27039198 DOI: 10.1007/s40620-016-0300-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
495 Beck-Kaltenbach N, Voigt K, Rumstadt B. Renal impairment caused by temporary loop ileostomy. Int J Colorectal Dis 2011;26:623-6. [PMID: 21184086 DOI: 10.1007/s00384-010-1086-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
496 Claro LM, Moreno-Amaral AN, Gadotti AC, Dolenga CJ, Nakao LS, Azevedo MLV, de Noronha L, Olandoski M, de Moraes TP, Stinghen AEM, Pécoits-Filho R. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease. Toxins (Basel) 2018;10:E384. [PMID: 30249039 DOI: 10.3390/toxins10100384] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
497 Lee SM, Son YK, Kim SE, An WS. The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot study. Mar Drugs 2015;13:741-55. [PMID: 25636157 DOI: 10.3390/md13020741] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
498 Adeniyi AB, Laurence CE, Volmink JA, Davids MR. Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa. Clin Kidney J 2017;10:363-9. [PMID: 28621342 DOI: 10.1093/ckj/sfw138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
499 Borràs Sans M, Pérez-Fontán M, Martinez-Alonso M, Bajo A, Betriu À, Valdivielso JM, Fernández E; NEFRONA INVESTIGATORS. The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease. PLoS One 2017;12:e0186921. [PMID: 29095847 DOI: 10.1371/journal.pone.0186921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
500 Falagario UG, Martini A, Pfail J, Treacy PJ, Okhawere KE, Dayal BD, Sfakianos JP, Abaza R, Eun DD, Bhandari A, Porter JR, Hemal AK, Badani KK. Does race impact functional outcomes in patients undergoing robotic partial nephrectomy? Transl Androl Urol 2020;9:863-9. [PMID: 32420201 DOI: 10.21037/tau.2019.09.31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
501 Lasserson DS, Scherpbier de Haan N, de Grauw W, van der Wel M, Wetzels JF, O'Callaghan CA. What is the relationship between renal function and visit-to-visit blood pressure variability in primary care? Retrospective cohort study from routinely collected healthcare data. BMJ Open 2016;6:e010702. [PMID: 27288374 DOI: 10.1136/bmjopen-2015-010702] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
502 Daimon M, Fujita T, Murabayashi M, Mizushiri S, Murakami H, Nishiya Y, Tanabe J, Matsuhashi Y, Yanagimachi M, Tokuda I, Sawada K, Ihara K. Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency. Front Med (Lausanne) 2020;7:221. [PMID: 32582730 DOI: 10.3389/fmed.2020.00221] [Reference Citation Analysis]
503 Nakano S, Masuda K, Asanuma T, Nakatani S. The effect of chronic renal failure on cardiac function: an experimental study with a rat model. J Echocardiogr 2016;14:156-62. [PMID: 27299760 DOI: 10.1007/s12574-016-0300-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
504 Seifert ME, de Las Fuentes L, Ginsberg C, Rothstein M, Dietzen DJ, Cheng SC, Ross W, Windus D, Dávila-Román VG, Hruska KA. Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. Am J Nephrol 2014;39:392-9. [PMID: 24818573 DOI: 10.1159/000362251] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
505 Levin A, Perry T, De Zoysa P, Sigrist MK, Humphries K, Tang M, Djurdjev O. A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients. BMC Cardiovasc Disord 2014;14:156. [PMID: 25381032 DOI: 10.1186/1471-2261-14-156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
506 Harasemiw O, Drummond N, Singer A, Bello A, Komenda P, Rigatto C, Lerner J, Sparkes D, Ferguson TW, Tangri N. Integrating Risk-Based Care for Patients With Chronic Kidney Disease in the Community: Study Protocol for a Cluster Randomized Trial. Can J Kidney Health Dis 2019;6:2054358119841611. [PMID: 31191908 DOI: 10.1177/2054358119841611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
507 Cloyd JM, Ma Y, Morton JM, Kurella Tamura M, Poultsides GA, Visser BC. Does chronic kidney disease affect outcomes after major abdominal surgery? J Gastrointest Surg. 2014;18:605-612. [PMID: 24241964 DOI: 10.1007/s11605-013-2390-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
508 Gibertoni D, Voci C, Iommi M, D'Ercole B, Mandreoli M, Santoro A, Mancini E. Developing and validating an algorithm to identify incident chronic dialysis patients using administrative data. BMC Med Inform Decis Mak 2020;20:185. [PMID: 32782026 DOI: 10.1186/s12911-020-01206-x] [Reference Citation Analysis]
509 Vigil A, Condés E, Vigil L, Gallar P, Oliet A, Ortega O, Rodriguez I, Ortiz M, Herrero JC, Mon C, Cobo G, Jimenez J. Cystatin C as a predictor of mortality and cardiovascular events in a population with chronic kidney disease. Int J Nephrol 2014;2014:127943. [PMID: 24672725 DOI: 10.1155/2014/127943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
510 Breau RH, Cagiannos I, Knoll G, Morash C, Cnossen S, Lavallée LT, Mallick R, Finelli A, Jewett M, Leibovich BC, Cook J, LeBel L, Kapoor A, Pouliot F, Izawa J, Rendon R, Fergusson DA. Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol. BMJ Open 2019;9:e025662. [PMID: 30610026 DOI: 10.1136/bmjopen-2018-025662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
511 Byler TK, Bratslavsky G. Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations. World J Urol. 2014;32:623-630. [PMID: 24710684 DOI: 10.1007/s00345-014-1287-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
512 Chonchol M, Kendrick J, Targher G. Extra-skeletal effects of vitamin D deficiency in chronic kidney disease. Ann Med 2011;43:273-82. [PMID: 21214426 DOI: 10.3109/07853890.2010.543923] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
513 Jeong S, Oh JM, Oh KH, Kim IW. Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients. PLoS One 2017;12:e0170535. [PMID: 28152049 DOI: 10.1371/journal.pone.0170535] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
514 McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Campbell KL. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol 2013;24:2096-103. [PMID: 24204003 DOI: 10.1681/ASN.2013030285] [Cited by in Crossref: 180] [Cited by in F6Publishing: 83] [Article Influence: 20.0] [Reference Citation Analysis]
515 Maeda K, Hamada C, Horikoshi S, Tomino Y. Usefulness of change in estimated glomerular filtration rate as a predicting factor of progression of chronic kidney disease. ISRN Nephrol 2013;2013:351364. [PMID: 24967224 DOI: 10.5402/2013/351364] [Reference Citation Analysis]
516 Wu FM, Tay MH, Tai BC, Chen Z, Tan L, Goh BY, Raman L, Tiong HY. Preoperative Renal Volume: A Surrogate Measure for Radical Nephrectomy-Induced Chronic Kidney Disease. J Endourol 2015;29:1406-11. [PMID: 26204258 DOI: 10.1089/end.2015.0318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
517 Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS; CRIC Study Investigators. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 2012;7:1938-46. [PMID: 23024164 DOI: 10.2215/CJN.03500412] [Cited by in Crossref: 234] [Cited by in F6Publishing: 140] [Article Influence: 23.4] [Reference Citation Analysis]
518 Chen Q, Zhang Y, Ding D, Xia M, Li D, Yang Y, Li Q, Liu J, Chen X, Hu G, Ling W. Estimated Glomerular Filtration Rate and Mortality among Patients with Coronary Heart Disease. PLoS One 2016;11:e0161599. [PMID: 27537335 DOI: 10.1371/journal.pone.0161599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
519 Tanaka T, Miura S, Tanaka M, Uehara Y, Hirano T, Saku K. Efficacies of Controlling Morning Blood Pressure and Protecting the Kidneys by Treatment With Valsartan and Nifedipine CR or Valsartan and Amlodipine (MONICA Study). J Clin Med Res 2013;5:432-40. [PMID: 24171055 DOI: 10.4021/jocmr1563w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
520 Huang F, Chen J, Liu X, Han F, Cai Q, Peng G, Zhang K, Chen W, Wang J, Huang H. Cigarette smoking reduced renal function deterioration in hypertensive patients may be mediated by elevated homocysteine. Oncotarget 2016;7:86000-10. [PMID: 27852066 DOI: 10.18632/oncotarget.13308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
521 Collister D, Saad N, Christie E, Ahmed S. Providing Care for Transgender Persons With Kidney Disease: A Narrative Review. Can J Kidney Health Dis 2021;8:2054358120985379. [PMID: 33552529 DOI: 10.1177/2054358120985379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
522 Patel ML, Sachan R, Verma A, Kamal R, Gupta KK. Neutrophil gelatinase-associated lipocalin as a biomarker of disease progression in patients with chronic kidney disease. Indian J Nephrol 2016;26:125-30. [PMID: 27051137 DOI: 10.4103/0971-4065.157799] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
523 Gipson GT, Carbone S, Wang J, Dixon DL, Jovin IS, Carl DE, Gehr TW, Ghosh S. Impaired Delivery of Cholesterol Effluxed From Macrophages to Hepatocytes by Serum From CKD Patients May Underlie Increased Cardiovascular Disease Risk. Kidney Int Rep 2020;5:199-210. [PMID: 32043034 DOI: 10.1016/j.ekir.2019.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
524 Yeo S, Moon JI, Shin J, Hwang JH, Cho I, Kim SH. Impacts of Coronary Artery Calcification on Intradialytic Blood Pressure Patterns in Patients Receiving Maintenance Hemodialysis. Chonnam Med J 2020;56:27-35. [PMID: 32021839 DOI: 10.4068/cmj.2020.56.1.27] [Reference Citation Analysis]
525 Ting F, Savdie R, Chopra S, Yuen C, Brenner P. Early Experience in Da Vinci Robot-Assisted Partial Nephrectomy: An Australian Single Centre Series. Minim Invasive Surg 2015;2015:671267. [PMID: 26167299 DOI: 10.1155/2015/671267] [Reference Citation Analysis]
526 Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M; Cholesterol and Recurrent Events (CARE) Trial Investigators. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 2006;332:1426. [PMID: 16714328 DOI: 10.1136/bmj.38814.566019.2F] [Cited by in Crossref: 127] [Cited by in F6Publishing: 52] [Article Influence: 7.9] [Reference Citation Analysis]
527 Russo P. End stage and chronic kidney disease: associations with renal cancer. Front Oncol. 2012;2:28. [PMID: 22649783 DOI: 10.3389/fonc.2012.00028] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
528 Damasiewicz MJ, Nickolas TL. Rethinking Bone Disease in Kidney Disease. JBMR Plus 2018;2:309-22. [PMID: 30460334 DOI: 10.1002/jbm4.10117] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
529 Slinin Y, Peters KW, Ishani A, Yaffe K, Fink HA, Stone KL, Steffes M, Ensrud KE; Study of Osteoporotic Fractures. Cystatin C and cognitive impairment 10 years later in older women. J Gerontol A Biol Sci Med Sci 2015;70:771-8. [PMID: 25362662 DOI: 10.1093/gerona/glu189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
530 Reichel H, Zee J, Tu C, Young E, Pisoni RL, Stengel B, Duttlinger J, Lonnemann G, Robinson BM, Pecoits-Filho R, Fliser D. Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2020;35:803-10. [PMID: 31953939 DOI: 10.1093/ndt/gfz260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
531 Hamroun A, Camier A, Bigna JJ, Glowacki F. Impact of air pollution on renal outcomes: a systematic review and meta-analysis protocol. BMJ Open 2021;11:e041088. [PMID: 33455930 DOI: 10.1136/bmjopen-2020-041088] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
532 Sarfo FS, Mobula LM, Sarfo-Kantanka O, Adamu S, Plange-Rhule J, Ansong D, Gyamfi RA, Duah J, Abraham B, Ofori-Adjei D. Estimated glomerular filtration rate predicts incident stroke among Ghanaians with diabetes and hypertension. J Neurol Sci 2019;396:140-7. [PMID: 30471633 DOI: 10.1016/j.jns.2018.11.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
533 Yang HJ, Dey D, Sykes J, Butler J, Biernaski H, Kovacs M, Bi X, Sharif B, Cokic I, Tang R, Slomka P, Prato FS, Dharmakumar R. Heart Rate-Independent 3D Myocardial Blood Oxygen Level-Dependent MRI at 3.0 T with Simultaneous 13N-Ammonia PET Validation. Radiology 2020;295:82-93. [PMID: 32096705 DOI: 10.1148/radiol.2020191456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
534 Luo Q, Xia X, Li B, Lin Z, Yu X, Huang F. Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis. BMC Nephrol 2019;20:18. [PMID: 30642279 DOI: 10.1186/s12882-018-1143-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
535 Navaneethan SD, Fealy CE, Scelsi AC, Arrigain S, Malin SK, Kirwan JP. A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease. Am J Nephrol 2015;42:274-81. [PMID: 26495987 DOI: 10.1159/000441155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
536 Thakar CV, Christianson A, Himmelfarb J, Leonard AC. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol. 2011;6:2567-2572. [PMID: 21903988 DOI: 10.2215/cjn.01120211] [Cited by in Crossref: 265] [Cited by in F6Publishing: 132] [Article Influence: 24.1] [Reference Citation Analysis]
537 Fabbian F, Bedani PL, Rizzioli E, Molino C, Pala M, De Giorgi A, Longhini C, Portaluppi F. Detection of urinary abnormalities in a community from northern Italy based on the World Kidney Day screening program. Int Urol Nephrol 2011;43:793-9. [PMID: 21053070 DOI: 10.1007/s11255-010-9861-1] [Reference Citation Analysis]
538 Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis 2016;68:414-21. [PMID: 27130720 DOI: 10.1053/j.ajkd.2016.03.415] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
539 Roy L, Zappitelli M, White-Guay B, Lafrance JP, Dorais M, Perreault S. Agreement Between Administrative Database and Medical Chart Review for the Prediction of Chronic Kidney Disease G category. Can J Kidney Health Dis 2020;7:2054358120959908. [PMID: 33101698 DOI: 10.1177/2054358120959908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
540 Werner K, Christensson A, Legrand H, Pihlsgård M, Sterner G, Elmståhl S. Cystatin C and creatinine-based eGFR levels and their correlation to long-term morbidity and mortality in older adults. Aging Clin Exp Res 2019;31:1461-9. [PMID: 30560432 DOI: 10.1007/s40520-018-1091-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
541 Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Magnesium—A More Important Role in CKD–MBD than We Thought. Diagnostics 2022;12:880. [DOI: 10.3390/diagnostics12040880] [Reference Citation Analysis]
542 Alfieri C, Forzenigo L, Tripodi F, Meneghini M, Regalia A, Cresseri D, Messa P. Long-term evaluation of coronary artery calcifications in kidney transplanted patients: a follow up of 5 years. Sci Rep 2019;9:6869. [PMID: 31053792 DOI: 10.1038/s41598-019-43216-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
543 Choi KL, Elliott WJ. Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke prevention. Curr Hypertens Rep 2005;7:367-73. [PMID: 16157081 DOI: 10.1007/s11906-005-0073-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
544 Zhang Q, Yang B, Chen X, Xu J, Mei C, Mao Z. Renal Gene Expression Database (RGED): a relational database of gene expression profiles in kidney disease. Database (Oxford) 2014;2014:bau092. [PMID: 25252782 DOI: 10.1093/database/bau092] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
545 Chang TI, Chertow GM. Chronic kidney disease and cardiovascular therapeutics: time to close the evidence gaps. J Am Coll Cardiol 2011;58:1162-4. [PMID: 21884955 DOI: 10.1016/j.jacc.2011.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
546 Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P; Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010;31:703-711. [PMID: 20037146 DOI: 10.1093/eurheartj/ehp507] [Cited by in Crossref: 506] [Cited by in F6Publishing: 401] [Article Influence: 38.9] [Reference Citation Analysis]
547 Härle P. [Rheumatological emergency on the edge of intensive care medicine]. Z Rheumatol 2019;78:915-24. [PMID: 31605194 DOI: 10.1007/s00393-019-00696-z] [Reference Citation Analysis]
548 Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Taal MW. High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients. Eur J Clin Nutr 2015;69:786-90. [PMID: 25293433 DOI: 10.1038/ejcn.2014.215] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
549 Bomback AS, Kshirsagar AV, Ferris ME, Klemmer PJ. Disordered aldosterone-volume relationship in end-stage kidney disease. J Renin Angiotensin Aldosterone Syst 2009;10:230-6. [PMID: 19864488 DOI: 10.1177/1470320309352353] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
550 Juutilainen A, Kastarinen H, Antikainen R, Peltonen M, Salomaa V, Tuomilehto J, Jousilahti P, Sundvall J, Laatikainen T, Kastarinen M. Trends in estimated kidney function: the FINRISK surveys. Eur J Epidemiol 2012;27:305-13. [PMID: 22286717 DOI: 10.1007/s10654-012-9652-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
551 Wei YC, Chen KF, Wu CL, Lee TW, Liu CH, Shyu YC, Lin CP. Stroke Rate Increases Around the Time of Cancer Diagnosis. Front Neurol 2019;10:579. [PMID: 31231302 DOI: 10.3389/fneur.2019.00579] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
552 Halle MP, Edjomo AM, Fouda H, Djantio H, Essomba N, Ashuntantang GE. Survival of HIV infected patients on maintenance hemodialysis in Cameroon: a comparative study. BMC Nephrol 2018;19:166. [PMID: 29976156 DOI: 10.1186/s12882-018-0964-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
553 Hashemi A, Nourbakhsh S, Asgari S, Mirbolouk M, Azizi F, Hadaegh F. Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study. J Transl Med 2018;16:230. [PMID: 30111315 DOI: 10.1186/s12967-018-1603-7] [Reference Citation Analysis]
554 Keven K, Kutlay S, Sengal S. Arterial stiffness in patients with kidney transplantation. Kidney Int 2005;67:1191; author reply 1192. [PMID: 15698464 DOI: 10.1111/j.1523-1755.2005.191_3.x] [Reference Citation Analysis]
555 Schantl AE, Verhulst A, Neven E, Behets GJ, D'Haese PC, Maillard M, Mordasini D, Phan O, Burnier M, Spaggiari D, Decosterd LA, MacAskill MG, Alcaide-Corral CJ, Tavares AAS, Newby DE, Beindl VC, Maj R, Labarre A, Hegde C, Castagner B, Ivarsson ME, Leroux JC. Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers. Nat Commun 2020;11:721. [PMID: 32024848 DOI: 10.1038/s41467-019-14091-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
556 Combe C, Rigothier C, Vendrely B, Chauveau P, Rigalleau V, Lasseur C. [Strategies to slow the progression of chronic kidney disease]. Presse Med 2007;36:1849-55. [PMID: 17656065 DOI: 10.1016/j.lpm.2007.04.034] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
557 Chang TI, Desai M, Solomon DH, Winkelmayer WC. Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol 2011;6:864-9. [PMID: 21233459 DOI: 10.2215/CJN.07290810] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
558 Molenaar FM, van Reekum FE, Rookmaaker MB, Abrahams AC, van Jaarsveld BC. Extraosseous calcification in end-stage renal disease: from visceral organs to vasculature. Semin Dial 2014;27:477-87. [PMID: 24438042 DOI: 10.1111/sdi.12177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
559 Alvarez JA, Law J, Coakley KE, Zughaier SM, Hao L, Shahid Salles K, Wasse H, Gutiérrez OM, Ziegler TR, Tangpricha V. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2012;96:672-679. [PMID: 22854402 DOI: 10.3945/ajcn.112.040642] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
560 Besarab A, Chernyavskaya E, Motylev I, Shutov E, Kumbar LM, Gurevich K, Chan DT, Leong R, Poole L, Zhong M, Saikali KG, Franco M, Hemmerich S, Yu KH, Neff TB. Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients. J Am Soc Nephrol. 2016;27:1225-1233. [PMID: 26494833 DOI: 10.1681/asn.2015030241] [Cited by in Crossref: 140] [Cited by in F6Publishing: 72] [Article Influence: 20.0] [Reference Citation Analysis]
561 Meremo AJ, Masalu MB, Sabi I, Ngilangwa DP, Kapinga J, Tagalile R, Munyogwa MJ, Mwashambwa MY. Prevalence and Risk Factors Associated With Chronic Kidney Disease Among Patients Presenting at a Haemodialysis Unit in Dodoma, Tanzania. East Afr Health Res J 2018;2:53-7. [PMID: 34308175 DOI: 10.24248/EAHRJ-D-16-00367] [Reference Citation Analysis]
562 Martin AK, Malhotra AK, Sullivan BL, Ramakrishna H. Troponin elevations in patients with chronic cardiovascular disease: An analysis of current evidence and significance. Ann Card Anaesth 2016;19:321-7. [PMID: 27052076 DOI: 10.4103/0971-9784.179638] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
563 Santos-Díaz G, Pérez-Pico AM, Suárez-Santisteban MÁ, García-Bernalt V, Mayordomo R, Dorado P. Prevalence of Potential Drug-Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital. Pharmaceutics 2020;12:E713. [PMID: 32751436 DOI: 10.3390/pharmaceutics12080713] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
564 Fleig S, Patecki M, Schmitt R. [Chronic kidney disease : What is currently available for treatment?]. Internist (Berl) 2016;57:1164-71. [PMID: 27844096 DOI: 10.1007/s00108-016-0150-7] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
565 Okubo R, Kondo M, Hoshi SL, Kai H, Saito C, Iseki K, Iseki C, Watanabe T, Narita I, Matsuo S, Makino H, Hishida A, Yamagata K. Behaviour modification intervention for patients with chronic kidney disease could provide a mid- to long-term reduction in public health care expenditure: budget impact analysis. Clin Exp Nephrol 2022. [PMID: 35084644 DOI: 10.1007/s10157-022-02185-1] [Reference Citation Analysis]
566 Mjøen G, Holdaas H. Impact of Living Kidney Donation on Long-Term Renal and Patient Survival: An Evolving Paradigm. Curr Transpl Rep 2015;2:22-8. [DOI: 10.1007/s40472-014-0038-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
567 Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-Dechent W, Arampatzis S, Chertow GM, Parfrey P, Ma X, Floege J. Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clin J Am Soc Nephrol 2017;12:315-22. [PMID: 27940458 DOI: 10.2215/CJN.04720416] [Cited by in Crossref: 77] [Cited by in F6Publishing: 44] [Article Influence: 12.8] [Reference Citation Analysis]
568 McGowan A, Silvestri G, Moore E, Silvestri V, Patterson CC, Maxwell AP, McKay GJ. Evaluation of the Retinal Vasculature in Hypertension and Chronic Kidney Disease in an Elderly Population of Irish Nuns. PLoS One 2015;10:e0136434. [PMID: 26327531 DOI: 10.1371/journal.pone.0136434] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
569 Rifkin DE, Ix JH, Wassel CL, Criqui MH, Allison MA. Renal artery calcification and mortality among clinically asymptomatic adults. J Am Coll Cardiol 2012;60:1079-85. [PMID: 22939556 DOI: 10.1016/j.jacc.2012.06.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
570 Ren H, Zhao L, Zou Y, Wang Y, Zhang J, Wu Y, Zhang R, Wang T, Wang J, Zhu Y, Guo R, Xu H, Li L, Cooper ME, Liu F. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus. Ren Fail 2021;43:477-87. [PMID: 33685340 DOI: 10.1080/0886022X.2021.1893186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
571 Wiernek SL, Kiesz RS, Wiernek BK, Buszman PP, Janas A, Martin JL, Trela B, Szewc RG, Buszman PE. Treatment of symptomatic coronary artery disease in patients with end-stage renal disease on hemodialysis with paclitaxel-eluting TAXUS stent. Hemodial Int 2015;19:402-11. [PMID: 25560380 DOI: 10.1111/hdi.12259] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
572 Esmeijer K, Geleijnse JM, de Fijter JW, Kromhout D, Hoogeveen EK. Dietary protein intake and kidney function decline after myocardial infarction: the Alpha Omega Cohort. Nephrol Dial Transplant 2020;35:106-15. [PMID: 30768201 DOI: 10.1093/ndt/gfz015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
573 Swärd P, Tofik R, Bakoush O, Torffvit O, Nilsson PM, Christensson A. Patterns of urinary albumin and IgM associate with markers of vascular ageing in young to middle-aged individuals in the Malmö offspring study. BMC Cardiovasc Disord 2020;20:358. [PMID: 32758145 DOI: 10.1186/s12872-020-01638-3] [Reference Citation Analysis]
574 Mandai S, Ando F, Mori T, Susa K, Iimori S, Naito S, Sohara E, Uchida S, Fushimi K, Rai T. Burden of kidney disease on the discrepancy between reasons for hospital admission and death: An observational cohort study. PLoS One 2021;16:e0258846. [PMID: 34731197 DOI: 10.1371/journal.pone.0258846] [Reference Citation Analysis]
575 Lima A, Tavares J, Pestana N, Carvalho MJ, Cabrita A, Rodrigues A. Sodium removal in peritoneal dialysis: is there room for a new parameter in dialysis adequacy? Bull Dial Domic 2019;2:151-7. [DOI: 10.25796/bdd.v2i3.21343] [Reference Citation Analysis]
576 Schulz CA, Christensson A, Ericson U, Almgren P, Hindy G, Nilsson PM, Struck J, Bergmann A, Melander O, Orho-Melander M. High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD. J Am Soc Nephrol 2017;28:291-303. [PMID: 27401687 DOI: 10.1681/ASN.2015101177] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
577 Pedrosa I, Cadeddu JA. How We Do It: Managing the Indeterminate Renal Mass with the MRI Clear Cell Likelihood Score. Radiology 2021;:210034. [PMID: 34904873 DOI: 10.1148/radiol.210034] [Reference Citation Analysis]
578 Ahn JS, Kim HJ, Jeon HG, Jeong BC, Seo SI, Lee HM, Choi HY, Jeon SS. Predictive preoperative factors for renal insufficiency in patients followed for more than 5 years after radical nephrectomy. Korean J Urol 2013;54:303-10. [PMID: 23700495 DOI: 10.4111/kju.2013.54.5.303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
579 Anyanwagu U, Donnelly R, Idris I. Individual and Combined Relationship between Reduced eGFR and/or Increased Urinary Albumin Excretion Rate with Mortality Risk among Insulin-Treated Patients with Type 2 Diabetes in Routine Practice. Kidney Dis (Basel) 2019;5:91-9. [PMID: 31019922 DOI: 10.1159/000493731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
580 Ahmed AM, Qureshi WT, O'Neal WT, Khalid F, Al-Mallah MH. Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis. J Nucl Cardiol 2018;25:1658-73. [PMID: 28050863 DOI: 10.1007/s12350-016-0756-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
581 Ketteler M, Rix M, Fan S, Pritchard N, Oestergaard O, Chasan-Taber S, Heaton J, Duggal A, Kalra PA. Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis. Clin J Am Soc Nephrol 2008;3:1125-30. [PMID: 18450923 DOI: 10.2215/CJN.05161107] [Cited by in Crossref: 63] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
582 Yap SA, Finelli A, Alibhai SM. Treating small renal masses: Costing it out. Can Urol Assoc J 2013;7:114-5. [PMID: 23671526 DOI: 10.5489/cuaj.718] [Reference Citation Analysis]
583 Molnár AÁ, Merkely B. The Added Value of Atrial Strain Assessment in Clinical Practice. Diagnostics 2022;12:982. [DOI: 10.3390/diagnostics12040982] [Reference Citation Analysis]
584 Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WH, Lipkowitz MS, Wright JT, Chang AR, Astor BC, Appel LJ. Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK). Am J Kidney Dis 2015;65:394-402. [PMID: 25441435 DOI: 10.1053/j.ajkd.2014.07.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
585 Seck SM, Guéye S, Tamba K, Ba I. Prevalence of chronic cardiovascular and metabolic diseases in Senegalese workers: a cross-sectional study, 2010. Prev Chronic Dis 2013;10:110339. [PMID: 23286359 DOI: 10.5888/pcd10.110339] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
586 Dubin RF, Deo R, Bansal N, Anderson AH, Yang P, Go AS, Keane M, Townsend R, Porter A, Budoff M, Malik S, He J, Rahman M, Wright J, Cappola T, Kallem R, Roy J, Sha D, Shlipak MG;  CRIC Study Investigators. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort. Clin J Am Soc Nephrol. 2017;12:60-68. [PMID: 28062676 DOI: 10.2215/cjn.02700316] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
587 Townsend RR, Chirinos JA, Parsa A, Weir MA, Sozio SM, Lash JP, Chen J, Steigerwalt SP, Go AS, Hsu CY, Rafey M, Wright JT Jr, Duckworth MJ, Gadegbeku CA, Joffe MP; Chronic Renal Insufficiency Cohort Investigators. Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study. Hypertension 2010;56:518-24. [PMID: 20660819 DOI: 10.1161/HYPERTENSIONAHA.110.153924] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
588 Chang SS. Renal surgery and its impact on chronic kidney disease: a continuing evolution in decision making. J Urol 2014;192:1017-8. [PMID: 25046600 DOI: 10.1016/j.juro.2014.07.078] [Reference Citation Analysis]
589 Lederer S, Ruggiero L, Sisen NM, Lepain N, O'Connor KG, Wang Y, Chen J, Lash JP, Fischer MJ. The National Kidney Foundation of Illinois KidneyMobile: a mobile resource for community based screenings of chronic kidney disease and its risk factors. BMC Nephrol 2018;19:295. [PMID: 30359229 DOI: 10.1186/s12882-018-1079-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
590 Makino K, Nakagawa T, Kanatani A, Kawai T, Taguchi S, Otsuka M, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Homma Y. Biphasic decline in renal function after radical cystectomy with urinary diversion. Int J Clin Oncol 2017;22:359-65. [PMID: 27747456 DOI: 10.1007/s10147-016-1053-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
591 Gregg LP, Hedayati SS, Yang H, Van Buren PN, Banerjee S, Navaneethan SD, Virani SS, Winkelmayer WC, Alvarez CA. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension 2021;77:948-59. [PMID: 33423525 DOI: 10.1161/HYPERTENSIONAHA.120.16117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
592 Bonjoch A, Juega J, Echeverría P, Puig J, Perez-Alvarez N, Bonal J, Loste C, Clotet B, Negredo E. Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV. HIV Med 2022. [PMID: 35470944 DOI: 10.1111/hiv.13317] [Reference Citation Analysis]
593 Fischer H, Weiss RE, Friedman AN, Imam TH, Coleman KJ. The relationship between kidney function and body mass index before and after bariatric surgery in patients with chronic kidney disease. Surg Obes Relat Dis 2021;17:508-15. [PMID: 33358080 DOI: 10.1016/j.soard.2020.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
594 Mak S. Cardiovascular Disease in Dialysis Patients Again. Hong Kong Journal of Nephrology 2008;10:47-9. [DOI: 10.1016/s1561-5413(08)60020-4] [Reference Citation Analysis]
595 Bansal N, Hyre Anderson A, Yang W, Christenson RH, deFilippi CR, Deo R, Dries DL, Go AS, He J, Kusek JW, Lash JP, Raj D, Rosas S, Wolf M, Zhang X, Shlipak MG, Feldman HI. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol 2015;26:946-56. [PMID: 25278510 DOI: 10.1681/ASN.2014010108] [Cited by in Crossref: 70] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
596 Prasad N, Yadav AK, Kundu M, Sethi J, Jaryal A, Sircar D, Modi GK, Kamboj K, Sahay M, Gopalakrishnan N, Kaur P, Vikrant S, Varughese S, Baid-Agrawal S, Singh S, Gang S, Parameswaran S, Kumar V, Ghosh A, Jha V. Prescription Practices in Patients With Mild to Moderate CKD in India. Kidney Int Rep 2021;6:2455-62. [PMID: 34514206 DOI: 10.1016/j.ekir.2021.06.011] [Reference Citation Analysis]
597 Samal L, D'Amore JD, Bates DW, Wright A. Implementation of a scalable, web-based, automated clinical decision support risk-prediction tool for chronic kidney disease using C-CDA and application programming interfaces. J Am Med Inform Assoc 2017;24:1111-5. [PMID: 29016969 DOI: 10.1093/jamia/ocx065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
598 Currie G, Taylor AH, Fujita T, Ohtsu H, Lindhardt M, Rossing P, Boesby L, Edwards NC, Ferro CJ, Townend JN, van den Meiracker AH, Saklayen MG, Oveisi S, Jardine AG, Delles C, Preiss DJ, Mark PB. Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol 2016;17:127. [PMID: 27609359 DOI: 10.1186/s12882-016-0337-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 11.3] [Reference Citation Analysis]
599 Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Takeuchi M, Maeda S, Yamagishi S. Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs). Oxid Med Cell Longev 2010;3:304-7. [PMID: 21150335 DOI: 10.4161/oxim.3.5.13069] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
600 Kosmas CE, Silverio D, Tsomidou C, Salcedo MD, Montan PD, Guzman E. The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular Disease. Clin Med Insights Endocrinol Diabetes 2018;11:1179551418792257. [PMID: 30083062 DOI: 10.1177/1179551418792257] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
601 Lutsey PL, Alonso A, Selvin E, Pankow JS, Michos ED, Agarwal SK, Loehr LR, Eckfeldt JH, Coresh J. Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study. J Am Heart Assoc 2014;3:e000936. [PMID: 24922628 DOI: 10.1161/JAHA.114.000936] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 8.5] [Reference Citation Analysis]
602 Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, Morito N, Higaki Y. The association between changes in lifestyle behaviors and the incidence of chronic kidney disease (CKD) in middle-aged and older men. J Epidemiol 2017;27:389-97. [PMID: 28385348 DOI: 10.1016/j.je.2016.08.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
603 Aoki T, Ishii H, Tanaka A, Suzuki S, Ichimiya S, Kanashiro M, Murohara T. Influence of chronic kidney disease and worsening renal function on clinical outcomes in patients undergoing primary percutaneous coronary intervention. Clin Exp Nephrol 2019;23:182-8. [PMID: 30218297 DOI: 10.1007/s10157-018-1622-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
604 Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O’Donnell CJ, Kathiresan S, Meigs JB, Keaney JF, Rong J. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant. 2011;26:920-926. [PMID: 20682604 DOI: 10.1093/ndt/gfq471] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 6.8] [Reference Citation Analysis]
605 Ohashi N, Sakao Y, Yasuda H, Kato A, Fujigaki Y. Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease. Int J Nephrol Renovasc Dis 2012;5:53-60. [PMID: 22536082 DOI: 10.2147/IJNRD.S23447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
606 de Boer IH, Astor BC, Kramer H, Palmas W, Seliger SL, Shlipak MG, Siscovick DS, Tsai MY, Kestenbaum B. Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 2008;3:125-32. [PMID: 18057305 DOI: 10.2215/CJN.03390807] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
607 Kang HG, Choi HJ, Han KH, Kim SH, Cho HY, Cho MH, Shin JI, Lee JH, Lee J, Oh KH, Park YS, Cheong HI, Ahn C, Ha IS. KNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): Design and methods. BMC Nephrol 2016;17:35. [PMID: 27012243 DOI: 10.1186/s12882-016-0248-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
608 Wada M, Ueda Y, Higo T, Matsuo K, Nishio M, Hirata A, Asai M, Nemoto T, Kashiyama T, Murakami A, Kashiwase K, Kodama K. Chronic kidney disease and coronary artery vulnerable plaques. Clin J Am Soc Nephrol 2011;6:2792-8. [PMID: 22157709 DOI: 10.2215/CJN.06780711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
609 Shanmuganathan R, Kumaresan R, Giri P. Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease. J Postgrad Med 2015;61:230-4. [PMID: 26440392 DOI: 10.4103/0022-3859.166510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
610 Wu J, Lei G, Wang X, Tang Y, Cheng H, Jian G, Wu X, Wang N. Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities. Oncotarget 2017;8:80688-99. [PMID: 29113336 DOI: 10.18632/oncotarget.21079] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
611 Raman M, Green D, Middleton RJ, Kalra PA. Comparing the impact of older age on outcome in chronic kidney disease of different etiologies: a prospective cohort study. J Nephrol. 2018;31:931-939. [PMID: 30187380 DOI: 10.1007/s40620-018-0529-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
612 Tsaur I, Schilling D, Haferkamp A. [Active surveillance: concept for renal cell carcinoma?]. Urologe A 2013;52:793-9. [PMID: 23616172 DOI: 10.1007/s00120-013-3197-2] [Reference Citation Analysis]
613 Bhavsar NA, Appel LJ, Kusek JW, Contreras G, Bakris G, Coresh J, Astor BC; AASK Study Group. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis. 2011;58:886-893. [PMID: 21944667 DOI: 10.1053/j.ajkd.2011.07.018] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
614 Canter D, Kutikov A, Sirohi M, Street R, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology 2011;77:781-5. [PMID: 21316090 DOI: 10.1016/j.urology.2010.11.050] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
615 Bhindi B, Asante D, Branda ME, Hickson LJ, Mason RJ, Jeffery MM, Boorjian SA, Leibovich BC, Thompson RH. Survival outcomes for patients with surgically induced end-stage renal disease. Can Urol Assoc J 2020;14:E65-73. [PMID: 31599719 DOI: 10.5489/cuaj.6010] [Reference Citation Analysis]
616 Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008;118:1645-1656. [PMID: 18431508 DOI: 10.1172/jci32691] [Cited by in Crossref: 71] [Cited by in F6Publishing: 240] [Article Influence: 5.1] [Reference Citation Analysis]
617 Hu EA, Coresh J, Anderson CAM, Appel LJ, Grams ME, Crews DC, Mills KT, He J, Scialla J, Rahman M, Navaneethan SD, Lash JP, Ricardo AC, Feldman HI, Weir MR, Shou H, Rebholz CM; CRIC Study Investigators. Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis 2021;77:235-44. [PMID: 32768632 DOI: 10.1053/j.ajkd.2020.04.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
618 Tesauro M, Canale MP, Rodia G, Di Daniele N, Lauro D, Scuteri A, Cardillo C. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract 2011;2011:653182. [PMID: 21403882 DOI: 10.4061/2011/653182] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
619 Metwalli AR, Linehan WM. Nephron-sparing surgery for multifocal and hereditary renal tumors. Curr Opin Urol 2014;24:466-73. [PMID: 25014245 DOI: 10.1097/MOU.0000000000000094] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
620 Reid R, Ezekowitz JA, Brown PM, McAlister FA, Rowe BH, Braam B. The Prognostic Importance of Changes in Renal Function during Treatment for Acute Heart Failure Depends on Admission Renal Function. PLoS One 2015;10:e0138579. [PMID: 26380982 DOI: 10.1371/journal.pone.0138579] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
621 Thüroff JW, Roos F. [Minimally invasive vs. open surgical procedures in the treatment of renal cell carcinoma]. Urologe A 2015;54:231-3. [PMID: 25656044 DOI: 10.1007/s00120-014-3673-3] [Reference Citation Analysis]
622 Sweigert PJ, Bansal VK, Hoppensteadt DA, Saluk JL, Syed DA, Fareed J. Inflammatory and Metabolic Syndrome Biomarker Analysis of Vascular Outcomes in End-stage Renal Disease. Int J Angiol 2017;26:43-8. [PMID: 28255215 DOI: 10.1055/s-0036-1593409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
623 Brady BM, Erickson KF. Integrated Care in ESKD: A Perspective of Nephrologists. Clin J Am Soc Nephrol 2019;14:451-3. [PMID: 30696662 DOI: 10.2215/CJN.13081118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
624 Sureshkumar KK, Katragadda V, Chopra B, Sampaio M. Role of induction therapy in low immunological risk-kidney transplant recipients: A mate-kidney analysis. Clin Transplant 2018;:e13442. [PMID: 30408257 DOI: 10.1111/ctr.13442] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
625 Rifkin DE, Sarnak MJ. Does inflammation fuel the fire in CKD? Am J Kidney Dis 2009;53:572-5. [PMID: 19324245 DOI: 10.1053/j.ajkd.2009.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
626 Kim HR, Jin HS, Eom YB. Association between MANBA Gene Variants and Chronic Kidney Disease in a Korean Population. J Clin Med 2021;10:2255. [PMID: 34070965 DOI: 10.3390/jcm10112255] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
627 Oh IH, Choi JW, Lee CH, Park JS. Estimating Negative Effect of Abdominal Obesity on Mildly Decreased Kidney Function Using a Novel Index of Body-Fat Distribution. J Korean Med Sci 2017;32:613-20. [PMID: 28244287 DOI: 10.3346/jkms.2017.32.4.613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
628 Park M. Islands in the stream: the risk of kidney disease from cardiovascular disease. Am J Kidney Dis 2015;65:647-9. [PMID: 25919498 DOI: 10.1053/j.ajkd.2015.01.014] [Reference Citation Analysis]
629 Wagnew F, Eshetie S, Kibret GD, Zegeye A, Dessie G, Mulugeta H, Alemu A. Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis. BMC Res Notes 2018;11:565. [PMID: 30081966 DOI: 10.1186/s13104-018-3670-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
630 Yang J, Brody EN, Murthy AC, Mehler RE, Weiss SJ, DeLisle RK, Ostroff R, Williams SA, Ganz P. Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable Coronary Heart Disease. J Am Heart Assoc 2020;9:e016463. [PMID: 32696702 DOI: 10.1161/JAHA.120.016463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
631 Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol 2011;6:785-92. [PMID: 21330486 DOI: 10.2215/CJN.09231010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
632 Li W, Cheng Y, Cheng Y, Ren H, Han N. Clinical efficacy of radical nephrectomy versus nephron-sparing surgery on localized renal cell carcinoma. Eur J Med Res 2014;19:58. [PMID: 25374003 DOI: 10.1186/s40001-014-0058-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
633 Ooi EM, Chan DT, Watts GF, Chan DC, Ng TW, Dogra GK, Irish AB, Barrett PH. Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease. J Lipid Res 2011;52:794-800. [PMID: 21297177 DOI: 10.1194/jlr.M011163] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
634 Chen SC, Chang JM, Liu WC, Tsai YC, Tsai JC, Hsu PC, Lin TH, Lin MY, Su HM, Hwang SJ, Chen HC. Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. Clin J Am Soc Nephrol 2011;6:724-32. [PMID: 21454721 DOI: 10.2215/CJN.07700910] [Cited by in Crossref: 64] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
635 Besouw MT, Holewijn S, Levtchenko EN, Janssen MC. Non-invasive measurements of atherosclerosis in adult cystinosis patients. J Inherit Metab Dis 2011;34:811-8. [PMID: 21305353 DOI: 10.1007/s10545-011-9281-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
636 Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr. 2008;88:1485-1494. [PMID: 19064507 DOI: 10.3945/ajcn.2008.25906] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
637 Altunrende F, Laydner H, Hernandez AV, Autorino R, Khanna R, White MA, Isac W, Spana G, Hillyer S, Yang B, Yakoubi R, Haber GP, Kaouk JH, Stein RJ. Correlation of the RENAL nephrometry score with warm ischemia time after robotic partial nephrectomy. World J Urol 2013;31:1165-9. [PMID: 22527672 DOI: 10.1007/s00345-012-0867-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
638 Jepsen P. Comorbidity in cirrhosis. World J Gastroenterol 2014; 20(23): 7223-7230 [PMID: 24966593 DOI: 10.3748/wjg.v20.i23.7223] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
639 Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099. [PMID: 28536104 DOI: 10.1136/bmj.j2099] [Cited by in Crossref: 375] [Cited by in F6Publishing: 333] [Article Influence: 75.0] [Reference Citation Analysis]
640 Tung YC, Chang CJ, Liu JR, Chang SH, Chan YH, Kuo CT, See LC. Outcomes after ticagrelor versus clopidogrel treatment in end-stage renal disease patients with acute myocardial infarction: a nationwide cohort study. Sci Rep 2021;11:20826. [PMID: 34675293 DOI: 10.1038/s41598-021-00360-0] [Reference Citation Analysis]
641 Bundy JD, Cai X, Scialla JJ, Dobre MA, Chen J, Hsu CY, Leonard MB, Go AS, Rao PS, Lash JP, Townsend RR, Feldman HI, de Boer IH, Block GA, Wolf M, Smith ER, Pasch A, Isakova T; CRIC Study Investigators. Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis 2019;73:806-14. [PMID: 30935773 DOI: 10.1053/j.ajkd.2019.01.024] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
642 MacIsaac RJ, Thomas MC, Panagiotopoulos S, Smith TJ, Hao H, Matthews DG, Jerums G, Burrell LM, Srivastava PM. Association between intrarenal arterial resistance and diastolic dysfunction in type 2 diabetes. Cardiovasc Diabetol 2008;7:15. [PMID: 18500986 DOI: 10.1186/1475-2840-7-15] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
643 Bacharaki D, Diamandopoulos A. Emperor’s syndrome in the COVID-19 era: Time for patient-centered nephrology? World J Nephrol 2021; 10(1): 1-7 [PMID: 33552939 DOI: 10.5527/wjn.v10.i1.1] [Reference Citation Analysis]
644 Decker E, Kendrick J. Research in the CKD clinic: highs and lows. Adv Chronic Kidney Dis 2014;21:344-8. [PMID: 24969385 DOI: 10.1053/j.ackd.2014.02.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
645 Li Y, Hou X, Liu T, Xu S, Huang Z, Xu X, Dong R. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study. Front Cardiovasc Med 2022;9:802181. [DOI: 10.3389/fcvm.2022.802181] [Reference Citation Analysis]
646 Florens N, Calzada C, Lyasko E, Juillard L, Soulage CO. Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins. Toxins (Basel) 2016;8:E376. [PMID: 27999257 DOI: 10.3390/toxins8120376] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 8.3] [Reference Citation Analysis]
647 Ismail MD, Jalalonmuhali M, Azhari Z, Mariapun J, Lee ZV, Zainal Abidin I, Wan Ahmad WA, Zuhdi ASM; NCVD-PCI investigators. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014. BMC Cardiovasc Disord 2018;18:184. [PMID: 30249197 DOI: 10.1186/s12872-018-0919-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
648 Otieno FCF, Ogola EN, Kimando MW, Mutai K. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening. BMC Nephrol 2020;21:73. [PMID: 32111192 DOI: 10.1186/s12882-020-1705-3] [Reference Citation Analysis]
649 Amdur RL, Feldman HI, Gupta J, Yang W, Kanetsky P, Shlipak M, Rahman M, Lash JP, Townsend RR, Ojo A, Roy-Chaudhury A, Go AS, Joffe M, He J, Balakrishnan VS, Kimmel PL, Kusek JW, Raj DS; CRIC Study Investigators. Inflammation and Progression of CKD: The CRIC Study. Clin J Am Soc Nephrol 2016;11:1546-56. [PMID: 27340285 DOI: 10.2215/CJN.13121215] [Cited by in Crossref: 145] [Cited by in F6Publishing: 93] [Article Influence: 24.2] [Reference Citation Analysis]
650 Lai CF, Chen YT, Gu J, Nerbonne JM, Lin CH, Yang KC. Circulating long noncoding RNA DKFZP434I0714 predicts adverse cardiovascular outcomes in patients with end-stage renal disease. Int J Cardiol 2019;277:212-9. [PMID: 30097337 DOI: 10.1016/j.ijcard.2018.08.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
651 Fukami A, Yamagishi S, Adachi H, Matsui T, Yoshikawa K, Ogata K, Kasahara A, Tsukagawa E, Yokoi K, Imaizumi T. High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population. Clin Cardiol 2011;34:189-94. [PMID: 21337348 DOI: 10.1002/clc.20834] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
652 Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD. Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 2008;8:2378-90. [PMID: 18925905 DOI: 10.1111/j.1600-6143.2008.02408.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 53] [Article Influence: 6.2] [Reference Citation Analysis]
653 Bayliss EA, Bhardwaja B, Ross C, Beck A, Lanese DM. Multidisciplinary team care may slow the rate of decline in renal function. Clin J Am Soc Nephrol. 2011;6:704-710. [PMID: 21273376 DOI: 10.2215/cjn.06610810] [Cited by in Crossref: 111] [Cited by in F6Publishing: 58] [Article Influence: 10.1] [Reference Citation Analysis]
654 Afsar B. Microalbuminuria, kidney function, and daily physical activity. Int J Nephrol 2013;2013:248416. [PMID: 24455256 DOI: 10.1155/2013/248416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
655 Batra G, Ghukasyan Lakic T, Lindbäck J, Held C, White HD, Stewart RAH, Koenig W, Cannon CP, Budaj A, Hagström E, Siegbahn A, Wallentin L; STABILITY Investigators. Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome. JAMA Cardiol 2021. [PMID: 34431970 DOI: 10.1001/jamacardio.2021.3079] [Reference Citation Analysis]
656 Chen Y, Zelnick LR, Huber MP, Wang K, Bansal N, Hoofnagle AN, Paranji RK, Heckbert SR, Weiss NS, Go AS, Hsu CY, Feldman HI, Waikar SS, Mehta RC, Srivastava A, Seliger SL, Lash JP, Porter AC, Raj DS, Kestenbaum BR; CRIC Study Investigators. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 2021;78:226-235.e1. [PMID: 33421453 DOI: 10.1053/j.ajkd.2020.12.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
657 Khan MH, Harlan DM. Counterpoint: clinical islet transplantation: not ready for prime time. Diabetes Care 2009;32:1570-4. [PMID: 19638528 DOI: 10.2337/dc09-0611] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
658 Jang HS, Kim J, Padanilam BJ. Renal sympathetic nerve activation via α2-adrenergic receptors in chronic kidney disease progression. Kidney Res Clin Pract 2019;38:6-14. [PMID: 30831675 DOI: 10.23876/j.krcp.18.0143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
659 Shin HS. Number of existing permanent teeth is associated with chronic kidney disease in the elderly Korean population. Korean J Intern Med 2018;33:1150-9. [PMID: 28407463 DOI: 10.3904/kjim.2016.386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
660 Yang YR, Chen YM, Chen SY, Chan CC. Associations between Long-Term Particulate Matter Exposure and Adult Renal Function in the Taipei Metropolis. Environ Health Perspect 2017;125:602-7. [PMID: 27713105 DOI: 10.1289/EHP302] [Cited by in Crossref: 55] [Cited by in F6Publishing: 26] [Article Influence: 9.2] [Reference Citation Analysis]
661 Thompson RH, Ordonez MA, Iasonos A, Secin FP, Guillonneau B, Russo P, Touijer K. Renal cell carcinoma in young and old patients--is there a difference? J Urol. 2008;180:1262-1266; discussion 1266. [PMID: 18707708 DOI: 10.1016/j.juro.2008.06.037] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 4.4] [Reference Citation Analysis]
662 Kaczmarek K, Lemiński A, Gołąb A, Słojewski M. Survival differences of patients with ureteral versus pelvicalyceal tumours: a systematic review and meta-analysis. Arch Med Sci 2021;17:603-12. [PMID: 34025829 DOI: 10.5114/aoms.2019.89893] [Reference Citation Analysis]
663 Wanner C, Oliveira JP, Ortiz A, Mauer M, Germain DP, Linthorst GE, Serra AL, Maródi L, Mignani R, Cianciaruso B, Vujkovac B, Lemay R, Beitner-Johnson D, Waldek S, Warnock DG. Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry. Clin J Am Soc Nephrol 2010;5:2220-8. [PMID: 20813854 DOI: 10.2215/CJN.04340510] [Cited by in Crossref: 86] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
664 Darlington O, Dickerson C, Evans M, McEwan P, Sörstadius E, Sugrue D, van Haalen H, Garcia Sanchez JJ. Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review. Adv Ther 2021;38:994-1010. [PMID: 33432542 DOI: 10.1007/s12325-020-01607-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
665 Smith DH, Thorp ML, Gurwitz JH, McManus DD, Goldberg RJ, Allen LA, Hsu G, Sung SH, Magid DJ, Go AS. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes 2013;6:333-42. [PMID: 23685625 DOI: 10.1161/CIRCOUTCOMES.113.000221] [Cited by in Crossref: 68] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
666 Hashimoto Y, Hamaguchi M, Okamura T, Nakanishi N, Obora A, Kojima T, Fukui M. Metabolic associated fatty liver disease is a risk factor for chronic kidney disease. J Diabetes Investig 2021. [PMID: 34561962 DOI: 10.1111/jdi.13678] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
667 Faour WH, Choaib A, Issa E, Choueiry FE, Shbaklo K, Alhajj M, Sawaya RT, Harhous Z, Alefishat E, Nader M. Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflamm Res 2021. [PMID: 34802072 DOI: 10.1007/s00011-021-01520-8] [Reference Citation Analysis]
668 Duni A, Liakopoulos V, Roumeliotis S, Peschos D, Dounousi E. Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread. Int J Mol Sci 2019;20:E3711. [PMID: 31362427 DOI: 10.3390/ijms20153711] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 17.7] [Reference Citation Analysis]
669 Franceschini N, North KE, Arnett D, Pankow JS, Chung JH, Baird L, Leppert MF, Eckfeldt JH, Boerwinkle E, Gu CC, Lewis CE, Myers RH, Turner ST, Weder A, Kao WH, Mosley TH, Chakravarti A, Kramer H, Zhang J, Hunt SC. The association of cell cycle checkpoint 2 variants and kidney function: findings of the Family Blood Pressure Program and the Atherosclerosis Risk In Communities study. Am J Hypertens 2009;22:552-8. [PMID: 19265784 DOI: 10.1038/ajh.2009.41] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
670 Yang CC, Sung PH, Cheng BC, Li YC, Chen YL, Lee MS, Yip HK. Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: A randomized, open-label, controlled phase II clinical trial. Stem Cells Transl Med. 2020;9:827-838. [PMID: 32297703 DOI: 10.1002/sctm.19-0409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
671 Kong JY, Kim JS, Kang MH, Hwang HS, Won CW, Jeong KH. Renal dysfunction is associated with decline of cognitive function in community-dwelling older adults: Korean frailty and aging cohort study. BMC Geriatr 2020;20:462. [PMID: 33172388 DOI: 10.1186/s12877-020-01862-8] [Reference Citation Analysis]
672 Abdel-Kader K, Jhamb M. EHR-Based Clinical Trials: The Next Generation of Evidence. Clin J Am Soc Nephrol 2020;15:1050-2. [PMID: 32094245 DOI: 10.2215/CJN.11860919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
673 Samir AE, Allegretti AS, Zhu Q, Dhyani M, Anvari A, Sullivan DA, Trottier CA, Dougherty S, Williams WW, Babitt JL, Wenger J, Thadhani RI, Lin HY. Shear wave elastography in chronic kidney disease: a pilot experience in native kidneys. BMC Nephrol. 2015;16:119. [PMID: 26227484 DOI: 10.1186/s12882-015-0120-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 7.4] [Reference Citation Analysis]
674 Chen J, Hamm LL, Mohler ER, Hudaihed A, Arora R, Chen CS, Liu Y, Browne G, Mills KT, Kleinpeter MA, Simon EE, Rifai N, Klag MJ, He J. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease. PLoS One 2015;10:e0132047. [PMID: 26132137 DOI: 10.1371/journal.pone.0132047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
675 Capitanio U, Larcher A, Fallara G, Trevisani F, Porrini E, Di Marco F, Baiamonte G, Re C, Bettiga A, Dell'Antonio G, Doglioni C, De Cobelli F, Bertini R, Salonia A, Montorsi F. Parenchymal biopsy in the management of patients with renal cancer. World J Urol 2021;39:2961-8. [PMID: 33385247 DOI: 10.1007/s00345-020-03572-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
676 Mills KT, Chen J, Yang W, Appel LJ, Kusek JW, Alper A, Delafontaine P, Keane MG, Mohler E, Ojo A, Rahman M, Ricardo AC, Soliman EZ, Steigerwalt S, Townsend R, He J; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease. JAMA 2016;315:2200-10. [PMID: 27218629 DOI: 10.1001/jama.2016.4447] [Cited by in Crossref: 115] [Cited by in F6Publishing: 90] [Article Influence: 19.2] [Reference Citation Analysis]
677 Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults. Clin J Am Soc Nephrol 2015;10:205-14. [PMID: 25605700 DOI: 10.2215/CJN.04910514] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
678 Johns TS, Yee J, Smith-Jules T, Campbell RC, Bauer C. Interdisciplinary care clinics in chronic kidney disease. BMC Nephrol 2015;16:161. [PMID: 26458811 DOI: 10.1186/s12882-015-0158-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
679 Foley RN, Wang C, Snyder JJ, Collins AJ. Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. Clin J Am Soc Nephrol 2009;4:965-72. [PMID: 19339409 DOI: 10.2215/CJN.05281008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
680 Doi K. Role of kidney injury in sepsis. J Intensive Care 2016;4:17. [PMID: 27011788 DOI: 10.1186/s40560-016-0146-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
681 McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Hale RE, Campbell KL. The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial. BMC Nephrol 2012;13:137. [PMID: 23082956 DOI: 10.1186/1471-2369-13-137] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
682 Ichihara N, Miyamura M, Maeda D, Fujisaka T, Fujita SI, Morita H, Takeda Y, Ito T, Sohmiya K, Hoshiga M, Ishizaka N. Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation. J Arrhythm 2017;33:469-74. [PMID: 29021852 DOI: 10.1016/j.joa.2017.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
683 Vaziri ND, Navab M, Fogelman AM. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol 2010;6:287-96. [PMID: 20308998 DOI: 10.1038/nrneph.2010.36] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
684 Rankin AJ, Zhu L, Mangion K, Rutherford E, Gillis KA, Lees JS, Woodward R, Patel RK, Berry C, Roditi G, Mark PB. Global longitudinal strain by feature-tracking cardiovascular magnetic resonance imaging predicts mortality in patients with end-stage kidney disease. Clin Kidney J 2021;14:2187-96. [PMID: 34804519 DOI: 10.1093/ckj/sfab020] [Reference Citation Analysis]
685 Li J, Huang N, Zhong Z, Joe P, Wang D, Ai Z, Wu L, Jiang L, Huang F. Risk factors and outcomes of cardiovascular disease readmission within the first year after dialysis in peritoneal dialysis patients. Ren Fail 2021;43:159-67. [PMID: 33441045 DOI: 10.1080/0886022X.2020.1866009] [Reference Citation Analysis]
686 Chang TI, Chertow GM. GFR estimating equations, CKD prevalence and the public health. J Intern Med 2010;267:354-6. [PMID: 20433581 DOI: 10.1111/j.1365-2796.2009.02172.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
687 Corsonello A, Fabbietti P, Formiga F, Moreno-Gonzalez R, Tap L, Mattace-Raso F, Roller-Wirnsberger R, Wirnsberger G, Ärnlöv J, Carlsson AC, Weingart C, Freiberger E, Kostka T, Guligowska A, Gil P, Martinez SL, Melzer I, Yehoshua I, Lattanzio F; SCOPE investigators. Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance : The screening for CKD among older people across Europe (SCOPE) study. BMC Geriatr 2020;20:350. [PMID: 33008303 DOI: 10.1186/s12877-020-01696-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
688 Jerums G, Panagiotopoulos S, Premaratne E, MacIsaac RJ. Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol 2009;5:397-406. [PMID: 19556994 DOI: 10.1038/nrneph.2009.91] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
689 Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol 2010;14:558-70. [PMID: 20700621 DOI: 10.1007/s10157-010-0328-6] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 5.7] [Reference Citation Analysis]
690 Hailpern SM, Santel F, Mazurek JA, Ramirez S, Remick JD, Klein J, Schubart UK, Nordin C. Hemoglobin A1c less than 6.5% on admission increases risk for in-hospital and 1-year mortality in patients with diabetes and chest pain. Cardiovascular Endocrinology 2014;3:85-91. [DOI: 10.1097/xce.0000000000000033] [Reference Citation Analysis]
691 . References. Kidney International Supplements 2012;2:259-74. [DOI: 10.1038/kisup.2012.30] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
692 Carrero JJ, Trevisan M, Sood MM, Bárány P, Xu H, Evans M, Friberg L, Szummer K. Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project. Clin J Am Soc Nephrol 2018;13:1314-20. [PMID: 30030271 DOI: 10.2215/CJN.04060318] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
693 Neogi T, Ellison RC, Hunt S, Terkeltaub R, Felson DT, Zhang Y. Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. J Rheumatol 2009;36:378-84. [PMID: 19012359 DOI: 10.3899/jrheum.080646] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
694 Ix JH, Katz R, Kestenbaum B, Fried LF, Kramer H, Stehman-Breen C, Shlipak MG. Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol. 2008;19:579-585. [PMID: 18235089 DOI: 10.1681/asn.2007070765] [Cited by in Crossref: 50] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
695 Charoen P, Nitsch D, Engmann J, Shah T, White J, Zabaneh D, Jefferis B, Wannamethee G, Whincup P, Mulick Cassidy A, Gaunt T, Day I, McLachlan S, Price J, Kumari M, Kivimaki M, Brunner E, Langenberg C, Ben-Shlomo Y, Hingorani A, Whittaker J, Pablo Casas J, Dudbridge F; UCLEB Consortium. Mendelian Randomisation study of the influence of eGFR on coronary heart disease. Sci Rep 2016;6:28514. [PMID: 27338949 DOI: 10.1038/srep28514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
696 de Boer IH. Vitamin D and glucose metabolism in chronic kidney disease. Curr Opin Nephrol Hypertens 2008;17:566-72. [PMID: 18941348 DOI: 10.1097/MNH.0b013e32830fe377] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
697 Ali A, Macphee I, Kaski JC, Banerjee D. Cardiac and vascular changes with kidney transplantation. Indian J Nephrol 2016;26:1-9. [PMID: 26937071 DOI: 10.4103/0971-4065.165003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
698 Foster MC, Coresh J, Bonventre JV, Sabbisetti VS, Waikar SS, Mifflin TE, Nelson RG, Grams M, Feldman HI, Vasan RS, Kimmel PL, Hsu CY, Liu KD; CKD Biomarkers Consortium. Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study. Clin J Am Soc Nephrol 2015;10:1956-63. [PMID: 26350438 DOI: 10.2215/CJN.02590315] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
699 Peralta CA, Muntner P, Scherzer R, Judd S, Cushman M, Shlipak MG. A Risk Score to Guide Cystatin C Testing to Detect Occult-Reduced Estimated Glomerular Filtration Rate. Am J Nephrol 2015;42:141-7. [PMID: 26381887 DOI: 10.1159/000439231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
700 Majumder EL, Billings EM, Benton HP, Martin RL, Palermo A, Guijas C, Rinschen MM, Domingo-Almenara X, Montenegro-Burke JR, Tagtow BA, Plumb RS, Siuzdak G. Cognitive analysis of metabolomics data for systems biology. Nat Protoc 2021;16:1376-418. [PMID: 33483720 DOI: 10.1038/s41596-020-00455-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
701 Mahfoud F, Böhm M, Schmieder R, Narkiewicz K, Ewen S, Ruilope L, Schlaich M, Williams B, Fahy M, Mancia G. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry. Eur Heart J 2019;40:3474-82. [PMID: 30907413 DOI: 10.1093/eurheartj/ehz118] [Cited by in Crossref: 74] [Cited by in F6Publishing: 53] [Article Influence: 37.0] [Reference Citation Analysis]
702 Kopić V, Barbić J, Petrović S, Šahinović I, Mihaljević D, Kopić A, Bošnjak A. PERIODONTAL DISEASE IN DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE. Acta Clin Croat 2019;58:709-15. [PMID: 32595256 DOI: 10.20471/acc.2019.58.04.18] [Reference Citation Analysis]